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Abstract
Y^bninobutyrio acid has bssxi shown to bs a major 
inhibitory nsurotransmitter in the central nervous system (CKS)« 
This study is oonoemed with the examination of a number of QABA 
anteigonists in two injjitro^ assay systems.
A series of cage-structured compounds including 
bicyolic phosphate esters (2,6,7f-Trioxa-l-phosphabicyclo (2,2,2,) 
ootan-l-oxides with suitable 4-substituents) have been shown to be 
potent aA'RA antagonists. These compounds do not act directly on 
the postsysnaptio QABA receptor site but probably at the same site 
as another potent QABA antagonist piorotoxinin. It has been shown 
that the substituent group on the bridge-head on the 4-oarbon 
atom in the molecule plays a very important role in the toxic 
potency and GABA antagonistic properties of these compounds. A 
very b u U ^  and branched substituent caused a great increase in 
potency. This property was utilised in the synthesis of a
series of these compoxxnds.
The binling of radiolabelled ligands (both agonists 
yirt antagonists) to synaptic membrane fractions can bo utilised 
as a convenient assay for the study of GABA receptors. Such 
assays tusing frozen--thawed rat brain synaptosomal membranes has 
been demonstrated to be stereospeoifio and saturable using (^)- 
GABA, the potent GABA agonist (^)-muscimol also with GABA 
antagonists using (^)-bicuculline methobromide and (^)-
<vi)
dihydropicrotoxinin, Utilifling these methods a number of 
agonists and antagonists have been examined to evaluate their 
ability to displaoe the stereospeoific binding.
The synthesised QIBA antagonists have also been 
used to evaluate their properties on the depolarising effeot 
of on the rat superior cervical ganglion in comparison to
results obtained by known GABA, antagonists.
The bicyolio phosphate esters were shown to bo very 
toxio when administered to mammals causing seizures and death» 
this effeot being attributed to the emtagonism of Q A M  in the 
CHS. They wore shown to bo potent inhibitors of GABA in the 
superior cervical ganglion. In binding studios with (%)- 
muscimol they did not displaoe any of the bound agonist and also 
were shown not to displaoe bound (^)Hiihydropiorotoxinin. The 
res\ilt8 obtained in this study have been discussed and compared 
with structure-activity relationships to other compounds of 
similar structure.
(vii)
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Introduction^^jf—jiininobutyrio acid (GASA) (Pig»l»l) was first discovsrsd 
in the mammalian central nervous system (CBS) as one of the amino acids 
in mouse hrain extracts (Roberts and Prankeli 1950a). Later these brain 
extracts were shown to have a Factor I which had inhibitory effects on 
the synapses in the crayfish stretch receptor (Bazemore, Elliott and 
florey, 1957). This inhibitory Factor I was found to be GABA. Further 
research on GABA eventually established it as a ma.jor inhibitory 
neurotransmitter (Curtis and Watkins, I960, Em.ievic and Phillis 1963, 
BmjeviS a«d Schwartz 1966, Emjevi’6 197A, Curtis 1975)» Since then a 
great deal of evidence has been accumulated which supports the 
proposal that GABA is a naturally occurin« inhibitory neurotransmitter.
1,2 Evidenc^ ^ ^  support G A B A a neurotransmitter.
To classify a compound as a neurotransmitt or it must ba able
to fill certain criteria:
1.2.L Synthesis
GABA is synthesised by the decarboxylation of glutamic acid 
(Roberts and Prankol 1950b) . This is done via an enzymatic
process involving L-glutamate-1-carboxylase (EC4, 1.1.15) usually 
referred to as glutamate decarboxylase (GAD). Evidence for this has 
been shown with metabolic experiments in which the immediate origin 
of GABA carbon atoms can be traced throu^ the carbon atoms of glutamate 
(Bert 1972). The  ^correlation of GAD apoenzyme levels with GABA content 
in brain areas and cell types has also been shown (Foimum, Storm-Mathisen
and Walberg 1970).
Pig. 1.2. An alternative complete metal)olic pathway from 
putresoine via monoacetyl putrescine and 
N-^cetyl-^-aminohutyric acid to GABA (Baxter 1976)
N H j- ( C H 2 ) , - N H :
putrescine
CH3-  C -  SCoA
acetyl CoA
IT-acetyl transferase
CH3-C-NH-(CHj)*-NH2 + HO2
monoacetyl putrescine
monoatmine oxidase
CH3-C“ NH-(CHj)3-CHO ♦ NH3
F-aoetyl-^-aminohutyraldehyde
aldehyde dehydrogenase
CH3-C-NH-(CHj)3-COOH
IT-acetyl-ir-aminobu,tyric acid
deacetylase
N H 2 - { C H , ) - C 0 0 H
GABA
An alternate pathway from putrescine via monoacetyl 
putrescine and H-acetyl-Y-aminohutyric acid to G A M  has also 
been reported to exist in mouse hrain (Seliev and Al^Therib» 1974 )
(Fig. 1.2).
1.2.2 Storage
There mxxst he evidence showing facilities for the 
storage of the compotind where it can easily he transported or made 
available at the presynaptio nerve terminals.
Fluid left in contact with the hrain sTirface was found 
to contain only traces of GABA indicating that GABA must he stored 
inside the nerve cells (Jasper and Koyama 19^9» Jasperf Khan and 
Elliott 1975).
Experiments performed with radioactively labelled G A M  
showed that half the radioactivity taken up by cortical hrain 
slices was concentrated in the nerve endings which also contained 
most of the GAD activity (Beal and Iversen 1969). When extracts 
of those wore tested directly on cortical cells they produced a 
significant inhibition (Kmjevic and Whittaker 1965). Immuno­
histochemical visualisation of GAD has boon used as an indication 
of the synaptic sites of G A M  synthesis (Wood ot al 1976).
1.2.3 Release
The transmitter must be released when there is 
physiological stimulation, this release must be quantal and 
calcium dependent.
In view of the teohnioal difficulties involved in 
demonstrating in vivo the synaptic release of any transmitter
due to the small amounts releasedi local calcium ion 
concentrations and efficient uptake mechanisms« fev studies 
have heen performed. However« calcium ion induced release 
of endo^nous QA3A. has been demonstrated in_viv^ into the fourth 
ventriole from the surface of the cerebellum and cerebral cortex 
of the cat (Obata and Takeda 1969» Obata 1976).
Studies on the release of OABA. in vitro usin« 
cortical slices or synaptosomes by electrical or chemical 
depolarising stimuli have been shown to be calcium dependent 
(Srinivasen, Heal and Mitchell 1969« De Belleroche and Bradford 
1972). This release is difficult to relate to that occuring 
in vivot except »dien a degeneration of a pathway does or does 
not influence the release in vitro from slices prepared from 
the appropriate region of the CHS (Hadler et al 1977)»
1.2.A Physiological action
The physiological action of the compound must be
the same when it is applied externally.
The proxKJsed aotion of QABA. is that it is a major 
inhibitory neurotransmitter in the CHS« this potent depressant 
effeot on central neurones has been demonstrated (Curtis Mid 
Watkins i960). It is therefore necessary to show a direct 
correlation between the endogenous inhibitory processes and 
those due to the application of GABA.
The inhibitory aotion of OABA was shown on cortical 
neurones (RandiS* and Straugb(Wl966« Kmjevic and Phillis 1963).
OABA was shown to cause a marked increase in membrane
conductance with a hyperpo lari sing action with the evoked 
inhibitory postsynaptic potentials and the effects of GABA, 
being reversed with the depolarisation caused by the injection 
of chloride ions into the neurones. GABA itself was shown to 
have no effect viien injected intracellularly, indicating that it 
probably acts on receptors on the surface of the cells.
Most neurones in the CHS are sensitive to the 
inhibitory effects of GABA (C\artis, Phillis and Watkins 1959i 
Kmjevio 1970). The mechanism of this action is a pronounced 
increase in chloride ion permeability (Ten Bruggencate and 
Engeberg 1971i Curtis et al 1963).
Ifader in vitro conditions GABA binds in a sodium- 
independent fashion to synaptic membranes of mammalian brain at 
sites which can be distinguished with substrate specificity from 
those associated with the sodium-dependeiit membrane transport of 
GABA and related amino acids (De Peudis 1977i Olson et al. 1973).
Therefore since GABA is found in all parts of the CHS 
it is likely to be one of the major inhibitory nourotransmittors 
(&njevi^ 1974).
1,2.5. Uptake and Inactivation
Some mechanism or mechanisms must exist in order to 
inactivate the action of the compo\and and or remove it from the 
nex^ synapse.
Uptake of GABA was shown in cerebral cortex slices 
(Elliott axxl Van Gelder 1958) which could remove GABA rapidly from 
the medium in idiioh they were soaked. This GABA was held in 
occluded form sjid was capable of being released by stimulation.
This showed GABA removal wats by active upteike into the
surrounding cells rather than by metabolic conversion. This
%
was by diffusion auid a carrier-mediated cellular uptadce into 
neurones* terminals and ^lial cells (Martin 1976).
Both low and hi^-affinity transport mechanisms 
have been described: the former may be more significant when 
subsynaptic concentrations of GABA are relatively h i ^
Immediately after synaptic release* whereas the latter is more 
important for maintaining very low extracellular concentrations 
of GABA.
The hi^-affinity uptake into the cells was shown to 
be an active process which was sodivun dependent (Varon* Weinstein* 
Baxter and Roberts 1963* Bennett* Logan and Snyder 1972) and did 
not involve the metabolic conversion of GABA into an inactive
I
substance extracellularly. Uptake into glial cells was shown 
to be a very important factor in GABA uptake (Henn and Hamberger 
1971* ShrieD^and Thompson 1974).
The primary degredative pathway of GABA metabolism is 
transamination catalysed by a specific enzyme* A-^unino— 
but3rrate : 2-o:^glutarate aminotransferatse (EC 2.6.1.19.) commonly 
known as GABA-T (Roberts and Bregoff 1953). The products of this 
reaction aire succinic semialdehyde and glutaunate* these are then 
rapidly converted to suooinate by a reaction catalysed by the 
enzyme SSA-BAD'*'-oxldoreductase (EC 1.2.1.16)* commonly known as 
succinic semialdehyde dehydrogenaise (SSA-D) (Albers and Salvador 
1938). This pathway is dependent on the availability of
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Fig. 1.3* synthesis and degredation of GABA, in*
relation to the Krebs cycle
Glucose
Pyruvic acid 
Acetyl Co A
Oxal(»cetic acid-------
Malic aci d 
Fumarie acid
t
Succinic acid-^----------
\
Succinic semialdehyde,
GABA”T
Co A
Citric acid
-HjO
Isocitric acid 
-Oxyglutaric add
Glutamic acid
GAD
GABA
:0j
tricarboxylic cycle (Kreb’s cycle) intermediate a-oxyglutarate.
The succinate is returned to the tricarboxylic cycle (Fi^. l-.3^ )
As with GADy GABA-T and SSA-D are found in most parts of the 
brain in conjimction with the presence of GABA (Salvador and .
Albers 1959).
' 1.2.6. Antagonism
Pharmacological agents which antagonise the action 
of the transmitter shotild have the same effect when the compound 
is applied directly.
There are several limitations involved with the 
evaluation of the pharmacological effects of systemically 
administered antsigonists. These are: metabolism of the drugt 
the blood-43rain barriery selectivity for the site and peripheral 
effects. Also aqueous solubility is an important factor involved 
with the study of potential GABA antagonists.
(+)-Bicuculline (Pig.2.4 ) and picrotoxinin (Pig,2r.2) 
block botli the hvperpplarising effect of GABA on neurones and the 
depolarisation of primal afferent terminals (Curtis and Johnston 
1974t Curtis 1978).
Local administration of piorotoxiny a mixture of- 
picrotin and'picrotoxinin by electro-osmosis was found to antagonise 
GABA inhibition of rabbit occTxlomotor neurones (Obata and Hi^stein 
1970). Picrotoxinin has also been shown to interfere with GABA- 
activated ionophores (Olsen 1976).
Binding studies suggest that (•l•)-bicuc^ ú.line may be 
a competitive antagonist at the GABA receptors (Zukiny Toung and 
Snyder 1974? NBhler and Okada 1977).
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Numerous oompoimds with a oaged structure (Fig. 2.1) 
such as tetramarthylamine disulphotetramlne (TETS), sllatranesf 
hicyclophosphate esters (R-(CH20)^ P « 0)y and bicyclocarhoxylate 
ortho esters (R<-(CH20)^ -C -R*)» cause tonic-olonic convulsions 
and death in hij^er animals in a manner similar to picrotozinin 
and (•t-)^icuculline (Caslda et al. 1976y Cooper et al. 197^)*
These substances also inhibit G A M  postsTnaptio responses (Bowery 
et al. 1976y Bowery et al. 1977) &nd have other actions resembling 
G A M  aintagonistsy such as the elevation of cerebellar cyclic GNP 
(Mattson et al. 1976). The actions of the cage convulsants can 
also be reversed by barbiturates (Bowery and Dray 1976y Casida 
et al. 1976).
The oagr convulsantsy especially the bicyclophosphate 
esters will be dealt with and discussed in more detail later.
1,3 Mechanism of G A M  Action 
1.3 .1 Postsvnaptic inhibition
The iziitial effect of an excitatory transmitter is a 
sub-threshold change in the potential of the cell membrane brou^t 
about by a change in the sodium ion permeabilityy this is an 
excitatory post synaptic potential (EPSP). These EPSP*s summate 
to initiate the action potential idiich is self generating 
(McLennan 1970).
In the case of inhibitory transmission a transient 
hyperpolarisation of the mwnbrane is causedy this is the 
inhibitory postssmaptio potential (IPSP). Ibese IPSP's counteract 
the EPSP's by lowering the excitability of the membrane and so 
reducing the change of an action potential. Tbls h3rperpo lari sat ion
11
is broia^t about by an increase in the membrane permeability 
causing an imrard flux of chloride ions (Obata, Takeda and 
Shinozaki 1970» Kmjevio and Phillis 1963? Ten Bru^gencate auid 
Engeberg 1971? Obata, Ito» Ochi and Sato»1967).
1.3.2 Presyoaptic inhibition
OASA can act on presynaptic fibres to cause a decrease 
in the output of excitatory tramsmitter. This action cam be 
antaigonised in a similair famhion in the spinal cord to those 
atctions in postsynaptic inhibition (Curtis et al. 1971? Davidoff 1972).
GABA, appeams to act presynaptically in the spinal cord 
and postsynaptically in the brain (Fadm 1976» Otsuka and Kbnishi
1976).
1*3.3 Excitatory effects of GABA.
On peripheral ganglion cells and their axons GABA has 
been shown to cause depolamjLsation.
This has been demonstrated in vitro on the rat superior • 
cervical gainglion both intracellularly (Adams and Brown 1973) and 
extracelliilarly (Bowery amd Brown 1976). This will bo described 
in more detail later.
In vivo observations have also been mauie on several 
ganglia in the oat and rabbit» recording potential changes» as 
a depolairisation» while applying GABA intravenously or 
intia-arterially (de Groat 1970» de Groat» Lalley and Block 1971? 
de Groat 1972? de Groat» Lalley and Saum 1972). In both the 
in vivo amd the in vitro experiments the results of the aigonists 
and amtaigonist paralleled those found in the CNS.
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The probable ionic mechanism of this depolarisation 
is an increase in the chloride ion permeability of the membrane 
(Obata 1976)• This increase is in the opposite direction to the 
chan^ brou^t about in the CHS. Therefore the action of GABA 
in both the peripheral and central nervous systems is to change 
the chloride ion permeability of the cell membranes.
1.4. QATU action in invertebrates
GABA has been shown to be a potent inhibitory 
transmitter in the neuromuscular jtmctions of some invertebrates. 
The crayfish stretch receptor neurones were inhibited by GABA
an inciTease in chloride ion permeability of the membrane 
(Tackeuohi Tackeuchi 19^5» Tackeuchi 1976). It was also shown 
that GABA decreases membrane resistance of crayfish synapses in 
the ventral cord of the crayfish (Purshpan and Potter 1959).
Particulate fractions of homogenised crustacean muscleI
were foxind to bind radioactive GABA and the binding sites having 
properties consistent with those expected of synaptic receptor 
sites (Olsen, Lee and Ban 1975)*
lontophoretic methods also showed that GABA stimulated 
the chloride ion permeability of the membrane in the crayfish 
muscle (Ticku and Olsen 1977). This would appear to be the same 
mechanism in mammalian CHS, by increasing the chloride ion 
permeability of the membrane.
1.5, Regional variation of GABA concentrations in the CHS 
1.5.1 Cerebral cortex
Inhibition by GABA in the cerebral cortex was shown
13
as the stellate cell inhibition of the pyramidal cells 
(Dreifussy Kelly and &njevic 1979)•
Usin^ immunocytochemical techniques to label GAD 
inhibition by GABA was observed in somatay proximal dendrites 
and axon terminals of nonpyramidal neurones in the rat visual 
cortex including the immediate subjacent vdiite matter (Ribak 
1978). Terminals formed symmetric synaptic junctions with 
dendritic shafts and somata of pyramidal and stellate neiironesy 
(Roberta 1978).
1.3*2 Cerebellum
Basket cells lyin^ close to the Purkinje cell layer 
can inhibit them by clixstering their terminals around the axons 
of the Purkinje cells (Otsuka et al. 1971)*
There is also inhibition of granule cells in the Golgi 
cell re^ons and it would appear that only granule cells caTise 
inhibition non-GABAergloally.
1.5.3 Hippocampus
Pericellular baskets around psrramidal and granule cell ' 
somata were shown immunohistochemically to have GAD present and 
hence these were assumed to be inhibitory with GABAergic terminaXs 
(Ribak et al. 1978). Ibere is again GABAergic inhibition of 
pyramidal cells by basket cells (Ben-Ariy Kanazawa and Sigmond 1976), 
1.5*^ Basal Ganglia
Some of the highest levels of GABA are found in the 
globus pallidus and substantia nigray therefore GABA pathways 
' are probably associated with extrapyramidal function (Feltz 1971).
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Immunohlstochemical techniques confirmed the 
abundance of QAD in both axodendritic auid axosomatic synapses 
in the substantia nigra (Roberts (1978). In the globus pallidus 
the medium sized neurones appeared also to be OAMergiC' (Rlbak 1978).
1 .5.5 Olfactory b\ilb
The greatest conoentration of OAMergic neurones was 
in the exterxial plexiform layer in the glomeruli of the glomerula 
layer (Ribcdc et al. 1977)« The granule and periglomerular cells 
inhibited the mitral cells (Graham 1973)«
1.5.6 Retina
TKerc. is ' 'daoA' QABA iS a  tsnrvSfvu
(Real 1976). GAB-positive terminals were also 
XX>stsynaptic to bipolau? cells and sometimes observed to form ~ 
reciprocal synapses with bipolar terminals (Roberts 1978).
1 .5.7 Spinal cord
GAMergio synaptic terminals were presynaptic to large 
and small dendrites motoneuron somata in the motor nuclei.
In addition small GAD terminals were presynaptic to larger axonal 
terminals whioh were in turn presynaptio to motonetiron somata. 
Tnmti^rir>]vi lT^ n^nyu^ ln^  tsohniques to localiB® GAD also showed that
it was present in terminals presynaptio to dendrites and cell 
bodies in both dorsal and ventral horns, this evidence is compatible 
with evidenoe desoribed earlier that GABA mediates postsynaptio 
inhibition of spinal intemeurones and motome\irones (Roberts 1978).
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1.5»5 Other areas
GABA, has heen foiuid in abundemce in all areas of 
grey matter emd is therefore probably the major inhibitory 
neurotransmitter in the mammalian neiuraaxis.
1.6 Stereochemistry of GABA 
Pig. 2.1
H M H o
GABAHJI-C-C— C— C. .« 1  I I oH H H
The above figure shows Y-aminobutyric acid to be a 
simple achiral molecule ^ich exists as a zwitterion in neutral 
conditions. The molecule allows free rotation about all the 
bonds and has three prochiral centres at <»rbon atoms 2» 3 and 4. 
These factors can contribute to the shape of the molecule and 
it would probably be in one specific conformation when it comes 
into contact with the recognition site on the receptor.
Sufficient evidence suggests that a GABA—iono|diore complex 
exists on the stirface of excitable membranes and when GABA 
attaches itself to these sites anion channels are opened. There 
may be several steps in this process involved with the increase 
in chloride ion conductance (Enna and Snyder 1973 f ^  Feudis 1977).
The receptor also shows no affinity towards some antagonist 
suggesting that they do not all react with the receptor site 
itself but at some place away from the GABA recognition site at 
th* ionophore complex.
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Fig* 1»4* Relative potencies of some amino acids as
depolarising agents on rat superior cervical ganglion an 
as displacing agents of (^)-GABA binding in CBS tissue.
Compound
0 A M
Structure 1C50
Binding
0.34*
Relative
Potency
Cervical
Ganglia
1.0^
Y-amino-^- 
hydroxy- 
butyric acid
muscimol
0-N
5.1
isoguvacine 1.4* 0.23
3-€unino- 
proi)ane
sulphonic acid
H 3N 3.4 X
* &ogagaard-Larsen (197^) 
t Bowery et al
X Bowery and Brown (19?4
#  Olsen et al (1979,
** Enna and Snyder (1977,
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Fig. 1.3 Semi-rigid 0 A M  agonists
G A M
HjN
trans^-aminocrotonic acid
cis-d-aminocrotonic acid
QAMf ciSf trans-«minocrotonic acid all reduce the
firing rate of spiral intemexirones hut only 0 A M  and
the transisomer are antagonised by bicuculline methochloride.
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Pig. 1.6. Some structurally-related inhibitors of 
C|/)BA • uptake
(THIP) (ACHC)
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Fig. 1.7* Comi}0\azid structures which impair GABA synthesis.
 ^C- »
Y^CETTIMIC GABA
t 1
(ii) Substrate competitor
3-MERCAFTOFSOPIOHIC ACtD
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1.7 I>nag8 which affect the actions of QABA 
1.7.1 Q A M  Mimetics
The Q A M  molecTile has considerable flexibility 
as a result of free rotation around the single bonds as shown 
previously. This conformational mobility can be reduced by 
analogues of Q A M  by the incorporation of unsaturation, ring 
structures or both into the basic transmitter molecule. Such 
restrictions can result in compounds having more selective 
actions than that of the transmitter itself, or having little 
or no action on G A M  processes.
It is also possible to investigate the effect of 
non-rigid, straight chain analogues of Q A M  but often these 
molecules with shorter or longer chains wore only very weakly 
active or not active at all - on the depolarisation action on 
the isolated rat superior cervical ganglion (Bowery and Brown, 
1974). Only 3-€uninopropane sulphonic acid and P-4iydroxy Q A M  
(Pig.l.A) were significantly active. S^inopropane sulphonic 
acid A* approximately three times as active as Q A M  as it is not 
taken up by the neuronal transx>ort S3rstem, 3-hydroxy G A M  is 
taken up by the neuronal transport system and has approximately 
four times less the potency of GAM.
Trans-, and cis-4-aminocrotonic acid (Pig. 1 .5) are both 
double bond analogues of G A M  and depress the firing rate of 
spinal intemeurones induced by GAM, but only the aotion of the 
trans-isomer is reduced by bicucixlline methochloride (Jchnston 
et al. 1973» Johnston 1976). Cis-4-eminocrotonlo acid is an
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&x)Alogpi6 of GABA in & foldod conform&'tlon» Various analoA^ss 
of trans^-ominocrotonio acid have been synthesised and tested 
with some success in the selectivity on GABA binding and uptake 
(Allan and Twiohin 1978), These findings supported the concept 
that extended conformations of GABA were important with respect 
to the bicuculline sensitive post synaptic receptors and h i ^ — 
affinity uptake and the proposal that folded conformations of 
GABA may interact with bicuculline-insensitive receptors 
(Johnston 1976, Johnston 1978).
Among cyclic amino carboxylic acid* the structure of 
isoguvacine • (Pig. l.d) seems optimal for.the-.aibtivation of GABA. t .
receptors (Krogsgaard-Larsen et al. 1977). Ibcperiments for
«* *potencies of isoguvacine on the GABA receptor using iontophoretic 
techniq\ies show that it was 2-^  times more potent cm agonist than 
GABA itself (Curtis et al. 1971b). But these results differ 
from those obtained using the isolated superior cervical ganglion 
of the rat which showed it to have a potency of 0.23 times that of 
GABA (Bowery et al. 1978).
Howsver guvacine (Pig.1.6) is inactive at the GABA 
receptor but is a potent inhibitor of neuronal uptake (Curtis 
et al. 1971)* The conformations adopted by GABA are folded for 
neuronal uptake and extended for the GABA receptors.
Cis->3-«mino-cyclohexaneoarbo37llc acid (ACHC) (Pig. 1.6) 
appears to be a selective inhibitor of the uptadce of GABA in the 
nerve terminal but has very little activity on the uptake in 
glial cells, but little affinity for GABA transaminase (Beal and
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Bowery 19771 Bowery et al. 19761)). ACHC has a flexible 
cyclohexane ring and can therefore exist in n\amerous 
conformât ions f the extremes being where the substituents are 
diaxial and diequilateral (the two different chait forms of 
the same ring). The diaxial conformation involves nn*.-ritmim 
interaotion between oppositely charged groups and would therefore 
hold the molecule in this conformation. In aqueous solution 
however this does not happen (Hewgill and Jeffries 1955). The 
diaxial conformation being equivalent to folded GABA the 
diequilateral conformation being eq\iivalent to extended GABA. 
Since it does not act at the GABA receptor as a specific agonist 
(Bowery et al 1976b) it is assumed that the flexibility of the 
ring does not permit interaction at the GABA receptor site.
Another relatively potent blocker of GABA uptake is 
nii>ecotic acid (piperidine-3-carboxylic acid Pig. 1.6) (Johnston 
et al.. 1976). In aqueous solution and in the solid statet 
nipecotic acid exists in the chair formation with the carboxyl 
group in an equatorial position. This conformation corresponds 
to GABA in its folded form (Ki^gsgaard-Larsen and Johnston 1975).
Huscimol (3-bydro3y-5*'^inomethylisoxazole) (Pig.l.d) 
is a cyclic, conformationally restricted analogue of GABA (Brehm 
et al. 1972). It is a very potent and selective GABA receptor 
agonist (Johnston et al. I968, Curtis et al. 1971a) being also 
a weak inhibitor of uptake into rat brain slices (Johnston 1971) 
and cultured astrocyte cells (Schousboe et al. 197B). The
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3-isoazolol moiety acts as a masked cau:*l)Oxyl group and 
restricts conformation (Johnston et al. 1968) and there is 
relatively free rotation of the aliphatic side chain of 
muscimol. Muscimol is not a substrate for or an inhibitor of 
OAM-transaminase, (Johnston et al. 1978). The properties 
and actions of muscimol will be dealt with in more detail later.
3-(p-ohloro)phenyl-GAM (Baclofen, Lioresal) 
has been reported to have an inhibitory action on the nervous 
system related to GABA, agonism, with GABA-like actions on cat 
motomeurones (Puil et al. 1976), weak GABA-like activity on 
the crayfish muscle, it inhibits specific GABA binding to mouse 
brain receptor sites and shows a weak inhibition of GABA upta;ce 
(Olsen et al. 1978c). However other studies show that it does 
not involve GABA receptors (Curtis et al. 197^c, Naik et al. 1976).
The bicyclic isoxazole, THIP (4,5,6,7-tetrahydro- 
isozazole (5t5‘^ )  pyridin-3*^1) an almost rigid muscimol auutlogue 
(Pig.1.6) is a less toxic compound than mTiscimol in vivo in mice 
and is not susceptible to metabolism (Krogsgaard-Larsen et al.
1978). TEEP can penetrate the brain easily after systemic injection 
and in general the effects of THIP are slightly weaker than, but 
qualitatively similar to, those observed with muscimol (Scheel- 
KrlJger et al. 1978).
Other methods of affecting GABA actions are possibly by 
stimulation of the calcium ion induced release of GABA. Althou^ 
benzodiazepines (e.g. diazepam) stimulate GABA action 
by inhibiting GABA transport into nerve and glial cells and by
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stimulation of release of GABA from cello but this action 
is not by a calcium ion dependent secretory mechanism but 
by reversal of the GABA pump (Olsen and Ticku 1977).
Also it would bo possible to influence GABA 
release by stimulation of GABA synthesis or precursors 
but precursor availability is apparently not critical to 
GAD activity and there are no examples of these typos 
(Tapia 1975).
l'T.2 Summary of the structure-activity requirements of GABA agonists.
The compound equivalent to GABA in a fully extended 
conformation tend to be agonists at the GABA recognition site 
whereas the compoiands which are in a folded conformation tend 
to be blockers of the neuronal and glial uptake of GABA. This 
suggests that GABA acts at its receptor in the extended 
conformation.
Binding studies with (^)-GABA in the presence of 
a number of substituted GABA analogues would appear to confirm 
this theory (iversen emd Suckling 1979).
A chiral aspect of the interaction cannot be
%
excluded. Muscimol (Pig. 1.4)Buid 4-aminocrotonic acid (Pig. i.5) 
are both very potent agonists and both pessess the hydrogen 
atoms of the prochiral assembly at carbon-4 may be involved.
Also in both these compounds the carbon^ atom has complete 
ft^e rotation.
Isoguvaoine (Pig.l.6)and isonipecotic acid (Pig.1.6) 
also possess the two hydrogen atoms at the appropriate carbon
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atom but since it is part of a ring this carbon atom does 
not have the seune degree of freedom of movement, making 
these compounds weaker agonists. The rin^ system of the 
muscimol however does not appear to interfere with the 
interaction of the molecule with the GABA-recognition site.
1.7.3 GABA "Inhibitors"
Drugs which act on GABA-mediated inhibition in 
the mammalian CBS cause convulsions duo to a subse<iuent 
decrease in GABA levels. The wa3rs in which this inhibition 
is produced can be categorised into three major different 
groups:
a) Drugs which impair the synthesis of GABA.
b) Drugs which block synaptic GABA release.
c) Drugs which impair the neurological inhibitory actions 
of GABA.
1) Drugs which impair the synthesis of GABA,
i. GAD (EC d.1.1.15^ inhibitors
DL-allylglycine (2-amino pent-4-enoic acid)
(Pig. 1.7 )produces irreversible inhibition of cerebral GAD 
in vivo (Horton and Meldrum 1973)., In vitro, both D- and L- 
allylglyoine are only weakly active as GAD inhibitors however 
(Orlowski et al. 1977).
2-Trifluomethylglutamic acid (Pig.l.7)also inhibits 
GAD in chick embryo brain in a specific way to cause a decrease 
in endogenous GABA levels (Raxido 1978).
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Y-Vinyl G A M  (4-aminohex-5-«noic acid) (Pig. Itj) 
inhibits GAD in vitro irreversibly (Metealf et al. I978) and 
that Y-acetylenic acid (4-eminohex-5-ynoic acid (Pig. 1.7) 
also causes an irreversible inactivation of G A M  in vitro 
(Jung et al. I978). 
ii« Substrate oompetition
The administration of 3Hnercaptopropionlc acid 
(Pig.l.'^ to rats causes convulsions preceded by a decrease 
in G A M  levels and GAD activity (Karlsson et al. 1974). This 
is due to enzytratic conversion to a Koto compound and 
competition with glutamate. When administered systomically 
seizures in rodents and baboons are also observed (Horton 
and Meldrum 1973)•
Antivitamin agents such as pyridoxines (e.g. 
mothoxypyridoxine)and other carbonyl trapping agents decrease 
G A M  levels in the brain and administration of these compounds 
causes generalised seizures in animals (Killam et al. I960, 
Purpuraet al. i960). The cause of the seizures is thought 
to be due to these compounds being GAD substrate competitors 
(Meldrum 1975)»
2. Drugs which affect the synaptic release of GABA
Tetanus toxin acts presynaptically to reduce the 
physiologically-induced release of G A M  (Curtis et al. 1973, 
Osborne and Bradford 1973? Davies and Tongroaoh 1977). Fboal
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injection of tetanus toxin into the ventral hippocampus 
induces generalised seizures in the rat comparahle to those 
seen after STstemic administration of larger quantities of 
the toxin (Mellanhy et al, I977).
3* Drugs which antagonise the neuronal inhibitory e ffe c t a or cia-ra 
The actions of OABA. can also he antagonised post- 
syckaptically by several different types of compoTjnds, The modes 
®®^iou of these compounds will be discussed in greater 
detail in the next chapter.
The phthalide isocruinoline alkaloids
These alkaloids occur naturally in plants of the 
botanical families Papaveraceae and Pumariaceae, For example 
(+) --^icuoulline is found in Corvdalis scoulerii and Aldumia 
fungosa (Manske 1933),
(+)-Bicuculline (Fig,2,4)was shown to have a potent 
convulsant activity in both vertebrates (Welch and Henderson 
1934a) and invertebrates (Olsen 1976), It also inhibits 
acetylcholinesterase (Svennby and Roberts 1973) and potentiates 
acetylcholine action (Miller and McLennan 1974),
The demonstration of its antagonism by OABA was first 
observed by Curtis et al, (1971 ). (+)-Bicuculline is only 
sparingly soluble in water and is hydrolysed to a less active 
derivative, hydroxy acid bicucine (Fig,2,5> (Welch and 
Henderson 1934b), Quaternary methohalide salts, however, are 
more aqueous soluble and are also potent selective OABA 
antaigonista : (Johnson et al, 1972),
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Another active phthalmsoquinaline alkaloid 
idiich was active when tested cn feline spinal intemeurones 
was ccrlxanine hTdrochloride (Pigf. 2.4). This has the same 
configfuration is hicucTilline and its quaternary methohalide 
salts, (IS, 9R) about the bond. (F±g. 2.d) (Albers
and O ’Brady 1959, Johnston 1976). In addition bicucine 
methyl ester (Fi^. 2 * 4 ) also active as a GABA anta^nist 
(Jasper and Koyiama 1969? Johnston 1976)'. ' ^
ii. Picrotoxin
Piorotoxin is a dru^ r obtained from the seeds of 
the plants Anamirta paniculata and Anamarita cocotilus 
and consists of a molar ratio of 1:1 of two compounds, 
piorotin and picrotoxinin. Picrotoxinin (Piq. 2.2) is 
the active constituent euid is about fifty times more potent a 
convulsant than picrotin (Jarboe et al. 1968). (Pig. 2.2).
Piorotoxinin is not very soluble in water but 
techniques using electro-osmosis showed that it successfully 
blocked vestibular inhibition and GABA action of rab'^ it oculomotor 
neurones (Obata and Highstein 1970) and the blockade of the 
actions of GABA and not glycine was also observed in the feline 
cuneate nucleus (Galindo 1969)* In Crustacea, picrotoxin 
also blocks the actions of GABA (Florey 1937)*
a-Bil^rcLropicrotoxinin (Pig.2.3),a reduced form of 
picrotoxinin, is sll^tly less active as a convulsfluxt than 
piorotoxinin (Jarboe et al. 1968), but it it possible to label 
this with (^) relatively easily by using tritiated hydrogen to
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reduce unlabelled picrotoxinin to form (^)-a-dihydro- 
picrotoxinin which could then be used in binding studies to 
elucidate more about the modes of actions of this dru^.
This will be discussed fully later.
Other analogues of picrotoxin have been examined 
for their ability to block the actions of OABA but despite 
the fact that tut in (Fig,2,2) and ahikimin are more aqueoxis 
soluble their actions appear to be less specific on OABAergic 
sytrbems (Curtis et al. 1973b).
iii. Caged convulsants
Several compounds with a ceigsd structure (Pig,2.l), 
such as bicycloijhosphato esters (R-CCHgO)^ P ■ O), 
bicyclocarboxylate ortho esters (R-CCHgO)^ C -R*)» silatranes 
(R-CCHgO)^ Si-R), and bicyclophosphite esters (R-(CH20)^ -P), 
tetramethylene disulphotetraminsy cause tonic-clonic convulsions 
axid death in higher animals in a manner similar to picrotoxinin' 
and biouculline (Casida et al. 1976). These substances have 
been shown to inhibit OABA postsynaptic responses (Bowery et al.
1977) and have other actions resembling OABA antagonistsy such 
as elevation of cyclic ONP in cerebellum (Mattson et al. 1976). 
These aotions are also reversed by barbiturates (Bowery and 
JiTBj 1976y Casida et al. 1976). 
a) Bicyclio phosphate esters
4-Alkyl-2y6y7 trioxa-1-phosphabicyclo (2y2y2) 
octan-l-ones were shown to be hi^ly toxic in mice and produced 
tonic-olonlo seizures and consequent death (Bellet and Casida 1973).
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not ftct &8 cholino8t6z*&86 inhil)ltor8 or c&u86 
•xc888iv8 paraoympathetic 8timulation (Bellet and Ca8ida 1973, 
Kinmerle et al. 1976)» They increase cyclic i^uanosine 
3*5’-phosphate levels in rat cerebellum due tc a primary 
action on the inhibitory GABA, mechanisms with no effect on 
cyclic adeziosine monophosphate. (Mattson et al. 1977).
The A'^thyl homologue is the toxic principle in 
the smoke produced by burning a fire retardent polyurethane 
foam based on a trimethylopropeme initiated short chain 
polyol and a phosphate flame retardant (Petajan et al. 1975).
The convulsions %rere found to be d\ie to antagonism 
of the actions of synaptically released GABA (Bowery et al.
1976a, Bowery et al. 1977) by examination of the superior 
cervical ganglion of the rat.
With decerebrated frogs, the injection of a 
bicyclic phosphate ester directly into the brain cavity produced 
seizures which could be abrogated by pithing the remainder of 
the brain (Casida et al. 1976). Cockroaches injected with
doses showed an increase in spike frequency of the abdominal 
nerve cord and the crayfish isolated aibdomlnal nerve cord 
showed an increase in spike activity althou^ high doses were 
needed and this prex>atration was relatively insensitive to 
these compounds.
The potency of the bicyolic phosphate esters requires 
a symmetrical cage, h i ^  electron density at the l-position and 
a suitable hydrophobic A-substituent (Casida et al. 1976,
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Coox>«r et al» 1978). The most impox*tant feature being a 
Suitable hydrophobie 4-eubstituent (Eto et al. 1976). The 
mechanism of action and role of these substituents in the 
bicyclic phosphate esters will be discussed in more detail later.
b) BicTclio phosphite esters
4-Alkyl 2,6,7-trioxa-l-phosphabicyclo (2,2*2) 
ocanes (P-(0CH2)^'^'^) (Pig. 2’. 1 )were shown to have essentially 
the same potencies for the corresponding 4~alkyl substituent 
as the bioyclic phosphate esters when tested on intra­
peritoneal injection. In mice, however, they were less stable 
in aqueotis solution (Wadsworth »rui Emmons 1962) so the 
bicyclic phosphate esters have been concentrated on as the 
bicyclic phosphite esters probably have exactly-the same 
pharmacological properties (Cooper et al. 1978).
c) Bioyolocarboxvlate ortho esters
1-eubstituted-4-eubstituted-2,6,7- triozabicyclo
(2,2,2) octanes of the tyi>e (R-C(0CH2)^-C-R* ) where the 
phosphorous atom is replaced by carbon in the bicyclic system 
always yields compounds of greatly reduced toxicity. However, 
if the optimal siibstituents are added (i.e. R « H, R* « t-C.H ) 
a relatively h i ^  toxicity is found showing that the overall 
configuration in the cage is most important to the toxic and 
aiBA antagonistic properties (Casida et al. 1976). Toxioity 
was greatly reduced with large alkyl or aromatic substituents 
on either R* or R ends of the molecule (Milbraith et al. 1979).
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d) Silatranea
The l-(aryl or alkyl)-2,8,9-trioxa-5-aza-l- 
silabioTClo (3»3t3) undecanee . or silatranes (Piff.2.l)have 
been shown to have toxic effects producing tonic-clonic 
convulsions similar to those produced by bicucidline and 
picrotoxinin when injected intraperitoneally in mice but 
had little effect on frogs (Voronkov I966).
In sublethal doses they act as a powerful analeptic 
and do not cause convulsions in animals with damaged central 
nervous systems, they also have no effect on the Inhibition of 
acetylcholinesterase and cholinesterase (Voronkov and Lukevios 
1969f Voronkov et al. 1977).
Silatranes elevate the cyclic gnanosine 3'^'- ‘ 
phosphate levels in rat cerebellum (cf. other OABA inhibitors) 
(Milbraith et al. 1979). However the phenobarbital-induoed 
sleeping time in rats is prolonged unlike the other QABA. 
inhibitors (Hattsson et al. 1977b).
The commercially available rodent poison 
p-chlorophenyl silatrane (l-(— chlorophenyl) -2,3,9-trioxa-5- 
aza-l-eilabicyclo (3»3?3) ‘undeoane) Produced by N and T Chemicals 
Inc. Rothway, H.J.) is equipotent with similar symptoms to 
those of the other QABA inhibitors after intraperitoneal 
injection in mice but was shown to be inactive on the isolated 
mouse diaphragm preparation on which it failed to cause the 
rapid twitching at low doses zioted for ther other OABA inhibitors 
discussed previously (Casida et al. 1976).
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Althou^ the caged structure, similar charge 
distribution and size of the molecule are similar to the 
other cage convulsants the silatranes show some difference 
in pharmacological properties,
e) Tetramethylenedisulphotetramine (TETS)
lETS, ( 2,6-0ithia-l, 3»517-tetraza-tricyclo
3 7(3.3.1.1. ’ ) decane-2,2,6,6-tetraoxide) (Pig. 2.1>ia8 been
shown to antagonise the actions of OABi in the isolated rat 
superior cervical ganglion (Bowery et al. 1975). It 
antagonises the actions of QABA on the rat cuneate nucleus, 
midbrain reticular formation and medulla (Collins et al. 1975,
Dray 1975). This is a very toxic compound in mice lAen injected 
intraperitoneally and the effects au?e again reversed by 
barbiturates (Casida et al. 1976), and idien administered 
systemically it antagonised prolonged spinal inhibition 
(Curtis and Johnston 1976b).
It has been commercially available as a poison 
(Produced by the Pish and Wildlife Service, Dhited States 
Department of the Interior, Denver, Colorado).
When tested by injection into the brain cavity of 
decrerebrated frogs seizures were produced in the same dose 
and in the same way as isopropyl bicsrclio phosphate ester, 
these seizTares were again abrogated by pithing the remainder 
of the brain (Casida et al. 1976). 'ESTS antagonises the OABA- 
mediated conductance in the crab neuromuscular junction (Large 1975).
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Therefore it would appear that there is a 
great similarity in the structure modes of action and 
effects of the other hicyclic compounds TETS*
Seizures in baboons after a minimal 
convulsant dose of lETS has an effect the same as 
picrotoxinin whereas larger doses of TESTS produce 
generalised seizures resemlUng the effects of bicuculline 
(Neldrum 1978).
iv) Other compounds iritiich inhibit the aetiowp nf* ntut
a) Cagrolactuw
The cyclized GABA, analoguey 2—pyrrolidoney is inactive 
as a GABA agonist (McGeer et al. 196I) in the crayfish stretch 
receptor neurone, but higher lactams do show oonvulsant 
activityy e.g. substituted caprolactams (e.g. 3y5y5- 
trimethyl n-butyolactam) and these may be associated with 
GABA antagonistic properties (Kerr et al. 1976)y in rabbit 
substantia nigra by striopalladial stimulation.. Caprolactam 
also antagonised GABAnnedlated increase in chloride ion 
permeability in crayfish but had little effect on displacing 
(^)<-GABA from mouse brain synaptosomal prepairatlons (Olsen 
et al. 1978).
b) d«^Pubocurarine
This is a potent GABA antagonist in the feline 
cerebral cortex and cuneate nucleusy but it also affects the 
actions of glycine and is probably a less-speoifio GABA 
inhibitor (Hill et al. 1973ay Hill et al. 1973b).
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o) Bengyl penicillin
Intravenous injections of 'benzyl penicillin 
antagonised OAMnoediated inhi'bition in the spinal cord of 
the frog and oat (Davidoff 1972b, Davidoff 1972c). 
lontophoretio application of benzyl penicillin also blocked 
QABi-lnduced spinal depressions irithout affecting the 
glycine-induced spinal depressions (Curtis et al. 1972).
The OABA-mediated increase in chloride permeability was 
antagonised by benzyl penicillin in crayfish muscle, it 
inhibits GASA binding to receptor sites in mammalian brain 
synaptosome preparations (Olsen et al. 1978c). However 
benzyl penicillin was found to show virtually no inhibition 
of GABA responses in crab muscle (Earl and Large 1973). A 
structural similarity of benzyl penicillin to GABA has 
been noticed (Curtis et al. 1972) and the evidence shows 
that it is a fairly specific GABA antagonist.
However, it has been suggested that the inhibition 
of GABA produced 'by penicillin in the rat olfactory cortex 
azid cuneate nucleus in vitro is different to the inhibition 
produced by biouculline or piorotoxinin (Pickles and Simmonds
1980). This inhibition be due to the penicillin blocking 
the chloride ion channels which are GABA-mediated in this 
preparation (Pickles 1979)* It has been shown also that 
penloillin deoreMes chloride ion conductance in crustacean 
mnsole (Hochner et al. 1976). Other evidence shows that 
Ivni^l block the GABA-mediated opening of the
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chloride ion channels so it acts in a similar way to 
picrotoxinin.
1.3 The role of GABA in neurologic euad psychiatric disorders
Reseau^ch on GABA and its nervous function has 
helped with an understanding of its malfunction. Defects 
in the GABA system cause various neurolojfical disorders.
1.8.1 Huntinxrfcon*» Chorea
Huntingt.on's chorea (Huntingdon's disease) is 
a hereditary eztrapyramidal diseaise which involves a 
severe reduotion of GABA in the corpus striatum substantia 
nigra« (Perry et al. 1973)« This reduction in GABA appeared 
to correlate with a reduction in levels of GAD (Bird and 
Iversen« 1974) but post-mortem effects emd the findings 
that GAD %fas also reduced in ether neurologic disorders casts 
doubts on the of these findings« (Spokes and Koch«
1978« Iversen et al. 1978). In some cases binding of (^)
GABA to this tissue was hardly affected (Enna et al. 1976)« 
indicating that treatment of a patient suffering from 
Huntingdon's chorea may be successful by the administration 
of a GABA-mlmetio vdiich proved unsuccessful in some cases 
(Chase and Taunminga 1978) and in other cases there was some 
degree of success (Bartholin! et al. 1978). These results 
may have been due to the inability«of the GABA agonists used« 
to enter the brain.
There is a possibility that two populations of 
Huntingdon's patients exist« one with low striatal (^) GABA
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binding and one with normal (%) OABA binding (iversen 
et al. 1978).
1«8.2 Parkinson*8 Disease
In Parkinson's disease, GAD is reduced in the 
striatum, globus pallidus and substantia nigra »rtiile (^)
GABA, binding is only reduced in the substantia nigra 
(Marsden 1978). This is probably due to a reduced dopamine 
input to the striatum and not related to cell loss as the 
GAB activity of patients treated with L-BOPA appears to be 
normal suggesting the GABAergic neurones are involved in a 
feedback loop idiich mediates the activity of nigrostriatal 
dopaminergic neurones (Lloyd et al. 1979).
1.8.3 - gchlzophrenia
GABAergic mechanisms eissociated with 
schi'Eophrenic symptoms were first suggested by Roberts 
(1972). A loss of post-mortem GAB activity in several brain 
regions has been reported (Bird et al. 1977) but these results 
may have been due to factors before death. A reappraisal of 
this evidence shows that GAB levels are not associated
A
with schizophrenia (iversen et al. 1978).
1.8.A V i t a m in  Be (l^idozine dependency)
Severe dietary deficiencies of Bg vitamins results 
in convulsions which could rapidly be abolished by 
administration of B^ (Tower 1936). Then a dependence to B^ 
was noted where removal of the vitamin catised a reappearance 
of the seizures. This is related to its function in the form
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2.1* Chamical stiMLC'tux'es and tha namos of convulsant "cage** compounds.
BICTCLOPSOSPHATES 
(4-eubst11uted-1 -pho spha-
2,6,7-trioxabic^lo (2,2,2) 
octane-l-ozides ) •
BICTCLOPHDSPHITES 
( 4-sub st i t ut ed-l-pho spha-
2,6,7-trioxabicyclo (2,2,2) 
octanes).
t-BDTTL BICTCLOCARBOmUEES 
(l-«ubst ituted-4-t-butyl-
2,6,7-triozabic7clo(2,2,2) 
octanes).
SILATRAHES
(l-eubstituted-2,S,9, 
-trioxa-5-aza-l-eilabicyclo (2, 
(3t3f3) undecane).
TETRAllErrHTIEHEDISnU’a O ^ ^  (TETS)
(2,6-Dithia-l,3?517-tetraza-tricyclo (3.3.1.!.^*') 
decauie-2,2,6,6, -tetraozlde .
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2. 1 AmlogjM 8_of_^icjclic_^to8£horu8_B8ter^_
2,6,7-Trioxa-l-ph08phaT3Ìc7clo(212,2) octane-1- 
oiides with siiitable 4-substituents (R) (pi^,2.l) ’’ere first 
shown to be hi^ly toxic in mannnals causing tonic-K:lonic 
convulsions and death ^thin minutes when injected intra— 
peritoneally in mice (Bellet and Casida 1973) by an unknown 
mechanism«
The toxic signs shown were found to be simileur to 
those produced with picrotoxinin (Casida et al. 1976) and a 
direct relationship with antagonism of the actions to GABA 
post synaptic responses was established (Bowery et al. 1977).
In crayfish isolated abdominal nerve cord the 
isopropyl derivative (OP (OCHg)^ C-C^H^-i) caused am increase 
in spike frequencies but relatively lamge doses were needed and 
the preparation wats fairly insensitive (Casida et al. 1976).
The actions of synaptioally released GABA ’^’ere amtaigonised in 
the nexirontuscxilar junction of crustaòeams by bicyolic ¡)hoephates 
(Korenaiga et al. 1977)«
In insects and mites various species were found to be 
insensitive to the toxic effects of bicyolic phosphate esters 
but in the Americam cockroach (Periplameta americama) death 
wauB catuBed after s3rmptoms showing^ a state of hyperexcitability 
amd motor inco-ordination also the isolated nerve cord 
preparation showed an increase in the spike frequency (Casida 
et al. 1976).
In the frog (Rana temperarla) the bicyolio phosphate
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estera have been shown to produce seizures in the 
decerebrated animal which were abro^^ted by pithing 
(Casida et al« 1976)« These actions on the tvog spinal 
cord were due to potent QABA-inhibition (Bowery et al.
1977).
Subacute toxicity in mice did not affect their 
susceptibility to subsequent administration and there was 
no gross effect on major organs in the body after 30 days. 
Similar findings were also found in chickens and frogs 
(Casida et al. 1976). There were similar effects on the 
toxioities in mammals and birds (Eimmerle et al. 1976).
In mammalian isolated tissue preparations there 
was a rapid twitching caused in the isolated mouse diaphragm 
after exposure to the isopropyl derivative (OP(OCHg)^C-C^H^-i) 
and in the isolated superior cervical ganglion of the rat a 
potent inhibition of the depolarising effect of flAHA was 
produced (Bowery et al. 1977). These actions were due to the 
antagonism of synaptically released GABA|in cuneate nucleus 
of the rat (Davidson et al. 1977) and other preparations 
(Bowery et al. 1976ab, Bowery ax¡á Dray 1976) and also the 
mammalian neuromusctilar junction (Kbrenaga et al. 1977).
Convulsions were produced in photosensitive 
baboons (Papio papio) which «rere similetr to those produced 
by bicuoulline and picrotoxinin (Neldmm 1978).
Although some bloyclic phosphate esters of modest
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activity vere reported to inhibit GABA binding to rat brain 
synaptosomal preparations (Enna et al. 197?) this effect 
was not seen using h i ^  doses of several compounds in GABA 
binding (Olsen et al. 1979b) or in musoimol bixiding to rat 
brain synaptosomal preparations (Bowery et al. 1979b).
In experiments on rat brain synaptosomal 
preparations using radio labelled (^)-a-dihydropicrotoxinin 
some reports have suggested a displacement «hich corresponds 
to the order of toxicity in other prepaurattions (Olsen et al. 
1978b, Ticku and Olsen 1979). However the maucimum specific 
binding was very low (approximately 155^ ) of the total binding. 
This will be disciissed in more detail later.
A similar' specific binding using (^)Miih7dropicro- 
toxinin was also shovn in crayfish muscle homogenates and the 
percentaige of specific binding was not greatly improved using 
a more sophisticated fractionation of the tissue (Olsen et al. 
1979d).
The actions of the bicyclic phosphate esters were 
different from other toxic phosphorus esters which inhibit 
acetylcholinesterase or cause excessive patraisympathetic 
stimulation (Bellet amd Casida 1973» Petajan et al. 1973, 
Kimmerle et al. 1976, Coult and Wilkinson 1977) and they were 
shown to have no effect on muscarinic cholinergic tramsmission 
(Mattson et al. 1977&).
They haul no effect on cyclio-AMP in amy pairts of the 
brain (Bellet auxl Catsida 1973» Casida et al. 1976, Coult amd
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Wilkinson 1977) even in convulsivs doses (Mattson et al.
1977flt) no inhibition or stimulation of cyclic-AMP
{^osphodiesterase in beef heart was demonstrated (Casida et al. 1976).
Cyclic-OQIP levels were elevated after 
intraperitoneal injections of bic3rclic phosphates in the rat 
cerebellum in subconvulsive doses but there was no elevation 
of OTclic-fflIP levels in the cortex (Mattson et al. 1977a).
These effects similar to those agents which interfere with 
aiBi-ergic mechanisms (Mao et al. 19751 Opmeer et al. 1976).
A similar action to bicuculline w m  observed with 
bicyclic phosphate esters in the inhibition of the QABA- 
activated enzyme, adenylate cyclase (BC4.6.1.1.) but they had 
no effect on the acetylcholine-aotivated enzyme, guanylate 
cyclaise (EC4*6.1.2. ) in the rat cerebellum (Coiilt aind Howells 
1979).
There was a decrease in the hezabarbitone sleeping 
time in mice (Casida 1976) which was attributed to barbiturate 
reversal of the GABA antagonism produced by these compoimds 
(Bowery and Dray 1976).
There was no involvement with electronic reactions 
such as phosphorylation and all^lation in the primary actions 
of these compounds (Eto et al. 1976, Casida 1976). However, 
it is likely that they are rapidly metabolised or excreted 
based on their brief actions in several species of animals and 
lack of cumulative effects (Kimmerle et al. 1976).
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Embryos in chicken eggs injected '^ith the ethyl 
analogue(o p (OCH2)2 ^-€2^ ^) developed normally but on hatching 
there %ras a very h i ^  incidence of fusion of the leg joints 
(Casida et al. 1976) and the ITAD content of the embryo '^ras 
lowered (Proctor et al. 1976).
A change in the basic shape of the caged structure 
of the bicyclo compounds caxised a loss of h i ^  toxicity but 
sTibstituting the {Bosphorus for arsenic or carbon showed 
the equivalent compoxands to be equipotent (Cooper et al. 197^).
*nxe imx>ortance of the steric role of R substituent 
of the 4-carbon atom on the bridge head of the molecule for 
hi£^ toxicity has been emphasised. The greater the bulkiness 
or branching of the bridge-head substituent the higher the 
toxicity (Eto et al. 1976» Cooper et al. 1979i Nilbraith et al. 
1979) amd the increase in ability to antagonise the actions of 
GABA has been shown (Bowery et al. 19771 <)lsen et al. 197de).
The suggested mode of action of the bicyclic phosphate esters 
is that symmetrical cage structure blocks a pore-type or anion 
channel receptor (Bowery et al. 1977» Nilbraith et al. 1979? 
Olsen et al. 1978e) with the two ends of the cage differing in 
properties» the bridge-head hydrophobic structTire fitting in 
one part of the channel and the small hydrophlllic end of the 
molecule fitting into a separate protein conformation.
nie very bxxUqr and branched bridged^ead substituents 
on the 4-carbon atom as in the tertiary butyl analogue (OP(OCH2)2
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C-C(CH^)^ and isopropyl analogue (OP(OCHg)^ C-C^H^-i) 
were the most potent in toxicity (Bto et al. 1976, Cooper 
et al. 1979) and in their abilities to antagonise the effects 
of QA3k (Bowery et al. 1977) on isolated tissues ««d in the 
displacement of (%)-a*-dihydropicrotoxinin binding (Olsen et 
al. 197Se, Tioku and Olsen 1979)*
It was therefore decided to synthesise several 
new bicyolic phosphate esters which had very bulky and 
branched bridge-heeui substitxients in order to elucidate the 
optimal size of the hydrophobic end of the molecule.
A series of these compoiands were then synthesised 
in order to evaluate their biochemical and pharmacological 
properties in comparison with the work already described in 
this chapter. The synthesis and results will be disctissed 
in the next chapter.
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2.2. Structures of picrotoxinin and related 
convulsants which cause GABA, antagonism. 
Also showing the nxunbering system.
CH.
¥ o h 'OH . picrotin
CHj («2
R=H. Coriajnytrin
R=OH, Tut in
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2. 2 Picrotoiinin
The excitatory effects of picrotozinin were first
with the action on GASA in Crustacea (Florey, 1931)* 
low concentrations of picrotoxinin the S3rnaptic 
effects of GABA are blocked in several different crustacean 
preparations. These preparations include the crayfish heart 
(Florey, 1957); the crayfish stretch receptor (Elliott and 
Florey 1956, Iwasaki and Florey 1969» and Hori et al. 1978); 
Mid the inhibitory neuromuscular junction of the crayfish 
(Robbins and Van der Kloot 1958, Takeuohi and Takeuchi 1969 
and Takeuchi 1976).
In other Crustacea, picrotoxinin antagonises the 
GABA-mediated inhibition of the nexiromuscular junction in the 
lobster (Grundfest et al. 1958 and Shank et al. 1974-) and 
crab (Epstein and Grundfest 1970, Earl and Large 1972).
Picrotoxinin also antagonises the peripheral 
synaptic inhibition and the inhibitory effects of GABA on 
inseots (Usherwood and Grundfest 1965) and the antagonist" of 
GABA-reoeptor interaction on the locust muscle («erman 1978).
In amphibia, picrotoxinin reduces tl*-» depolarisation 
by GABA on the afferent fibres of the spinal cord of the toad 
in vitrot (Tebisis and Philliss I969) and in the spinal cord 
of the frog (Barker and Kicoll 1973)* blocking both the dorsal 
and ventral root responses to GABA, the dorsal root responses 
beinff antagonised more potently than the ventral root responses 
Uicoll et al. 1976).
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In mammals picrotozinin has heen sho«m to 
antagonise the actions of 0 A M  in vitro and in vivo,
Picrotozinin suppresses both vestibular 
inhibition and the inhibitory actions of 0 A M  on 
oculomotor neuzx>ns in the rabbit (Obata and Highstein 1970).
Picrotozinin increased the concentration of 
cyclic-^9IP in rat cerebellian in non-convulsant doses which 
can be antagonised by treatment with benzodiazepines or 
0 A M  (Costa et al. 1976). In other work on rat 
cerebellar C3rclic-GNP levels the actions of picrotozinin 
are reported to lower these levels and this can be 
antagonised by the 0 A M  agonist| muscimol (Biggio et al.
1978). In oultTxred rat cerebellar Purkinje cells, which 
are spontaneo\2sly bioelectrically active, picrotozinin 
antagonised the inhibitory actions of 0AM. It also 
increased the firing rate of these cells in low concentrations. 
This action was reversible but in hi^er concentrations the 
firing rate was decreased (OShwiler 1975)« However in the 
oat cerebellar cortez picrotozinin did not interfere with 
the depression of Purkinje cell firing by 0 A M  (Kawamura 
and Provini 1970). These conflicts in the reported results 
may be due to the relatively low aque ous solubility of 
piov’/^tozinin and so investigations have depended on 
electro osmotic ejection of piorotozinin from solutions 
(Curtis 19^)*
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As with the frog spinal cord the dorsal and 
ventral root responses to GABA are antagonised by 
pic <rotoxinin in the rat spinal cord in vitro (Bowery and 
Brown 1972, de Groat 1970, Evans 1978)«
Vhen atdministered systemically picrotozinin 
first modifies the spinal dorsal root potentials cmd the 
associated excitability changes in afferent fibres (Bell 
and Axxlerson 1972, Levy and Anderson 1972). Therefore 
slow penetration of the blood-brain barrier is an unlikely 
explaiiation for this latency in action and it is probably 
accounted for by the complex inter relationships of the 
inhibitory systems and neuronal pathways.
Vihen administered intravenously in cats 
picrotoxinin produces cardiovascular changes which occiu* 
in two phases. The first phase is a decrease in arterial 
pressure and sinus rate due to activation of the central 
parasympathetic centres and the second phase is an increase 
in arterial pressure and sinus rate due to activation of 
sympathetic centres in the brain (DiMicco et al. 1977).
There have been reports of specific antaigonism 
of GABA in cat cTUieate neurones (Galindo 19^91 Kelly and 
Renaiad 1973).
Picrotoxinin does not displace radioactively- 
labelled GABA from mammalian synaptosomal brain fractions 
(Zukin et al. 1974, E m »  et al. 1977) or crayfish muscle 
preparations (Olsen et al. 1977). In invertebrate
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preparations piorotoxinin inhibits neurophysiological 
effects of GABA, non-competitively apps8u:‘ingf to compete 
with chloride ions at the ionophore site (Takeuchi and 
Takeuchi 1979)»
In crayfish muscle picrotozinin auid the less 
potent but relatively similar amalogue a-dihydropicrotozinin 
anta^nised the OABA-inducedf radioactively-labelled chloride 
ion uptake (Ticku and Olsen 1977? Olsen et al. 1978d).
The specific binding was approximately 20^ on the microsomal 
(P^) fraction of the crayfish tail muscle. Binding was 
not affected by chloride ion concentration. Bicuculline, 
ainother QATU antagonist (Cxirtis auid Johnston 1974)? also 
inhibited the dihydropiorotoxinin binding but only at high 
concentrations whore it causes various non-specific effects 
(Olson, 1976, Olsen et al. 1976). This would also suggest the 
binding sites «for GABA amd picrotoxinin are different.
Using autoradiography, ^-:4ihydropicrotoxinin has 
been reported to be localised at similar locations to the 
GABA receptor binding sites in rat brain synaptosomal 
preparations (Olsen et al. 1978®? Ticku et al. 1978). The 
rtAUA binding was found to be enhanced by some detergents 
(e.g. Triton XlOO) but treatment with detergents on the 
dihydropiorotoxinin binding resulted in a destruction of 
specific binding (Ticku et al. 1978).
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Dihydropicrotoxinin binding in rat brain 
synaptosomal preparations was also siffected by a series 
of convulsant drugs» the **cage convulsant** drugs (Olsen 
.et al. 197db) and both depressant and excitant 
bsurbiturates (Ticku and Olsen 197Ô).
The binding studies which are detailed here 
are reports of the material which has been published 
to date 8tnd will be discussed in greater detail in a 
later chapter vdiich investigates the specific binding 
of (^) - a-d^ydropicrotoxinin binding to rat brain 
synaptosomal fractions.
54
Fig. 2.4« Structures of bicuculline met ho chloride and 
those of other G A M  antagonists active in 
maunmalian CNS, hicucine ester» hydrochloride 
and corlumine hydrochloride
cr
BICUCULLDIE NBTH0CHL0RI13B
a
BICDCIHE ME?EHTL ESTER 
HTDROCHI^RIDB
CORLOMIHE
HTIXIOCHLORIDE
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2.3 Bicuoulline
The phthalideisoquinoline alkaloid bicuciilline 
(Fig.2.4') was shown to he a potent convulsant in rabbits 
and frogs (Welch and Henderson 1934&)f the convulsant activity 
being shown to be due to antagonism of a QABA.-mediated 
prooess (Curtis et al. 197a yb).
In insects bicucTilline causes severe convulsions 
in the house fly (Nusca domestics) amd also antagonises the 
GASA-nnediated inhibitory postsynaptic potentials (iPSPs) in 
the cockroach (Periplauieta americana) coxal mixsclesy (Olsen 
et al. 1976, Walker et al. 1971).
In cmstacea the restilts obtained with bicuculline 
have been variable. In the crayfish (Eustacus armatus) stretch 
receptor the inhibitory action of GABA auid impulses in the 
inhibitory nerve fibres was antagonised (McLennan 1970b » 
McLennan 1973) y »«d also at the neuromuscular junction of the 
crayfish (Combarus olsu:‘kii) (Takeuchi and Onodera 1972) but 
this W8ts only a weak antagonistic effect. Conflicting reports 
on the crayfish stretch receptor suggested bicuculline had 
little effect (Swagel et al. 1973).
These negative results were supported by 
biououlline showing only a weak antagonistic effect on 
neuromusoular inhibition in the lobster (Homarus amerioanus) 
(Shank et al. 1974) and hermit crabs (Bari and Large 1972).
Other work was also Indicative of the dubious nature 
of biouculline as a GABA antagonist (Godfraind et al. 1970y
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Strau^ian et al. 1971) in invertebrates. However, at 
physiological pH there is a conversion of bicuculline 
by hydrolysis to the hydroxyacid bicucine (Pig.2.5) which 
is a much less active convulsant than bicuotilline (Welch «-wH 
Henderson 1934b). Aqueous solutions of bicucxxlline at neutral pH 
can be converted to bicucine by lactone hydrolysis from the lone 
pair of electrons on the nitrogen atom. This process was slowly 
reversed by acidification (Olsen 1976, Olsen et al. 1975). This 
reMon may account for the negative results reported above, 
the solubility at neutral pH of bicuculline in aqueous solution 
is also much reduced than in acidic conditions. Further, it 
may precipitate if too high concentrations are used thus giving 
a negative result in experiments designed for investigation of 
antagonistic properties.
Quaternisation of bicuoiilline to produce (*f)- 
bicuculline methiodide (*^<wnethyl bicuculline**), methochloride 
and methcbromide (Fig.2.4) produced increased water sclubility 
MnA lactone hydrolysis cannot readily take place in these 
derivatives. These derivatives have been shown to be more 
potent convulsants than bicuoulline idien the blood-^rain 
barrier is b3n>assed by route of administration in some 
vertebrates (Pong and Graham 1972, Johnston et al. 1972).
(•f)-Bicuoulline methiodide was found to be unstable 
in aqueous solution, however, if left for long periods at 
room temperature, decomposing to give an inactive, water-
/i-j
insoluble oil| (Cryer 1979) whereas (+)-bicuoulllne 
methochloride was stable (Johnston et al. 1972)•
Subsequently (4>)-4iouculline methobromide was found to 
be much more easily prepared and just as stable amd 
potent as (+)-bicuculline methochloride (Cryer 1979)* 
Consequently this quaternary salt was used in all 
experiments.
In the fros (Rana temporaria) spinal cord the 
actions of bicucTilline have been reported to block both 
dorsal and ventral root res|)onses to QASA specifically 
(Barker et al. 1973atby Bichol et al. 1976), hcwever other 
reports on this prepau:‘ation claim that the blockade was 
not specific to GABA (Pixner 1974).
In the rat spinal cord bicuculline blocked 
dorsal root responses to GABA (Evans 1978) and specifically 
antagonised the depolsu^ising effect of GABA on the rat 
superior cervical ganglion (Bowery et al. 1976a).
In iontophoretio studies doubt has been cast on 
the effectiveness of bicuculline as a specific GABA antagonist 
in the rat oaiidate nucleus (Bemardi et al. 1976)t rat 
cerebellar Purkinje cells (GEwhiler 1975) and also in cat 
(Godfraind et al. 1970).
In rat brain slices bicuciilline is insensitive to 
the hig^^fflnity uptake of radio labelled GABA (Olsen et al. 
1976, Iversen aiad Johnston 1971) and there was a  stimulation
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of release of GAEA (Johnston and Mitchell 1971 )• Sttidies 
with rat hrain synaptosomal fractions have shown that 
bicuculline acts with the synaptic receptors by displacement 
of radiolabelled GABA. (Curtis et al. 1971afb, Johnston 
1978* Lester and Peck 1978)« in a stereospecific manner (Enna 
et al. 1977)* There was a heterogenity of the GABA and 
bicuculline birtding sites (Greenlee et al. 1978) and GABA 
and bicuculline binding sites may be distinct from each 
other due to the differential effects of chaotropic salts 
(e.g. ClOj ) in binding with (^)-bicuculline methobromide 
to demonstrate a hig^ and low affinity site (Mohler 1978«
Hohler and Okada 1978) and the effects of mild detergents 
(e.g. Triton X100)(Enna and Snyder 1977).
Bicuculline has a similar effect on the cat 
cardiovascular system causing a decrease in arterial pressure 
sinus rate due to activation of GABA mediated central 
parasympathetic centres followed by an Increase in arterial 
pressuz^ sinus rate due to activation of sympathetic 
centres in the brain (DiMicco and Gillis 1979).
Ibe mode of action of bicucxilline is not due to any 
effect of enzymes involved with GABA synthesis or degradation 
(Beau^ and Johnston 1972) nor does it effect the uptaüce or 
release of GABA (Johnston and Mitchell 1971).
Other effects of bicuoulline not related to its 
QABA-reoeptor actions aire its inhibition of acetylcholinesterase 
in motise brain (Svenneby and Roberts 1973) But no evidence was
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2. 4 The act long of ^»rbiturates
The actions of barbitiirates may be due to their 
effects on the OABl-mediated inhibitory transmission (iTicholl et al 
1973)* Pentobarbital has been reported to prolong OAM-mediated 
responses in frog motomeTarones(lficholl 1973&)t cultured spinal 
cord cells (Ransom and Barker 1976), hippocampus (Richoll et al. 
1973) auad “the superior cervical ganglion (Bowery and Dray 1976, 
Dray and Bowery 1979)« This action can be reversibly antagonised 
by piorotozinin (Bicholl 1973&» McDonalds and Barker 1973).
Pentobarbital, at therapeutic concentrations does 
not alter OABA. uptake or release (Peck et al. 1976, Olsen et al.
1977) 'by acting presynaptically nor does it inhibit binding on 
the postsynaptic %ABA receptor (Rhina etnd Snyder 19771 Peck et al. 
1976, Collins and Cryer 1978, Olsen et al. 1978a) but it can 
prevent (4')-biouculline from displacing QABA. from its binding site 
(Collins and Cr3rer 1978).
Beirbiturates also have am effect on cation aonductance 
mechanisms (Blaustein 1976, Sato et al. 1976). Pentobarbital 
also inhibited a-DBP binding in rat brain membranes suggesting 
the site of action of it being at the piorotozinin binding lit# 
in the OABA recepto.- ionoi>hore influencing the chloride ion 
channels (Ticku and Olsen 1978). However the convulsant 
“barbiturate M B B  (Fig. 2. 0  inhibited %-a-lHP binding much more 
potently, suggesting a similar inhibition of QABAHnediated effects 
in closing the chloride ion channel and depressant and 
amtioonvulsant “barbiturates could prolong OABAHsediated
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inhibition by increasing the lifetime of the aativated ion 
channel.
2. 5 Action of benzodiazepines-
Benzodiazepines have been shown to facilitate 
GABA-er^o transmission in the mammalian CBS (Costa et al.
1976, Ouidotti et al. 1979i Haefely et al. 1975, 1979).
A highly specific, high affinity binding of 
radio labelled benzodiazepines to proteins in synaptic membrsuies 
in the CBS has been demonstrated in vitro (NBhler and Okada 1977b, c, 
Braestrup euad Squires 1977) and in vivo (Chang auad Snyder 1978). 
Althou^ there is an excellent correlation between the affinities 
of various benzodiazepines for binding sites in accordance with 
their muscle relaxant actions (iCShler and Okhda 1977b) no other 
psychotropic drugs or neurotransmitters inhibit benzodiazepine 
binding including GABA, barbiturates, glycine and strychnine 
(Haefely et al. 19791 Creese 1978) but GABA and m\iscimol increase 
benzodiazepine binding (Regan et al. 1980, Taillman et al. 1978).
Distribution of benzodiazepine binding sites in the 
CBS is uneven but it may be located presynaptically on GABA neurone 
or post-eynaptioally on GABA-oeptive neiirons. A marked decrease 
in their number in the striatum combined with a fall of GAD 
activity in Huntington's Chorea patients suggests a presynaptic 
location (OkBula et al. 1978).
Benzodiazepines reversed the bicuctilline induced GABA 
blockade in rat isolated superior cervical ganglion and medullary
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netirons (Bowery and Dray 1978, Dray and Straughai\1976) but 
did not inhibit (^)-biouculline binding in rat synaptic 
membranes (HBhler and Okada 1977a).
(^)-lSP binding was inhibited by benzodiazepines 
in rat synaptio membrsuies (Olsen et al. 1980, Ticku et al. 1981) 
and piorotozinin antagonised the aotions of benzodiazepines 
in vivo (stein et al. 1975)»
There was no inhibition of (^)-OABA binding 
(Snyder and Enna 1973* Olsen et al. 1973o) or (^)Hnusoimol 
binding (Beaumont et al. 1978)) in mammalian brain synaptio 
membranes. However, studies on the sodium independent (^)- 
QABA binding on fresh synaptic membranes of the rat cerebral 
cortex cause in increase in the affinity of the membranes for 
QABA suggesting that the benzodiazepines bind to an endogenous 
modulator «diich is located on the GABA reoeptor. The modulator 
has been isolated and benzodiaizepines bind specifically and '•dth 
high affinity with the same rank order as their anxiolytic actions 
(Qiiidotti et al. 1979» Costa and Ouidotti, 1979)»
Other observations in vivo have suggested the 
exist«noe of two types of benzodiazepine reoeptor, one of which 
is not associated with the GABA reoeptor and could mediate the 
anxiolytic actions and the second type of receptor coupled to the 
modulator of the GABA receptor is responsible for the other 
pharmacological effects of the benzodiazepines and not their 
anxiolytic aotions (ELepner et al. 1979» Huot et al. I98I).
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CHAPTER 3 : CHEMICAL S7HTHESIS AHD ACUTE TOXICITIBS OF
BICTCUC PHOSPHATE GABA ABTAGOinSTS
3*1 Introduction
3.2 Proparatlon of 4-(2t2tdimeth7l propyl)
2t6|7t trioxa-l-phosphablcyclo (2»2t2) 
octan-l-one.
3.3 Préparât ion of 4.-(lf2, dimethyl propyl)
2f6t7t trioza-l-^osphahicyclo (2f2f2) 
octan-l-one.
3*4 Préparation of 4-cyclopentyl 2f6,7i-trioxe-l- 
phosphahicyclo (2y2f2) octan-l-one.
3.3 Attempted preparation of 4-(lyl»2» trimethyl 
propyl (THEXTL) 2,6,7i trioxa-l-idioephabicyclo
(2,2,2) octan-l-one.
*
3.6 Attempted preparation of 3,4, dimethyl 
pentauial.
3.6 .1 By metal assisted borohydride 
reduction of axi acid chloride
3.6.2 By the use of Bis (triphenyl-phosphine) 
Copper (l) tetraborohydrate
3.6.3 By the tuse of ohlorosucoindimide 
oxidation of the alcohol.
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3.7 Attempted preparation of 3i4f4 trimethyl 
pentanal
3*7.1 ^  reduction of the corresponding
acid chloride with lithium tri-t- 
hut03Qr-e.luminohydride •
3*7^2 acid hydrolysation from 1-methoxylf 
3t3f4 trimethyl 1|2» pentene
3.8 Attempted prepau?ation of 1,1, 2 trimethyl/ 
ethoxypropaine by increase in the carbon chain 
usin^ trimethyl oxosulphoniim iodine/sodium 
hydride complex.
3*9 Acute toxicity of bicyclic phosphate esters 
3*9'*1 Method 
3*9*2 Results
3*10 Discussion of synthetic routes 
3*11 Conclusions
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Preparation of 4-(2.2.dimathyl propvl (imnPBnffPYL'
2i6|7, trioxa-l-phoaphabicyolo (2,2,2) octan-l-one. (CHART l)
3,3 dimethyl hutan-l-ol (64.0g, 0.63 moles) (l) and 
48^ hydrobromic acid (157 om^, 0.92 moles) were refluxed 
together for 3 ^urs. The organic layer was extracted with 
5^  sodium hydrogen carbonate, washed with water, dried with 
magnesium sulphate and distilled to ^ive Bromo-3,3,dimethyl butane 
(2) (BP . 35-37°C at 12 mmHg. Yield - 74^)
The Bromo-3,3,dimethyl butane (2) (?6.5g, 0.46 moles) 
was prepared into a grignard reaigent in dry ether (137 cm^) 
by reaction with magnesium (ll.4g, 0.47 moles) and to this 
was added triethylorthoformate (68.5g, 0.46 moles) and stirred 
on a boiling water bath for 1 hour. The reaction mixture was 
then poured into water and saturated with ammonium chloride 
solution (1000cm ). The ether layer was dried with magnesium 
stilphate and concentrated before distillation of 1,T, dietho:^
4,4, dimethylpentane (B.P. - 64 - 74°C at 12 mmHg, Yield - 52?^ ) (3) 
The 1,1, diethooQr, -4,4,dimethylpentane 
(22,7gt 0.12 moles) was refluxed for 10 minutes with 
hydroohlorio acid (I50 cm^), washed with saturated sodiimi 
hydrogen carbonate solution (50 cm^), washed with water, the 
organic layer sepaumted and dried with magnesium siilphate.
This was distilled to give 4,4, dimethylpentanW (B.P. 55®C at 
12mmHg, Yield - 25^). (4)
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The 4f4, dimethyl pentanal (4.85g, 0.04 moles)(4) 
was added to 10^ sodium hydroxide solution 31cm^, 0.06 
and 40^ methanol solution (20cm^, 0.2 moles) and stirred at 
room temperature for 2 hours. The mixture was then heated 
to 50®C for 1 hour. This was then oontinuously extracted 
with chloroform for 5-6 hours and after concentrating was 
run on a silica gel column usin^ ohloroformsmethanol (9sl) 
as the elutant. The fraction obtained which produced an Rf 
value of 0.36 when chromatographed usin^ the same elutant 
and located with 50^ sulphuric acid spray^ appeared on the 
silica plate as a black spot when the plate was heated.
This was concentrated emd the product recrystallised from 
diohloromethane; appeared as white needle-shaped crystals 
(0.597fiff Yield « 12^, m.pt 137-139^0 imcorreotedy 
Empirical formula H - 11.445^ , 0 - 27.23ji, results
for microanalysis : C » 56.60ji, H - 10.60ji, values 
differing due to one molecule of water present).
Analysis repeated:
HgQ 0^ Mwt - 176
Calculated
Found
C 61.33 
C 61.72
H 11.44 
H 11.17
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The 2|2| bishydroxymethyl-4f4fdimethyl pentan-l-ol(o.S97 ,^ 
3»4 nmole) (5) vas stizred for ^—6 hours with phosphorous
oxychloride (0,52g, 3.4 mmole). The products went liquid/solid 
after 30 minutes, the flask was then heated to 70°C for 1 hour 
and water (20cm^) added. The reaction mixture was then boiled 
Tintil the product had dissolved in the water, this was then 
allowed to cool and white needle-shaped crystals of 
4-(neopentyl) 2,6,7, trioxa-1-phosphahicyclo (2,2,2) octan-i-one (6) 
formed. These were filtered and allowed to dry over calcixim 
chloride in a dessicator for 3 days. (0.330g. Yield > 47^ , 
mpt. (sealed tube) 198-200^0 (uncorrected). Empirical formula 
^ 7^ 3’ theoretical values for micro-analysis : C » 49*09^, 
k « 7.783^, results for micro-analysis C « 49.193^ 1 H « 7.653^ .
These figures are well within the 0.33^  limits etnd can 
therefore be assumed to be the correct compound. lOf ■ 220.21.
BUR spectrum (9OMH2) with respect to TN^ i  values.
Ss 0.89 (S) 9H (3 X CH3); 1.24 (S) 2H (CHg);
4.57 (d) 6H (3 X CHg cyolo, J - 6.8H^ P - coupling).
Calculated
Found
c 4 9 .0 9  
c 4 9 .1 9
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The 2,2, hishydro3^ ethyl-4,4,dimethyl pentan-l-o 1(0.597^, 
3»4 mmole) (5) was stirred for 5*^ hours with phosphorous
03^hloride (0.52g, 3«4 mmole). The products went liquid/solid 
after 30 minutes, the flask was then heated to 70®C for 1 hour 
and water (20cm^) added. The reaction mixture was then hoiled 
TUitil the product had dissolved in the water, this was then 
allowed to cool and white needle-«haped crystals of 
4-(neopentyl) 2,6,7, trioxa-1-phosphabicyclo (2,2,2) octan-i-one (6) 
formed. These were filtered and allowed to dry over calcium 
chloride in a dessicator for 3 days. (0.330ff. Yield « 47^ , 
mpt. (sealed tube) 198-200^ 0 (uncorrected). Empirical formula 
^ 7^ 3* theoretical values for micro-€Uialy8is : C » 49*09^,
*H « 7*7836, results for micro-emalysis C ■ 49*1936, H ■ 7*6536*
These figures are well within the 0.336 limits and can 
therefore be assumed to be the correct compouzid. MW ■ 220.21.
BUR si>0otrum (9010^) with respect to TM^ ^  values.
i s  0.89 (S) 9H ( 3  X  0Hj)i 1.24 (S) 2H (CHj);
4.57 (d) 6H (3 X CHg cyclo, J - 6.8H^ P - coupling).
Calculated C 49*09 H 7*78
Found C 49*19 H 7*65
83
3.3 Praparation of 4-fl.2. dlmethrl nremrl^ 2a6a7. triont-1- 
phosphabicarclo (2t2,2.) octaui-l-one. (CHART II)
2^ ethyl propanal (72g, 1 mole) ‘ (7) was condensed 
with diethyl malonate (l60§^ y 1 mole) in the presence of 
benzene (lOOom^)i piperidine (4.50m:?) and glacial acetic 
aoid (l2cm^) until 1 mole (l8g) of water was collected.
The product was washed with water (3 i lOOcm^), dried with 
magnesium sulphate and distilled to give diethyl isobutylidene 
malonate. (8)(b.pt.ll8-120°C, 12 mmHg. Yield - 78ji) (Cope et al.
1941).
The diethyl isobutylidene malonate (l67g» 0,78 moles) 
was added to an iodomethane grignard reagent (O.78 moles ♦ in 
dry ether (300cm^). The mixture weu3 cooled to 0®C and copper (l) 
chloride (l#6g) was added. The mixture was stirred for a 
further 30 minutes and then poured onto cold 10^ sulphuric 
aoid (650cm^)y washed with sodium hydrogen carbonate solutiony 
water and dried with magnesium sulphate. Then it was 
concentrated and distilled to give diethyl (ly2ydimethyl propyl) 
malonate.(9)(^»pt 118-120^0y 12mmHg. Yield « 92^)* (Eliel et al.
(1956)
The diethyl (ly2ydimethyl propyl) malonate (9)
(l64gy 0.76 moles) was refluxed with potassium hydroxide 
(l64gy 0.76 moles) for 10 hours emd allowed to oool. The 
product was then washed with ethanol (0.78 litres) and 
dissolved in water. The solution was th4n acidified with
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concentrated hydrochloric acid, weushed with water and 
•retracted with ether. This was dried with ma^esium 
sulphate and concentrated. The residues then heated 
to 160®C for 5 hours and allowed to cool. This was 
distilled to jfive dl, 3i4f dimethyl pentanoic acid, ( lo )
(b.pt. 109°C, 12mmHg, Yield . 58J6).
The dl, 3,4f dimethyl pentanoic acid (lO)
(58fiff 0.45 moles) was refluxed with thienyl chloride 
(66.6^y 0.33 moles) for 1 hoxir. This was cooled awf^  
distilled to give 3,4i dimethyl pentoyl chloride (h.pt. 
43-55°C, 12mmHff. Yield - 8?5i). (ll)
The 3»4» dimethyl pentoyl chloride (ll)
(22.3St 0.13 moles) in dry diethyl ether (lOOcm^) was 
added to Lithim aluminium hydride (7»2g, 0.I9 moles) in 
dry diethyl ether» (23O cm^). The products were concentrated 
and distilled to ¿five 3,41 dimethyl pentan-l-ol. (h.pt.
71°C, 12mmHg. Yield 845^ ). (12)
The 3,4t dimethyl pentad-l-ol (8.1g, 0.33 moles) 
was dissolved in pyridine (20cm^) and tosyl chloride (l3«3£Tt
0.07 moles) was atdded at O^C. Thiv was then potired into 
water after 1 hour and extracted with ether. The product 
was dried with ma^esium sulphate, concentrated to ^ v e  a 
yellow oil, 3t4t dimethyl pentan-l-yl tosylate, (13) with some 
pyridine present and this was used directly in the next stage, 
by addition to a mixture of sodium hydrogen carbonate
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(l3g* 0.18 moles) in dimethyl suli>hozide (20cm^). This 
wais heated to 150®C in an inert atmosphere of nitrogen, 
allowed to cool, thrown into water and extracted with 
ether. This was washed with water (3X 30cm^), dried 
with magnesium sulphate, concentrated and distilled in 
an inert atmosphere of nitrogen to give 3,4, dimethyl 
pentanal. (b.pt. 40-^2^C. Yield « 209^ ). (Kbmbleum et al.
1959). (14)
The 3f4t dimethyl pentanal (4.91STf 43 mmole) ( 14 ) 
was added to lOJ^  sodium hydroxide solution (26cm^, 63 mmo^s)
8tnd stirred at room temperature for 2 hours. The ¡mixtTire 
was then heated to 3P°C for 1 hour and then continuously 
extracted with chloroform for 3~^ hours. After concentrating 
it was run down a silica gel column using chloroform : methanol 
(9:1) as the elutant. The fraction obtained which produced 
an Rf value of 0.32 when chromatographed using the same 
elutant and located on the silica gel plate api>eared as a 
black spot after spraying with 30^ sulphuric acid and heating 
the plate. This was concentrated and the product 
reoxystallised from diohloromethane as a white solid.
(l.76g, m.pt. 79-81^C uncorrected. Yield « 2yf>),
The 2,2, bishydrojqrmethyl 3f4i dimethyl pentan-l-ol
(l.76g, 1.0 mmole) (15) was stirred for 5-6 hours with phosphorous 
oxychloride (l.3g, 1 mmole). The products went liquid/solid 
after 30 minutes, this was then heated up to 70®C for 1 hoto*
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and water (50cm^) added. This was then boiled until the 
product had dissolved in the watery allowed to cool and white 
needle-ehaped crystals of 4-(lf2, dimethyl propyl) 2,6,7, 
trioxa-l-phosphabicyclo (2,2,2,) octan-l-one (l6) formed; 
these were filtered and allowed to dry over calcium chloride 
in a dessicator for a few days. (281.2mg, Yield ■ 13ji, m.pt, 
(sealed tube) 190°C uncorrected). 
lOiR spectrum (90NH^) with respect to TNS S  values
J: 0.81 (d) 6H (2 X CH^, J - 6.8H^); 0.91 (d) 3H (l x CH^, 
J - 6.8H^7ir 1*4 (m) IH (2-CH); 1.8 (m) IH (3-CH);
4.6 (d) 6H (3 X CHg cyclo, J ■ 6.8H^ P-coxiplin^).
C^H^^O^P mwt - 220
Calculated
Found
C 49.09 
C 48.82
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3.4 Preparation of 4-cyolopentyl 2.6t7t-trioxa~l~ 
phosphabicyclo (2.2.2) ootan-l-one. (CHART XI)
2-cyclopentyl-2-hydro:^ethyl propcme l,3i 
diol (0.6gt 3*4 mmole) waa stirred for 5^6 hoiirs with 
phosphorous oxychloride (0«52g 3*4 mmole). The products 
were liquid/solid after 30 minutest this was then heated 
to 60^0 for 1 houTt and water (20cm^) added. The water 
was boiled until the product completely dissolved in itf 
then allowed to cool and tdiite needle-shaped crystals of 
4-cyclopentyl 2t6t7"-trioza-l-phosphabicyclo (2|2t2) octan-1- 
one formed. These were filtered aaod dried over calcium 
chloride in a dessicator for three days (300 m^t Yield «
30^ t m.pt. (sealed tube) 214-216^0 uncorrected).
miR spectrum (90NH ) with respect to valuesz
f ! 1.58 (m) 9H (cyclopentyl H»s); 4*5 (d) 6H 
(3 X CHg oyclo, J - 6.8H^ P - coupling), 
mwt a 218 
C 49.99 H 7.10
C 49.54 H 6.93
®9®15°3^
Caloulated
Found
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3.5 Attempted preparation of 4-(l.l.2« Trimethyl propyl (THEXYL)) 
2«6.7t-Trioxa-l-Pho8phabicyolo (2.2.2.^ Octan-l«one.
(See Chart III)
A grignakrd reagent was prepared using 
lodomethane (96.Ig 0.68 mole) and magnesium (l6.2g* 0.68 mole) 
in dry diethyl ether (280cm^). This was then added to 
Ethyl 2-03rano 3 isopropyl hutanoate (l22.5fft 0.68 moles) 
in ether (280cm^) with copper (l) chloride as a catalyst.
The temperatTire was kept to »13^0 and %dien the grignard 
was added the mixture was refluxed for 1 houTt allowed to cool 
and. poured ~ onto cold lOji sulphuric acid (300cm^). It 
waa separated emd extracted with ether (3X lOOcm^) before 
adding ac^ueous lOf^L sodium thiosulphate (lOOcm^). Then it 
was dried with magnesium sulphate and concentrated before 
distillation of ethyl 2-cyano-' » -^7 3i3fd trimethyl
T t - / pentanoate. (85.5fif» b.pt. 126®C. 12mmHg.
Yield . 64i>).
The theiqyl oyanoate was prepared (83.3fft 
0.43 moles)» etdded to boiling potassium hydroxide (8l.9g) 
in water (l02om^) and refluxed for 6 hours» before cooling 
tunA acidifying with concentrated hydrochloric acid 
(230cm^). A solid was obtained trtiich was filtered and the 
solution extracted with diethyl ether then dried with 
matgnesium sulphate a«d concentrated before distillation of 
3*3*4 Trimethylpentanonitrile(48.0g» b.pt. 6l^C. 12mmHg.
Yield - 895t).
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3i3f4f Trimethyl pentr.anonitrile 
(48«0gt 0.38 moles) was heated under reflux with 30^ 
concentrated stilphuric acid (330cm^) for 10 hours amd 
allowed to cool. This was then extracted into diethyl 
ether (2 x 20cm^) and extracted from the ether into 
IN sodium hydroxide solution (200cm^) then acidified 
with concentrated hydrochloric acid before extracting 
baok into ether (lOOcm^). Ibe product was dried with 
maignesium sulphate and concentrated before distillation 
of 3f3t4 trimethyl pentanoic acid. (I9*3gt ~b.pt. 118°C. 
12mmHg. Yield - 355^ ).
3t3»4 trimethyl pentanoic acid (6.2gt 
43 mmole) in dry diethyl ether (?0' cm^) was added to 
Lithium Aluminium hydride (2.0gt 52 mmole) in dry diethyl 
ether (70cm^) to reduce it to 3*3i4 trimethyl pentah-l-ol. 
(5»6gt b.pt. 84°C, 12mmHg. Yield « 79^)*
3,3,4 trimethyl pentanal (4»2g, 32 mmole) 
was dissolved in pyridine (l2cm^) and to this was added 
tosyl chloride (6.35gi 32 mmole) dissolved in pyridine 
(I7cm^) and stirred for 1 hour. The reaction mixture 
was poured into water and separated with ether before 
drying with magnesium sulphate and concentrating. The 
mixture was then added to a solution of sodium hydrogen 
carbonate (S.Og) in dimethyl sulphoxide (60cm^) and 
heated to 150°C for 5 minutes in an inert atmosphere of
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initrogen before distillation of 3y3*4t trimethyl pentanal
under nitrogen as a colourless liquid. (l.7g» h.pt.
42-46^01 12mmHg under nitrogen. Tield - 41^)*
NNR spectrum (9(^.) with respect to TMs£values.z
Si 0.84 (d) 6H (2 z CH^ isopropyl, J « 6.8H^);
1.02 (s) 6H (2 X CH^, 3-oarhon); 1.52 (m) IH (CH isopropyl
J - 6.8Hjg); 2.24 (d) 2H (CHg, J - 3.0H^); 9.88 (t)
IH (aldehyde oarbon, J * 3.0H^) mwt ■ 114.
The 3,3,4 trimethyl pentanal (l.7g, 13 mmoles) 
was added to 10^ sodium hydroxide solution (8om^, 20 mmoles)« 
40jC methanol solution 5cm^,65 mmoles), and stirred at 
room temperature for 2 hours. The mixture ^as then heated 
to 50°C and stirred for a further hour at this 
temperature before continuously extracting with chloroform 
for 5 to 6 hours.
After oonoentrating it was run on a silica gel 
column uniTig chloroform s methanol (9sl) as the elutant. 
Fractions obtained with the lowest Rf value of 0.40 after 
locating on a silica gel plate with 309^ suli^uric acid spray 
yiH heating to give a black spot were collected and 
concentrated to form a idiite liquid/solid which when sampled 
for presence of the triol by meiuao of RKR/1R analysis showed 
that the fraction collected was the oorresponding diol. 
Therefore apparently no triol was formed in this reaction by 
the method which under similar conditions consistently forme 
the triol. This may have been due to unknown variations in
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Attempted prepairation of 3t4t dimethyl pentanal 
"by metal assisted borohydride reduction of an acid 
chloride (ll) (CHART V)
The oadmium chloride auid dimethyl formamide were 
prepared from 8mhydro\i8 CdCl2 and dry HIP to give CdClg. 
l^HIF (7*3 mmoles).
Sodium horohydride (0.46gy 12 mmole) was 
dissolved in acetonitrile (60om^) and hexamethyl ^ liosphoramide 
(3.0cm^) and then stirred for 5 mins with CdCl2. liHIP 
(2.2g 7«5 mmoles) at -5 to 0®C (ice-salt hath) (ll) 3?4t 
dimethylpentoyl chloride (l.8gy 12 mmole) in acetonitryl 
(l2cm^) was suided with rapid stirring for 5 min. This was 
then washed with dilute hydrochloric acid« saturated 
sodium hydrogen carbonate and water before extracting with 
ether distilling over nitrogen. Ho useful product was 
obtained fi^m this reaction. (Johnstone and Telford 1978)»
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3.6.2 Attempted preparation of 3.4 dimethyl pentanal (14) 
by the use of Bia (triphetnrlphogiJiine) Copper(l) 
tetrahydroborate in the reduction of acid chloride 
(CHART VI)
(i) Bis (triphenyliahoephine) copper(l) tetrabydroborate 
hydrated copper sulphate (l6g, 64- mmole) was 
stirred in a solution of triphenylphosphine 
(34fft 200 mmole) in ethanol (1400 cm^) to ^ve, 
after 1 hour» a pale green solution. Finely 
poirdered sodium borohydride (l2gt 320 mmole) was 
added tdiilst stirring, until a pink precipitate 
fcrmed, hydrogen was given off. After 1 hour, the 
crude product vfas collected by filtration and 
dissolved in chloroform (500 cm^). The reaction 
mixture was filtered as ethanol (800 cm^) wais 
added to the filtrate. The precipitate was collected 
by filtration, and washed with ethanol and ether 
to give bis (triphenylidiosphine) copper (l) 
tetrahydroborate (30g, 50 mmole, 79^ based on 
copper stilphate) as white needles, m.pt. 169->174°C 
(mcorrected.)
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(ii) l^ aduetittn of \,d dimethylpentoyl chloride (ll)
(CHART VI)
3,4t dimethyl pentoyl chloride
49 mmole) in acetone (860 cm ) was treated 
with triphenyl phosphine (26gt 99 mmole). To this 
solution« at room temperature« solid his (tri- 
I>henylphosx)hine) copper (l) tetrahydroborate 
(297fff 49>• mmoles) wsis aidded and the reaction 
' mixture stirred for 45 min. The white precipitate« 
trio (triphenylphosphine) copper chloride 
(43«5fif» 48«8 mmole) was removed by filtration and 
the acetone filtrated and concentrated to dryness.
/ hThe residue was extracted with ether (860 cm / 
concentrated before redissolving in
chloroform (550 cm^) and the resulting solution 
stirred over copper (l) chloride (8.6g). The 
reaction mixture was filtered« the chloroform 
evaporated and the residue extracted with methanol« 
dried with NgSO^ and concentrated before distillation. 
Very little aldehyde was foTjnd mixed with the products 
but the complex was retrieved as Tris (phenylphosphine) 
copper (l) chloride. (43*5ffi 48.8 mmole« 99-li)
(Fleet« Puller and Harding« 1978).
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3.6.3 Attempted preparation of 3.3.A trti— th-rl wrriwtwjti (9A'S
end 3.4- dimethyl pentanal by the nee of a »
ohloreeucciiiamide oxidation of the alcohol (123 
(CHART IV)
H-chlorosixccinamide (ll.AfiTt 83 mmole) 
was dissolved in dichloromethane (260 cm^) and cooled 
to O^C with nitrogen passing over. To this dimethyl 
sulphide (7.3 cni^ ) added and cooled further to 
-23®C (COg-CCl^ hath). Then 3f4i dimethyl pental-l-ol 
(6.63^y 37 mmole) dissolved in dichloromethane (63 cm^) 
was added and the reaction mixture stirred for 2 hours 
at -23°C. Then Triethylamine (3.3fiTf 90 mmole) in 
dichloromethane was €uided dropwise and stirred for 3 
before allowing the mixture to return to #oom temperature. 
The reaction mixture was extracted with ethert washed 
with 1^ hydrochloric acid and water before drying over 
magnesium sulphate. The product could then be distilled 
over nitrogen at reduced pressure for collection.
Only a small samplef b.pt. 42-60^0 y 12 mmHgy had about 
30^  aldehyde with most of the product bein^ unreacted 
alcohol. This method was therefore unsatisfactory for the 
synthesis of either the thexyl (24) or dimethyl propyl 
(14) aldehydes. (Corey and Kim, 1972).
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3.7 Attempted praparatlon of 3t3«4 Trimettorl pentanal 
(CHART VII)
(i) IsobutyraldehTdey 2 metlyrl propanal (l80 cm^)
wais added dropwlse to cyclohexylamine (99£Tt 1 mole) 
and refluxed on a Deain-Stark condenser until 18 cm^ 
of water had been collected. The residue was 
distilled under reduced pressure over nitrogen to 
give isobutyraldéhyde cyclohexylimine (26)
(I3ff b.pt. 12mmHg 84-850C, 90?^ ).
(ii) Ethyl nAgnesium bromide wcus prepared by reaction 
of magnesium (21.4fff 0.89 mole) with ethyl bromide 
(98g, 0.89 mole) in dry tetrahydrofuran
(200 cm^) and reflinced for 30 min. Then isobjity- 
raldehyde (l36gy O .89 mole) in tetrahydrofuran 
(130 cm^) was added dropwise and refluxed for 6 hours 
before cooling. Isopropyl bromide (llO.AfiT» O .89 mole) 
was added and the reaction mixture was refliaxed for 
a further 6 hours before pouring onto (w/v) 
hydrochloric acid (lyOOO cm^) and refluxed for a 
further 3 hours. The reaction mixture was extracted 
* with ether* washed with sodium hydrogen carbonate*
washed with water* dried over NgSO^ and concentrated 
before distillation at reduced presstœe over nitrogen 
to give 2*2*3 trimethyl butanal (28) (20g* b.pt.
12 mmHg* 38>43^C* 209(). (Stork Reaction)
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(ill) Sodiim (l»2gf 32 mmole) was aulded to j^lene 
(13 cm^) and heated until the sodium melted.
This was then stirred vigorously and allowed to 
cool -to form sodium sand, which was further cooled 
to 3^C (acetone-COg hath). T-hutyl 
chloroacetate (7»9gt 32 mmole) mixed with (28)
22f3 trimethyl but^ial (6.0, 32 mmole) 
was aulded dropwise keeping the temperature at 3^C. 
The product was then potired onto watery sepau:*atedy 
wathsed with salt water, dried with maignesium 
sulphate amd distilled at reduced pressure. The 
lower boiling xylene (32-30°C, 12mmHg) wau3 discarded 
ami only the product boiling at lOO^C, 12mmHg 
collected, as t-butyl 4,4»5 trimethyl 2,3 epoxy- 
hexanoate (29) (2.34ffi b.pt. 12 mmHg 120-130°C.
205i).
(iv.a) (29) (2.34g, 10 mmole) waus refluxed with 10^ 
hydrochloric acid (30 cm^) for 1 hour before 
cooling and sepairating with ether. This was washed 
with sat. sodium hydrogen carbonate, washed with 
water, dried over NgSO^ and distilled over reduced 
pressure. The product obtained was only starting 
material (29) so more drastic conditions were used.
(iv.b) The (29) was pyrolised^by heating up
to 200^0, unfortunately this did not produce the
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hoped for reaotion either, so this method to synthesise 
the thesyl aldehyde (24) was also rejected.
3.7.2 Attwapted preparation of 3.3.4fcrimethyl pent*^ »AT hy
reduction of the corresponding acid via preparation of the
acid_oh loride_jfith _lith iim ^^ ri-t-^22tQ 2j^^ 222!llS 2l!Z[!Zld^
(CHART VIII)
(i) 3f3»4 trimethyl pentanoic acid (2l) (19.3g,
134 mmole) was reflTszed with thiozyl chloride 
/l9.4£Tt mmole) for 1 hour and the product 
distilled at reduced presstire to ^ ve 3t3y4 trimethyl 
pentoyl chloride (30) (l8.5fiT, h.pt. 12mmHg, 89^ )
(ii) 3f3i4 trimethyl pentoyl chloride (8.5fif, 52 mmole) 
was dissolved in dry tetrahydrofuran (50 cm^) and 
cooled to -25°C (acetone>.C02 hath). Then lithium 
tri-t-huto:gr aluminohydride (25.4£Tt 100 mmole) in 
dry tetrahydrofuran (150 cm^) was added dropwise, 
and stirred for 1-2 hours until the reaction mixture 
had reached room temperature. This was then thrown 
onto ice (800g) and 10^ HCl added (200 cm^), extracted 
with ether, washed «rith sat. sodiim hydrogen 
carbonate, washed with water and dried over NgSO^ 
before distillation at reduced pressure, b.pt. 12mmHg 
88-1429^  produced an impure product with only 10-20^ 
of the correct aldehyde present so the synthesis was 
rejected. (Brown and McFarlin, 1956; Ho, et al. 1970).
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was added dz^pwise with stlrrin^y and the 
mixture heated on a water hath to 30^C for 
1 hour. This was allowed to cool and water 
(20 cm^) was added. Then it was extracted 
with ether, washed with water, dried with MgSO^ 
and distilled over nitrogen at reduced pressure, 
h.pt. 1 PirnnHg 36-409^ but this was an impxire 
mixture of starting materials 8tnd the method 
was again rejected as being unsuitable.
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3.7.3 Attempted preparation of 3.3.4 trimethyl pentanal by 
acid hydroIvaation from 1 methorvl 3.3«A trimethyl
1.2. pentene (CHART IX)
1 methoa^l 3t3t4 trimethyl lf2y pentene 
(5»9Sf 45 mmole) waus refliaxed with 5^ HCl (30 cm^) 
for 1 hour. It was separated andthe product washed 
with sat. sodium hydrogen carbonate« washed with 
water, dried with MgSO^ before distillation, at 
reduced pressure to give the aldehyde. (l.Og, 
b.pt. 12mmHg 48-52°C, 17^). This product was not 
pure amd contained about 255^  of 2,2,3 trimetHyl 
butanal which could not be separated, and interfered 
with the next stage, triolisation, so much that this 
method waua also rejected.
3.8 Attempted preparation of 1,2,2. trimethyl ethoxy 
propa«s bv increase in the carbon chain using 
trimethvl oxosulphonium iodine, sodium hydride 
complex from 3.3. 4 trimethvl pentauMtl. (CHART X) 
Sodium hydride (SOjt dispersion) was 
washed with dry ether to get rid of the mineral oils 
and dried over nitrogen to drive off any exoess ether. 
Then trimethyl oxosulphonixm iodide (13*2g, 60 mmole) 
in dimethyl auljdioxide (60 cm^) was added. 2,2,3 
trimethyl butanal (28) (6.0g, 52 mmole) in dimethyl- 
sulphoxide (20 om^)
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TABIE 1
Resiilts for intravenous injection into female albino 
mice showing the mortality onset times and times to 
death.
Dose
seooenxTi rniu 
Mortality Onset Times to
(mg/Kg) Rate Times Death
0.13 0/6 30 sec -  1 min -
0.16 1/6 15 sec - 1 min 1 min 30 secs
0.20 4/6 30 sec - 1 min 2 - 9  min
0.25 4/6 Immediate - 1 min 1 - 2  min
- ...........
0.31 lo / io Immediate - 30 isec 30 secs
. . . ____ ____
tibie 1 (b) of various Lethal Dose values for i.V .  in mice on
Feooentrl PETO showing the limits and probit slope.
Dqssi» with Probit ( i S . E  .-1 Slone of alone )
LDIO 0.150 (0.102 - 0.175)
LD30 0.178 (0.140 - 0.203)
LD50 0.200 (0.170 - 0.231)
LDTO 0.225 (0.197 -0.276)
LD90 0.267 (0.231 - 0.379)
102
10.25 
* 2.75
TABIg 1
Results for intraveno\is injection into female al'bino 
mice showing the mortality onset times and times to 
death.
Dose
(rng/K^ )
Mortality
Rate
Onset
Times
Times to 
Death
0.13 0/6 30 sec - 1 min -
0.16 1/6 15 sec - 1 min 1 min 30 secs
— ^ •—  ■ —
0.20 4/6 30 sec - 1 min 2 - 9
0.25 4/6 Immediate - 1 min 1 - 2  min
0.31 lO/lO Immediate - 30 sec 30 secs
. ____________  - -  •
TABIZ 1 (h) of various Lethal Dose values for i.v. in mice on 
ITeopentvl PBTO showing the limits and probit slope.
DQse«^ with . 
(limits) Mg
Probit (i S JJ.
Slope of slope )
LDIO 0.150 (0.102 - 0.175)
LD30 0.178 (0.140 - 0.203)
LD50 0.200 (0.170 - 0.231)
LDTO 0.225 (0.197 -  0.276)
LD90 0.267 (0.231 - 0.379)
102
10.25 
i  2.75
TABIg 2
RasTilts for intravanous injaction into femala albino 
mica showing mortalityt onsat timas etnd timas to daath.
Doss Mortality Onsot Timas to
(img/Kg) Rato Timas Daath
0.5 3/3 immadiata—15 sac 1-2 min
0.3 2/3 30 sac-60 sac 1-2 min
0.25 2/3 10 soc-30 sac 1-2 min
0.15 1/3 30 sac 4 min
0.10 0/3 30 soc-2min racovarad by2 min
Tabla 2 M
Tabla of various Lathal Dosa valuas for i.v. in mica on 
Dimathyl Propyl bicyclic phosphata showing tha limits and 
probit slops.
Dosas with -1 ProbitSlops
(- SX. 
of slops )
LDIO 0.991 (0 .0 0 5 -0 .1 7 8 )
LD30 0.167 (0 .0 3 6 -0 .2 4 2 )
LD50 0.212 (0 .1 0 3 -0 .3 7 2 )
LD70 0.267 (O .181-0.919)
LD90 0.375 (0 .2 5 8 -5 .3 8 1 )
Mrs. C. Barclay oarriad out this analysis.
103
3.9
3.9.1
Acute toxicity of Taicyclic pho8T>hate esters
The cage compoiuidsy including the bicyclic 
ph08X)hate esters, were found to he h i ^ l y  toxic in 
mice, producing seiziires emd consequent death 
(Bellet and Casida, 1973). This was found to he 
due to the antagonism of the actions of synaptically 
released GABA (Bowery et al, 1976 and 1977) hy 
examination of the superior cervical ganglion of the 
rat.
To establish the acute toxicity in mice, 
intravenous injections were performed with various 
doses to give an which may then he compared
to other liD^ Q experiments performed hy other hicyclic 
phosphates of known toxicity in mice and their 
subsequent |)otencie8 of antagonism on the actions of 
GABA.
Method
The compounds were dissolved in 
dimethylsulphoxide for intravenous administration 
to female albino mice in the tail. The mice were 
randomised into groups of six.
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Results;
Severe toxic-«igns were seen at all doses and 
onset times and times to death appeared to be dose-related.
Initial signs were tremor and panting 
respiration with occasional vociferation. This was followed 
by a brief phase of violent convulsions and terminated by 
prostration ««d maui'ked tonic extensor spasms. At this point 
some of the suiimals were salivating and haematuria was 
observed. Many of the mice became cyanosed. Death appeared 
to be due to respiratory failure. Surviving animals often 
bouts of convulsions when prostrate. Most surviving 
animals recovered within 10 minutes, recovering their upri^t 
posture althou^ remaining tremorous and subdued for some time.
At the dose used of 0.31 mg/Kg there was 100^ mortality
%fith 10 mice \ised, death being in l®ss than 30 seconds in all cases.
TABU! 1 shows the effect of 4~(2,2,Dimethyl projjyl)— 
2,6,7,-trioxa-l-phosphabicyclo (2,2,2) octan-l-one. Statistical 
analysis using probit analysis maximum likelihood sho^ '^ ed the 
oompovmd to hav. an LDjq of 0.20 i 0.03 mg/Kg with complete
mortality at 0.31 mg/Kg.
These results for the BTeopentyl PBTO show that
it is a very potent convulsant in mice having about half the 
potency of t-butyl PBTO (t-butyl PBTO toxicity i.v. in mice 
LD-^ is 0.12 with limits (O.IO - O.U) mg.Kg"^), (Cooper et al.
1978) and has a similar potency to isopropyl PBTO (toxicity
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3.10 PiBCuasion of STirthetic routes
All the syntheses of the hicyclophosphates 
involved the cyclisation of the corresponding triol into 
the hicyclophoophato using phosphorus oxychloride.
(Cooper et al. 1978). The major synthetic prohlems arose 
with the preparation of the parent aldehydes which were 
used to synthesise the triols hy reaction v^ ith 5^  aqueous 
sodium hydroxide (0.15 mole) and 40 ^ formaldehyde (0.4 mole) 
(Permer euid Solomon« 1954)*
(i) The parent aldehyde (4) was sjnthesised hy the
acid hydrolysis of diethoxy 44 dimethyl pentane (3) 
giving a 25^  yield of the product.
The starting material used was the primary 
alcohol (l) which had one carhon atom less than 
the aldehyde necessitating the lengthening of 
the basic carhon chain.
This was done hy hromination of the alcohol 
■i n order to make a grignard rea.gent which could 
then he added to triethyl orthoformate to give (3) 
which could he hydrolysed.
Preparation of dimethyl propyl PHPQ
This method of lengthening the carhon alkyl 
chain was tried several times hy making the grignard agent 
and reacting with triethyl orthoformate for the 
dimethyl propyl compound hut all of these resulted in
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failTire even when dimethyl phenyl orthoformate wsus 
used insteeul of the trimethyl orthoformate.
Therefore some different synthetic route had 
to be established to synthesise the paurent aldehyde ■ 
needed to make the triol and hence the corresponding 
bicyclophosphate ester.
It was assumed that some method of either oxidising 
the corresponding alcohol (12) in Chart II to the 
aldehyde or reducing the corresponding acid (lO) in 
Chart II would be a suitable method since the original 
simple synthetic route successfully used for the Heopentyl 
compound would not work for this compound.
CHART IV. The alcohol (12) was prepared and then 
oxidised using a complex prepared from dimethyl sulphide 
and N-chlorosuccinamide under carefuuly controlled 
conditions (Vilsmaier and SprOgel 1972; Corey and Kimy 1972). 
Even thoufl^  excellent yields were reported for this process, 
in practice little success was established with a little 
aldehyde present in the b\ilk of imreacted alcohol. After 
several attempts to obtain good yields by changing solvent 
from toluene to dichloromethene, this method was rejected 
in order to concentrate on other methods to s3nithesiso this 
aldehyde. The same method also proved unsuccessful for 
the the:^l aldehyde (24)»
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CHART V. Ko direct reductions of the corresponding 
acid (lO) and (2l) were practical as the conditions 
needed to reduce an acid are often too severe for the 
reduction to stay at the aldehyde stage withoizt 
reducing to an alcohol so the reduction methods used 
were those with the corresponding acid chloride (ll) amd 
(30).
A metal-assisted borohydride reduction of the 
acid chloride which has been reported to give good 
yields. (60-8056) (Johnstone and Telford, 1978), was 
attempted using cadmium chloride/'dimethylformamide 
but again this failed to work. (See Methods and Chart V).
A second method of reducing the aoid chloride 
(1 1) a-wd (30) to. the corresponding aldehyde attempted, 
was by the \ise of Bis(triphenylphoiphine) Copper (l) 
tetraborate. This has been reported as simple and 
effective, giving yields of 86^ , (Fleet, Puller and 
Harding 1978). It did not work in these experiments 
with the acid chloride and aldehjrde being lost and the 
copper complex being obtained unchsunged at the end of the 
reaction. (See Methods and Chart VI).
In Chart VII a simple three stage synthesis 
enabled the prei>aration of an aldehyde with a carbon 
atom less than the aldehyde needed (28). This was done 
by the condensation of 2 methyl formaldehyde and
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cyclohezylamine to give good yields of ieobutyralde- 
hydecyclohezylimlne (26), To thiSi usin^ a grignard 
reagent, the Stork Reaction was performed with the 
addition of the alkyl group to give the basic thexyl 
shape which was important to the final product. This 
aldehyde (23) however, could not be reacted directly 
with the sodium hydroxide amd methanol solutions to 
obtain the desired triol because the first tv;o 
substituted methyl groups were attached directly to the 
carbon atom which would form the bridge head in the 
bicyclophosphate ester. It was therefore essential to 
increase the basic carbon chain by one carbon atom. This 
was first attempted by the addition of t-butyl ohloro- 
acetate, usin^ sodium sand and proved fairly successful, 
isolating t-butyl 4 ,4 t5  trimethyl 2,3 epoxjdieianoate (29) 
in a yield of 205^ . However, vrtien an attempt was meule to 
hydrolise this into the desired Aldehyde using 10^ HCl 
it was not successful, having no effect on the 
epoxyhexanoate (29 ). When more drastic conditions wore 
used and (29) was pyrolised the molecule turned into a 
polymer idiich was of no use, therefore this method of
the carbon chain was rejected and a different 
method then attempted (Chart X).
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This method involved increasing the carhon 
chain from the aldehyde (28) in an epoxy propane compound 
(32) similar to that in the previous attempt, described 
above. This was done using an oxosulphonium iodine/ 
sodium hydride complex.
The products, after distillation and analysis proved 
to be an impoare mixture of starting materials, ao again 
the method of increasing the carbon chain from the 
aldehyde (28) was dropped in favour of other methods of 
prepauraition of the desired aldehyde.
Some success was obtained by the acid hydrol3rsis 
of (1 methoxyl) 3t3?4 tri-methyl 1,2 pentene (3l) in 
Chart IX), but a mixture of two aldehydes (31) and (28) 
in a ratio of about 3 : 1 respectively was obtained. This 
mixture was difficult to separate by distillation, and when 
used as a mixture in the triolisation only a slight trace 
of the correct triol (25) was obtained, which was not enough 
to separate auid ring close with the phosi>horyl chloride.
Moot of the product of this reaction was the diol infering^ 
the possibility of the close proximity of the multibranched 
alkyl chain to the carbon atom which is to form the bridge­
head has some effect in preventing the formation of the 
bulky triol.
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3.11 Conclusions
As mentioned earlier the difficulties in 
the synthesis of the bicyclic organophosphorus esters 
were encountered in the synthesis of the aliphatic 
aldehyde which could be triolised fairly simply and then 
ring closed with phosphorus oxychloride for the final 
products.
Synthesis of these aldehydes was fairly simple 
in the case of the cyclopentyl and neopentyl compo\ands 
because of the success of acid hydrolysis of the diethoxyl 
compounds. When this was attempted for th^dimethyl propyl 
awH thexyl compounds it failed, therefore other methods 
of the conrespending: «Idehydes had to bo attempted.
Several methods outlined previously wore tried from the 
literature available, with varying degrees of success, 
often giving very low auid unsatisfactory yields and by 
products, which were difficult to separate from the 
aldehyde which was needed for the triolisation.
Eventually the tosylation method proved 
successful in both cases of dimethyl propyl and thoxyl 
compounds. This method gave the comparatively good 
yield of over 40^ ^aad the products formed were relatively 
pure idiich wais essential for the next stage involving 
triolisation of the aldehyde.
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When the dimethyl pentanal was successfully 
triclised a comparatively good yield of 23^ was obtained 
for the triol. This was successfully ring closed to give 
the dimethyl propyl bicyclophospbatei but due to the 
surprisingly high water solubility of this compound a 
low yield of 135^  was obtained because some was lost in 
the excess of water in the crystalisation.
When triolisation of the thexyl compound was 
attempted from the aldehyde, suprisingly it did not work as 
expected and shown in all the other comparable reactions. 
After purification by four runs on the silica colTimn it 
was found analytically that there was no corresponding 
triol present and that the reaction had caused the 
aldehyde to form into the diol. Unfortunately the reaction 
conditions could not be changed for other reactions because 
all the aldehyde was used in the one reaction, and time did 
not permit for the resynthesis of the theryl aldehyde.
This was a pity because it was this bridge head substituent 
(thexyl) which most resembled that of the t-butyl substituted 
bicyclo phosphate, the most potent compound. The 
lipophillicity, size and shape of the thexyl group would 
probably cause the corresponding bicyclophosphate to be 
an extremely potent compound and so help as a tool in the 
understanding of how these antagonist have their actions.
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CHAPIER 4 : PSARM4COLOGICAL EVALUATION OF OABA ANTAGONISTS
AND SYNTHESISED BICYCLIC PHOSPHATES ON THE ACTIONS 
OP GABA AND CARBACHOL ON THE ISOLATED SUPERIOR 
CERVICAL GANGLION OP THE RAT
4.1 Introduct ion
4.2 Methods and materials
4.3 Results and conclusions
4.3.1 The effect of the depolarisation 
caused by GABA using a set, submeurimal 
dose varying the concentration of 
the antagonists
4.3.2 Conclusions
4.3.3 The effect of the depolarisation caTised 
by carbachol using a set, submaximal 
dose and varying the concentration of 
the antagonists.
4.3.4 Conclusions
4.3.5 The effect of the depolarisation caused 
by GABA using a set concentration of 
several antagonists and varying the 
concentration of GABA in order to obtain 
a dose-response relationship.
4.3.6 Conclusions
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4.1 Introduction
GABA waA demonstrated to be involved in the 
inhibitory mechanisms of sympathetic ganglia (De Groatt 1966, 
1969). When GABA vras applied to the cat superior cervical 
ganglion in vivo by intra-arterial injection it caused a 
depolarisation which was different from the effects shown by 
stimulating cholinoreceptors in the ganglion and appeared to 
resemble the central inhibitory effects of GABA (De Groat 1970). 
This depolarisation was different from the hyperpolarisation 
caused by GABA in mammalian centralneurones (Kmjevic and 
Schwartz 196?» Dreifuss et al. 1969). However there was a 
similarity with the central actions of GABA with respect to 
uptake and transport mechanisms for GABA in the ganglion 
(Bowery and Brown 1972).
GABA appeared to cause a depolarisation of the neurones 
by a membrane permeability change to chloride ions (Adams and 
Brown 1974) which was comparable to permeability changes in 
central neiirones meastired in a simileu:' way with intracellular 
electrodes (Krnjevic and Schwartz 1967).
The difficulties encountered with iontophoretic 
application of drugs etnd the possibilities of the effects of 
endogenous GABA (Curtis et al. 1971c) could more easily be 
assessed under in vitro conditions using an extracellular 
recording technique with surface electrodes (Pascoe 1936,
Brown I966) in which drugs could be applied in known
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concent rat ions •
The depolarisation can be detected on the ganglion 
surface when measured with respect to the postganglionic trunk* 
this dex>olarisation was transient and peaked after 10-13 seconds 
before diminishing with G A M  still present. It wets a low 
amplitude depolarisation with a maximum peak of approximately 
2 millivolts (Bowery and Brown 1975)«
The cholinomimeticycarbachol,also depolaur'ised the 
gemglion but this was a sustained depolarisation lasting 
several minutes with a transient hyperpolarisation on washing 
out the drug. Bicuculline eind picrotoxin selectively auitagonised 
the depolarising actions of G A M  with much less effect on those 
of carbachol. (Bowery and Brown 1974).
This depolarisation was not mediated by acetylcholine 
receptors as it was not blocked by concentrations of the 
acetylcholine antagonists* hexaméthonium or hyoscine* in 
sufficient concentrations to antagonise the effects of carbachol.
4«2 Methods ajid Materials.
The method used was that essentially described by 
Bowery and Brown (1974) with a modification for superfusion 
(Brown and Matrsh 1973)*
Male Wistar rats* about 230g in weight were anaesthetised 
with urethane (l.4g/Kg* intraperitoneally). The superior cervical 
ganglion was removed with suitable lengths of pre— and post— 
gBuiglionic trunks attached. The connective tissue sheath was
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stripped off auid the ganglion mounted vertically with two 
silver/silver chloride electrodes placed in contact with 
the ganglion and its postganglionic trunk. The preparation 
was superfused with &ebs-Henseleit solution* aerated with 
95^ oxygen : 5?^  carbon dioxide, at a constemt rate of Icm^ 
minute.
All the dru^ used were added to the superfusion 
solution. The ganglion siirface potential, measured with respect to 
the postganglionic trunk, weis continuoiisly monitored with the 
electrodes connected to a high impedance (^IMA) X-^ recorder 
(Smiths Servoscribe IS) to produce a continuoiis voltage-time 
record. A full scale deflection of 2mV or 3mV was routinely used.
The depolarising agonist drugs (GABA and carbachol) 
were applied for one minute at 13 minute intervals. Antaigonist 
drugs were atdded to the superfusion fluid and applied continuously 
10 minutes before auidition of agonist doses. The antaigonists 
were then wanhed out for 13 minutes with ErebsrHenseleit solution 
before the addition of more aigonist doses. Hyoscine (2.6mN), a 
muscau?inic antaigonist, wan present in the superfusion fliiid to 
limit the action of canbachol to the nicotinic receptors 
(Bowery and Bro%m 1974).
The following^ compoimds were used:
\-amino-n-butyric acid (4 aunino-n*^utyric acid, GABA; BDH); 
carbachol ( carbauaizioyl choline chloride, BEH); hyoscine 
hydrobromide (Hartindale Samoore); picrotoxinin (Sigma); 
bicuculline methobromide; Isopropyl bicyclic phosphate
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(4-(l methyl ethyl) 2,6,7 trioxo-1-phosphabicyclo (2,2.2) 
octan-l-one); dimethyl propyl hicyclic phosphate 
(4-(lf2, dimethyl propyl) 2,6,7 trioxa-l^phosphabicyclo (2.2.2) 
octaui-l-one); neopentyl bicyclic phosphate (4-(2,2, dimethyl 
propyl) 2,6,7 trioxa-1-phosphabicyclo (2.2.2) octan-l-one); 
cyclopentyl bicyclic phosphate (4-(cyclopentyl) 2,6,7 trioia-1- 
phosphabicyclo (2.2.2) octan-l-one); tertiary butyl bicyclic 
phosphate (4-(l,l, dimethyl ethyl) trioxa-1-phosphabicyclo (2.2.2 ) 
octan-l-one.
The superfusion solution was Krebs-fienseleit solution 
with the following composition:
Sodium chloride, NaCl, lld.OmM; Potassium chloride, KCl, 4*8mN; 
Maignesium sulphate hydrated, MgSO^. 7H2O, 1.19nM; Potassium 
dihydrogen phosphate, KHgPO^, l.lSmM; Calcium chloride, CaCl2, 
2.52mM; sodium hydrogen carbonate, BaHCO^, 23.0mH; D—glucose,
-0,, ll.OmM, Plus hyoscine hydrobromide, 2.6mM, added to 
suppress any muscarinic actions of carbachol. The solution was 
aerated with a 95?^  oacygen : 5?^  carbon dioxide mixture to bring 
the solution to pH 7*4*
4.3 RESULTS: ASP C0HCL05I0H5
4.3,1 The effect of the depolarisation caused by GABA using a set,
quhn»Timal^^^£iaa^_^^^^»r]^^g_^he__concentration_of_the_^utagoni8t^^
A dose of GABA of 30mM was chosen as the set dose 
because it gave approximately 70-80^ of the maximal response.
This was applied for 1 minute each time.
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(4-(l methyl ethyl) 2,6,7 trioio-l-phosphahicyclo (2.2.2) 
octan-l-one); dimethyl propyl bicyclic phosphate 
(4-(l,2, dimethyl propyl) 2,6,7 trioxa-l-^osphabicyclo (2.2.2) 
octan-l-one); neopentyl bicyclic phosphate (4-(2,2, dimethyl 
propyl) 2,6,7 trioxa-1-phosphabicyclo (2.2.2) octan-l-one); 
cyclopentyl bicyclic phosphate (4-(cyclopentyl) 2,6,7 trioxa-1- 
phosphabicyclo (2.2.2) octan-l-one); tertiary butyl bicyclic 
phosphate (4-(l,l, dimethyl ethyl) trioxa-1-phosphabicyclo (2.2.2 ) 
octan-l-one.
The superfusion solution was Krebs-fienseleit solution 
with the following composition:
Sodium chloride, NaCl, ll8.0mH; Potassium chloride, KCl, 4*8mN; 
Maignesium sulphate hydrated, MgSO^. 7H2O, 1.19nM; Potassium 
dihydrogen phosphate, KH2P0^ , l.lSmM; Calcium chloride, CaCl2, 
2.52mM; sodium hydrogen carbonate, NiaHCO ,^ 23.0mM; D-nglucose, 
ll.OmM, Plus hyoscine hydrobromide, 2.6|iM, added to 
suppress any muscarinic actions of carbachol. The solution was 
aerated with a 955S oacygen : 55^  carbon dioxide mixture to bring 
the solution to pH 7*4*
4.3 RESULTS: AHD COHCLPSIONS
4.3.1 The effect of the depolarisation called by GABA using a set,
qijhn»TTmaT_jiQge_and_var]^ijgjbhe_^o^ of the antagonists.
A dose of GABA of 30mM was chosen as the set dose 
because it gave approximately 70-^0^  of the maximal response.
This was applied for 1 minute each time.
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Flg.d.l. Effect of increasing concentrations of 
t-butyl bicyclophosphate (■), picrotozinin (o) 
aoicL (-i-)-bicuculline methobromide (v) on ganglion 
depolarisation produced by Y-€uninobutyric acid 
(g a m ) at a submaximal concentration of 3|iM. 
Depolarisation is expressed as io reduction in 
response obtained in the absence of antagonist. 
Each point and vertical bar gives the mean and 
standard error for at least six measurements. 
Lines are drawn by eye.
-4
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Fis.4*2. Effect of increasing concentrations of 
isopropyl bicyclophosphate (v) and cyclopentyl 
bicyclophosphate (▼) on ganglion depolarisation 
produced by Y-aminobutyric acid (GAM) at a 
submaximal concentration of 3mM. Depolarisation 
is expressed as io reduction in resx>onse obtained 
in the absence of antagonist. Each point and 
vertical bar gives the mean and staindand error 
for at least seven meausurements. Lines axe drawn 
by eye.
100
50
Antagonist concentration (log M)
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Fi^.4>.3> Effect of increasing concentrations of 
IToopontyl ‘bicyclophosphate (□) and Dimethyl propyl 
bicyclophosphate (^) on ganglion depolarisation 
produced by Y-aminobutyric acid (GABA.) at a 
submaiimal concentration of 3mN. Depolarisation 
is expressed as reduction in response obtained 
in the absence of antagonist. Each point and 
vertical bar gives the mean and standard error for 
at least 7 measurements.
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Fovir concentrations for each antagonist were 
tested these being lO”^ ,  lO"^ 8tnd 10“^ .
The antagonist was applied 10 minutes previous 
to the dose of GASA and a reduction in the depolarisation due 
to GABA was seen in all antagonists testedf even at the lower
7concentration of 10~ N antaigonist present in the superfusing 
fluid. The antagonist was then washed out completely 
(30-60 minutes) before another concentration of antagonist 
coTild be applied and the effect on the depolarisation to 
GABA (30|jH) could be measured on the polygrax)h.
Approximately seven determinations for each 
concentration of antagonist were performed in order to 
determine the percentage inhibition of the GABA response. The 
restilts of these determinations w e ^  collated and analysed 
sho%ri.ng the mean per centatge inhibition of GABA with standard 
errors of the mean for 6-9 determinations.
These results were then represented graphically 
(pigs. 4.1 - 4.3). Prom these graphs it could be seen that 
all seven of the euitaigonists tested were very effeotive in their 
ability to inhibit the depolarisation caused by GABA in this 
preparation.
The IC values (the concentration which caused a50 '
503G reduction in response to GABA) were calculated from the 
graphs tabulated in Table 3*
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TABIE 3
The values (the concentration of antagonist which caused 
a 309^  reduction in the response to QAM), calculated from the 
values obtained in Figs. 4.1-4.3 for each antagonist.
Antagonist IC^Q Value
(+)-Bicuculline methobromide 7.4 X 10“^
•
Picrotoxinin 3.1 I 10“^
Cyclopentyl bioyclic phosphate. 1.8 I 10“^
ITeox>entyl bicyclic phos|)hate 3.0 I 10" ^
Dimethyl propyl bicyclic phosphate 1.0 X 10“^
Isopropyl bicyclic phosphate 5.1 X 10“^
Tertiary butyl bicyclic phosphate 8.6 X 10“^M
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i. (») - BicuoTxlline methobromide
An I&cn value of 7*4 x 10“^  was obtained with50
biououlline which proved to the the least potent in 
antagonism of the responses to Q A M  (30|iN).
ii. Picrotoxinin«
AnlC^Q value of 3*1 x 10“^  was obtained for 
picrotoxinin showing it to be approximately twice as 
potent as (■••) - bicuculline methobromide in this 
.preparation.
iii. Cvolopentyl bicvclic phosphate.
AnlC^Q value of 1.8 x lO“^  was obtained showing 
it to be a more potent G A M  antagonist than picrotoxinin 
«jMi (-f) - bicuculline methobromide but not as potent an 
antagonist as the tertiary butyl bicyclic phosx>hate.
iv. Heopentvl bicyclio phosphate.
An value of 3*0 x 10“^  was obtained for this; 
being more potent than (4*) — bicuculline 
methobromide t about equipotent to picrotoxinin and not 
as potent as the terti8u:7 butyl bicyclic phosphate.
V .  D i m e t h 2 ^ _ £ r o £ 3 ^ _ b i c j c l i c j h o 8 j h a ^ .
An IC^ value of 1.0 x lO“^  was obtained for this 
compound was more potent than all the other compounds
in inhibiting Q A M  but eigain not as potent as the tertiary 
butyl derivative.
v i .  I s o ^ o j2 [ l_ ^ ic jjo l ic j^ o s ^ a ^ .
An value of 5*^ x 10“^  showed it to be the50
least potent of the bicyclic phosphate esters which
125
were tested here but it wae more potent than 
(■*■)• bicuculline methobromide. 
viii. Tertiaury butyl bicyclio phOBTAAte
This was the most potent antagonist tested with
„•7
an of 8.6 z 10 'N which was 8.6 times the potency 
of bicuculline methobromide.
4,3,2 Conclusions;
The most potent antagonist of the effects of Q A M  on 
depolarisation of the surface of the superior cervical ganglion 
of the rat was the tertiary-butyl analogue. This finding would 
agree with other structure-toxicity sti:idies on the bicyclic 
phosphates (Eto et al. 19761 Bowery et al, 19771 Cooper et al. 
1978» Olsen et al. 1979)* In accordance with other structure- 
toxicity studies the other bicyclic phosphates were in the 
order of dimethyl propyl, cyclopentyl, neopentyl and ^isopropyl 
derivative, being the least active, this was however of the 
same order as (>f) - bicuculline methobromide which was fouzid 
to be the least active of compoiands tested.
Picrotoxinin was found to be equipotent as the neopentyl 
bicyolic phosphate and of the same order of potency as the 
other bicyclic phosphates in agreement with Davidson et al. 
(1977)* In this study, however, it was found to be more than 
twioe as potent as (■•-) - bicuculline methobromide which is in 
contradiction with some of the studies on mammalian QAM-ergic 
oystema (Oahwiler 1973« Olsen et al. 1973)* When the hij^er
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TABIE A
Table of % inhibition (or potentiation) of the depolarising 
effect of o€Ufbachol (33Mlf) on the superior cervical ganglion 
of the rat in the presence of a hig^ concentration (lO"^) of 
several OABA. antagonists.
Antagonist Ho. of
det erminat ions
^ Inhibition 
of response to 
carbachol (33|iM) 
by antagonist 
(10-4)
Inhibition
or
Potentiation
caiused
(•h)-Biouculline
methobromide
7 31.9 - 2.4^ ^Inhibition
Picrotoxinin 6 21.5 - 4.0ji Inhibition
Cyclopentyl
bicyclic
phosphate
T - 4.9 - 1.3?^ Potentiation
Keopentyl
bicyclic
phosphate
7 -16.0 i 4.8?i Potentiation
Dimethyl propyl
bicyclic
phosphate
7 -20.6 i Potentiation
Isopropyl
bioyclic
phosphate
6 -14.2 i 2.yfl> Potentiation
Tertiary butyl
bicyolio
phosphate
5 -19.5 - 3.9^ Potentiation
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4.3»3 The effect of the depolarisation oaiiBed by orbachol
using a sett submaximal dose and a single hirii concentration 
of antagonist.
A dose of ocurbaohol of 33(iH was ohosen as the 
set dose because it gave approzimatelj dO^ maximal response.
This was applied for 1 minute each time.
The hipest concentration of antagonist (10~^) was 
\ised to test the effects of carbachol after previously 
obtaining a depolarising response in the presence of no 
antagonist.
Approximately six determinations for each antagonist 
dose of 1 0 ^  were ¡)erformed in order to determine the effects 
of the antagonists, on carbachol. The results of these 
experiments are tabulated in Table 4 showing the mean percentage 
inhibition of carbaohol with standard errors of the mean for
3-T determinations.
i. j^»][_-»_M(:mculline methobromide.
At the concentration used (10"^) there was an 
inhibition of approximately of the normal control 
response to carbachol.
ii. Piorotoxinin.
This also caused an inhibition to the effects of 
carbachol but not as potently as (+) - bicuculline 
methobromide giving a 20^ reduction from the control 
value.
iii. The bicvclio lahosphates.
All five compounds tested caused a potentiation in
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the depolarising effect of carhachol (33|iM) on the 
ganglion ranging from a 3^ potentiation for the 
cyclopentyl derivative to a 20^ potentiation with the 
tertiary hutyl derivative and the dimethyl propyl 
derivative.
Conclusions:
All determinations were done only at the highest 
concentration of emtagonist (lO”^ ). The inhibition of 
carbachol responses caused by (-f) — bicuculline methobromide 
was found to be in skgreement with reports on the cervical 
ganglion (Bowery et al. 1978b, Cryer 1979)« It is not known 
i^ether the actions of (-t*) — bicuculline methobromide are 
specific for carbachol antagonism.
Picrotoxinin also inhibited the depol&u:‘ising actions 
of carbachol in a similar fashion to (-f ) — bicuculline 
methobromide but would appear not to be as potent an auitagonist. 
The mechanisms cf these actions have not been investigated 
thoroughly could be non-specific actions due to the hi£^ 
concentrations of antagonists in the preparation as there was 
very little antagonism for concentrations which dramatically 
affected the actions of GABA on the ganglion.
In all cases with the bicyclic phosphates there was a 
potentiation of the depolarisation of the ganglion surface cn
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application of carbachol; this was followed by a transient
hyperpolarisation when the carbachol was washed out. The
mechanism of action of this effect is not known but may be
non-epecific due to the high concentration of antagonist
applied. When lower concentrations of bicyclic phosphates,
sufficient to antagonise the depolarisinjf actions of GABA
«
wore used very little effect on depolarisation caused by 
csu:‘bachol was observed.
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Pi^.4,5.Log concentration-depolarisation relationship 
for Y-aminohutyric acid fOAM) on rat superior cervical 
ganglion in the absence (v) and in the oresence of 
23|iM dimethylpropyl hicyclophosphate (■) and 24mM 
picrotoxinin (a). GABA, doses were applied for 1 min 
periods at 15 min intervals. Antagonists were added 
30 min before testing to allow equilibration. Each 
point and vertical bar gives the mean and standard 
errors for at least 5 observations.
GABA concentration (log M)
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Pig, A, 6. Log concentrât ion-depolau:*i sat ion relationship 
for Y-ejninobutyric acid fGABA.) on rat superior cervical 
ganglion in the absence (v) and in the presence of 
6,5|iM (+)-bicuculline methobromide (a ) and 23nM cyclopentyl 
bicyclophosphate (□). GABA doses were applied for 1 min 
periods at 15 min intervals. Antagonists were added 30 min 
before testing to allow eq\iilibration. Each point and 
vortical bar gives-the mean and standard errors for at least 
5 observations.
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Pig.4.7.Log concentrâtioh-dspolarisation relationship 
for V-«minobutyric acid (GABA.) on rat superior cervical 
ganglion in the absence (v) and in the presence of 23mM 
Ueopentyl bicyclophosphate (■)• GABA doses were applied 
for 1 min periods at 15 min intervals. Antagonists were 
added 30 min before testing to allow equilibration. Each 
point and vertical bar gives mean and standard errors 
for at least 5 observations.
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4.3.5
relationship»
The concentration of antagonist applied in each case 
was that which gave a 5O-6O56 inhibition of the submaiimal 
concentration of GABA determined in the previous sot of 
experiments»
A range of 5 increasing concentrations of GABA was 
used in order to obtain a range of results which would provide 
a good dose-response curve» The concentrations used wore 
3 X 10”^  for the minimum concentration up to 3 x 10^^ to 
obtain a "ift-rTHnim effect»
The results from 5-8 experiments wore used in the control 
(without the presence of any antagonist) and repeated in the 
presence of a predetermined concentration of antagonist»
The resTilts of those experiments are
represented graphically in Fl^s» 4»4 - 4»7.
The graphs were plotted semi-logarithmically whore 
depolarisation in mV (normalised to ImV for a concentration of 
3 X 10“^  GABA) on the ordinate against the log of the 
concentration of GABA as a control experiment and also in the 
presence of antagonist on the abscissa»
Bicneulline methobromide (6»5 x lO“^ )
A shift in the dose-response curve to the rii^ it 
indicating competitive antagonism to GABA as the 
control and experiment in the presence of antagonist
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11.
4.3.6
111.
cTirves were parallel to each other.
Pioroto-rinin  ( 2.4  x 10~^)
This also caused a significant inhibition of the 
resi>onses to GABA, but the maximum height of the dose 
response curve with picrotoxinin present was reduced 
to about 5036 of that of the control dose-response curve 
indicating a non-competitive type of antagonism. 
T^^^i2[clio_j^08^ate|^. ‘(2.3"*2.5 ^ lO”^ )
the antagonism in these experiments seemed 
to be of a non-competitive natxire with all the dose- 
response curves being moved to the ri^t and also 
reduced in height indicating that a maximal response 
would not be obtained with a greater increase in the 
concentration of GABA applied. The results from 
the graphs show that there was little difference in 
the effects of all the different derivatives used.
Conclusions;
There was some difference between the effects 
of (+) - bicuctilline methobromide, the bicyclic phosphates and 
picrotoxinin indicating they may not have the same mode of 
action in the antagonism of the effects of GABA in this 
prepauration.| siiiggesting different modes of action.
The least effective in shifting the dose-response 
curves to GABA depolarisation of the cervical g a l l o n  from the 
graphs would appear to bo (+) - bicuculline methobromide but it 
must be noted that the concentration of this drug in the 
experiments was about one fourth that of the other drugs used
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so this would account for the unexpected apparent weakness 
of (+) - hicuculline methobromide thus it was not possible to 
make any direct comparisons with the effect of the other 
comx)o\ind8.
Picrotoxinin was also a potent inhibitor of the 
depolairisin« effects of GABA, and the inhibition produced 
appeared to be non-competitive suggesting its actions are at 
a different site to that of the GABA receptor. These findings 
are in agreement that piorotoxinin exerts its actions at the 
ion channel (Ticku and Olsen 1977). Picrotoxinin was more potent 
than some of the bicyclic phosphates but the results showed that 
potencies of these compounds were similar to that of picrotoxinin.
All the analogues of the bicycylic phosphates had similar 
potencies **-'*^^  were potent inhibitors of the depolarising 
actions of GABA. Similar results in agreement with those found 
for the isopropyl analogue by Bowery et al. (1976a, 1978a) were 
obtained in these experiments. The tertiary butyl compound 
was also shown to have a similar amtagonistic activity as found 
by Bowery et al. (1977). The other analogues of bicyclic 
phosphates all appeared to exert a similar antagonistic activity 
and this method would appear to bo a useful one to elucidate 
the potency of those compoiinds but not a good method for 
distinguishing between the different analogues.
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Pig.A.8. Log concentration-Kiepolaxisation relationship 
for oarbachol on rat superior cervical ganglion in the 
absence (o) euid in the presence of 6.5mM (+)-bicuculline 
methobromide (■). Carbachol doses were applied for 1 min 
periods at 15 min intervals. Antagonists were added 30 min 
before testing to allow equilibration. Each point and 
vertical bar gives the mecui auid standard error for 6 
observations.
Carbachol concentration (log M)
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Pig.4.9. Loi concentration-depolarisation relationship 
for carhachol on rat superior cervical ganglion in the 
absence (o) and in the presence of 25mM picrotoiinin (a ). 
Carbachol doses were applied for 1 min periods at 15 min 
intervals. Antaigonists were added 30 min before testing 
to allow equilibration. Each point and vertical bar is the 
mean and standard error for at least 4 observations.
Carbachol concentration (log
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concentrât ionniepolari sat ion re-lationship 
on rat superior cervical ganglion for Y-aminobutyric 
acid (g a m ) in the absence (v) and in the presence of 
23mM t-butyl bicyclophosphate (□) and 25mM isopropyl 
bicyclophosphate ( o ) .  G A M  doses were applied for 1 min 
periods at 15 min intervals. Antagonists were added 
30 min before testing to allow equilibration. Each point 
and vertical bar gives the mean and standard errors for 
at least 5 observations. Linos are drawn by hand.
GABA concentration (log M)
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P i g . 4.lOrLog-concentration relationship for carhachol on rat 
superior cervical ganglion in the absence (o) and in the 
presence of 23mM ITeopentyl bicyclophosphate ( ▼ ). Carbachol 
doses were applied for 1 min periods at 15 niin intervals. 
Antagonists were added 30 min before tf^sting to allow 
eqTiilibration, Each point and vertical bar is the mean and 
standard error for at least five observations.
10r6 10-5 10-A
Carbachol concentration (log M)
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relationahip.
Ab in the previous experiment the concentration of 
antagonist used was that idiich gave a inhibition of the
gulaoaxiinal concentration of GAM.
A range of four increasing concentrations of carhachol 
was used in order to obtain a range of results to give a 
dose—response curve. The concentrations used were 1 i lO”^  
for the minimum concentration up to 3 x lO“^  for the maximum 
concent rat ion.
The res\ilts from 4 - 6  experiments were used in the 
controls (without antagonist present) and then repeated in the 
presence of antagonist.
• The graphs were again plotted semi—logarithmically 
where depolarization in mV(normalised to ImV for a 
concentration of cau*bachol of 3 x 10 ~h) 
on the ordinate against the log of the concentration of 
carbachol as a control and also in the presence of antagonist
on the abscissa. (Figs. 4*8 - 4>10)
(4.^ - Bicuculline methobromide (6 x lO“^ )
A sligjit shift of the dose-response curve to the 
rigjit shows that (+) - bicuculline methobromide does 
have an antagonistic effect on carbachol. This is not
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a £p:^ at antagonismy auid as reported previously there 
was about a reduction in the response to 
carbachol with a mugh hi^er concentration of the 
antagonist.
ii. Picrotoxinin (2.4 x 10
Aga.jTi there wais a sli^t shift of the dose—response 
curve to the ri^t indicating some antagonism hut as 
reported previously in hig^ concentrations of 
picrotoxinin (lO^^) there was only a 20^  reduction in 
the response to carhachol.
iii, Neonentyl hicvclic phosphate (2.4 x io“5m )
The dose-response curve was shifted slightly to the 
left but the effect was insignificant. This would 
appear however to have a sli^t potentiating effect 
on the responses to carbachol as shown in higher 
concentrations in the previous experiments.
4,3,8 Conclusions:
The results using GAB4 antagonists, with carbachol, in 
lower concentrations (i.e. those which would effectively block 
the responses to G A M  significantly), are inconclusive as the 
results indicated in the graphs but it could be seen that 
there was a trend for (+) - bicuculline methobromide and 
picrotoxinin to shift the dose-response curves to the rif^t 
and this would suggest some antagonism as borne out with the 
hi^er concentrations used previously. However the trend to
U 3
V ' *
shift the dose—response curve to the left with neopentyl 
hicyclic phosphate also bears out that these compounds 
have a sli^t potentiatin« effect on the actions of carbachol 
even in large concentrations are needed.
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U 7 A
A Study of the QABA receptor using binding studies.
5.1 Introduction
Investigation of the 'biochemical nature of receptors 
is important in the understanding of the basic physiology of the 
actions of transmitters and also to investigate the mechanism of 
action of drugs which exert their actions at the receptor site or 
those which are related to the receptor site. These methods can 
therefore be useful in the designing of now drugs which may exert 
their effects at these sites (Toiing ot al. 1976).
The technique of binding studies with a suitable 
radioactive ligand allows convenient investigation in an in vitro 
system. It is important that the binding site really represents 
a physiological or pharmacological receptor.
Correlations between binding studies and other in vitro 
preparations include opiate receptor binding affinities with the 
effectiveness in inhibiting or blocking inhibition of electrically 
induced contractions of guinea-pig ileum (Creese and Snyder, 1975)« 
Clearly in the measurement of in vivo responses to a drug 
many more variables are involved and not j\ist the affinity of the 
drug for its receptor; these may be reduoed by application of 
drugs by microiontophoresis and measuring the response of individual 
neurons but this method, althou^ giving good comparative data 
among drugs, is often difficult to quantify. However, dopamine 
reoeptor binding has been used to predict in vi^  behavioural 
responses to some antisohisophrenio drugs (Creese et al. 1976).
This technique with binding studies with radiolabelled 
ligands does allow convenient investigation of an toj^Ltro system. 
In these binding studies however, it is important that the actual
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tindin® observed mxist be actual binding to the receptor sites 
and not those involved with uptaüce mechanisms, or non-specific 
sites such as enzymes or charged moeties in the tissues being 
\2sed« For example some reuiiolabelled ligands can bind to inert 
materials, radiolabelled opiates bind to glass fibre filters with 
affinities in the nanomolar range to exhibit an apparent 
pharmacological specificity but obviously not matching any 
biological effects (Snyder et al. 1975a)*
To ensure that the binding is to the actual receptor the 
following basic criteria must be fulfilled; (Snyder, 1975b,
Birdsall and Hulme, 1976).
1. Specificity.
2. Saturability.
3. Compeuraibility.
4. Localisation.
5.1.1 Specificity.
Concentrations of drugs which are pharmacologically 
active at a peirticular receptor site should displace the saturable 
component of the binding and pharmacologically active concentrations 
of drugs acting at different receptors should be ineffective. Known 
structure-activity relationships must be complied with and the 
receptor must have a hié^ i affinity for the radiolabelled ligand.
For example in the mammalian muscarinic cholinergic system only 
those drugs such as acetylcholine will displace the radioligand in 
pharmacologically active concentrations and the effects of other 
types of drugs such as noradrenaline do not displace the radioligand
(Snyder et al. 1975^)*
U 9
5,1.2 Saturability.
^ requirement for binding is 'that there are only a 
finite number of sites in the tissue and these are of high 
affinity. This refers to reversible ligands used with 
dissociation constants in the nanomolar range. Therefore the 
hi^er the concentration of radiolabelled drug added the binding 
will increase to the point where all sites are occupied» but no
further! so it is saturated.
Too large a number of sites t accompanied by a low 
affinity suggests that the binding is not to a receptor. Maximal 
don .sities of nourotransmittor receptor-binding sites are usiaally 
about 10-100 pmoles ligand bound per gram of tissue. If all 
ligands do not yield a similea* number of binding sites then it 
is probable they cannot be identified with the same receptor.
These criteria have been shown in the binding of (^) quinudidinyl 
bonzylate to muscarinic cholinergic receptor binding in guinea-pig 
ileum muscle (Tamamura and Snyderi 1975)*
5.1. 3 Comparabilityj.
The pharmacology of the binding should correlate 
quantitatively with the pharmacology of receptor-mediated effects 
uid phyeiologioal responses. Kicellent correlations have heen 
reported between measurements of stimulation and blockade of 
p-reoeptor adenylate cyclase activity and measurements of 
competition for (^)niihydroalprenololbinding (MuJdierjee et al.
1976).
5ele 4- Localisation.
Binding should be localised to tissues which are known to
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show the pharmacological response and should not be found 
where the trcuismitter is known to be absent«
Autoradiograi^io studies using ( ^ )  muscimol on rat 
cerebellar tissues have shown that is is only associated with 
those areas which have the characteristics of the aABA-receptor, 
being saturable with kinetic constant similar to those in homogenate 
preparations (Palacios et al. I98O, DePeudis at al. I98O).
5.2. atudies with brain tissues on the opiate receptor.
The method of using binding studios with radiolabollod 
ligands was originally developed to study the opiate receptor by
Gtoldstein ot al, (l97l)«_
The analgesic potency of the opiates is highly
steroospocific and almost all the pharmacological activity of
these stereoisomers is found in those with a configuration of
(-) - morphine for example (+) and (-) - levorphanol«-
The (+) - isomer dertrorphan, has been shown to bo pharmacologically
inert and has neither agonist nor antagonist properties (Kbsterlitz
et al. 1974* Pert and Snyder 1973).
StvulieB with the opiate narcotic (^H) - (-) - levorphanol
ae the radioligand on o m d e  fraotione of mouse train tieeue 
ehowed that the total stereospecific binding was only about zf,. 
However, using a modification of Goldstein’s procedure, reports of 
stereospecific binding of opiates to rat brain homogenates 
represented a major part of the total binding (Simon et al. 1973, 
TereniuB 1973, Pert and Snyder 1973). The modifications involved 
uming very low oonoentrations of labelled opiate with h i ^  epeoifio 
activity washing membr«ie. after incubation to remove unbound
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qnH loosely iDOund radioactivity.
These stereospecific binding sites were found to be 
closely associated with membrane fractions of tissue homogenates 
most concentrated in the synaptosomal coll fraction of the 
homogenate suggesting location of the sites is in the vicinity 
of synapses (Port ot al. 1974, Hitzman et al. 1974).
However, despite the small aunount of storeospecific 
binding produced by Gtoldstein, ho «as able to demonstrate the 
existence of throe different typos of interaction between the 
opiate and the receptor tissues; thus enabling him to differentiate 
between steroospocific interactions and non-specific interactions 
of the opiate and receptors:
a) Kon-satTarable interaction which consisted of physical solution 
of lipophillic opiate molecules in the lipid membranes of the
tissue.
b) Non-specific saturable binding consisting of interactions 
between the protonatod nitrogen atom in the opiate and anionic 
groups in the membrane proteins and macromolecules.
c) Stereospecific interaction of the (-) - opiate with the actual
opiate receptor.
Therefore, in order to calculate the stereospecific binding to the 
opiate receptor several experiments were carried out:
i) The tissue was incubated with (-) - opiate which was the 
radiolabelled ligand to give the sum of all three types of 
binding listed above,
ii) The tissue was incubated with excess (+) - opiate and 
radiolabelled (-) - opiate. The bound radioactivity could
152
then be measured and subtracted from the total bound 
radioactivity above to gfive the non-specific saturable 
binding.
iii) The tissue was then incubated with excess non—radiolabelled
— opiate ajid radiolabelled (—) — opiate and radioactivity 
measured. This procedure caused the radiolabelled (-) - 
opiate to be excluded from the non-specific and the 
stereospecific sites. Therefore the stereospeoific binding 
could be obtained by subtraction of this from that calculated 
for the non-specific sites.
The studies discussed so tax did not distinguish between 
a potent agonist or a potent antagonist in the binding assay. This 
problem was resolved when it was shown there was an inhibition of 
binding of all agonists and an enhancement of binding of antagonist 
was produced in the presence of sodium ions (Port and Snyder 1974) 
demonstrated by increase in the number of h i ^  affinity binding sites 
for naloxone «-«d a decrease in the h i ^  affinity binding sites for 
dihydromorphine. Those results wore consistent with a model 
involving the conformational change of the opiate receptor in the 
presence of sodium ions. When s pure antagonist (e.g. naloxone) 
was allowed to compete with a labelled antagonist, thsre was little 
or no change in the IC^ of the competitor when sodium ions were 
But when an unlabelled agonist (e.g. dihydromorphine) was 
allowed to compete with a labelled antagonist, the lO^g for the agonist 
increased dramatically in the preeenoe. of sodium ions (Simon et al.
1975) suggesting a change in affinity for the receptor but no change
in the number of binding sites.
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then be measured and subtracted from the total bound 
radioactivity above to give the non-specific saturable 
binding.
iii) The tissue was then incubated with excess non—radio label led
(-) - opiate and radiolabelled (-) - opiate and radioactivity 
measured. This procedure caused the radiolabelled (-) - 
opiate to be excluded from the non-specific and the 
stereospecific sites. Therefore the stereospecific binding 
could be obtained by subtraction of this from that calculated 
for the non-specific sites.
The studies discTissed so far did not distu^guish between 
a potent agonist or a potent auitagonist in the binding assay. This 
problem was resolved when it was shown there was an inhibition of 
binding of all agonists and an enhancement of binding of antagonist 
was produced in the presence of sodium ions (Port and Snyder 1974) 
demonstrated by increase in the number of high affinity binding sites 
for naloxone and a decrease in the h i ^  affinity binding sites for 
dihydromorphino. Those results were consistent with a model 
involving the conformational change of the opiate receptor in the 
presence of sodium ions. When a pure antagonist (e.g. naloxone) 
was allowed to compete with a labelled antagonist, there was little 
or no change in the IC„ of the competitor when sodium ions were 
added. But when an unlabelled agonist (e.g. dihydromorphine) was 
allowed to compete with a labelled antagonist, the IC^ for the agonist 
increased dramatically in the, presence, of sodium ions (Siiion et al. 
1975) suggesting a change in affinity for the receptor but no change 
in the number of binding sites.
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Pig. 5.1. A schematic model of the opiate receptor 
( after Snyder 1975a)»
agonist
V mixed agonist- ant agonist antagonisto
ionophore
Receptor in agonist 
conformation
Receptor in antagonist 
conformation
Pig. 6.2, Model of GAB^ receptor-ionophore indicating action 
of GABA, picrotoxinin and related cage convulsants. 
The receptor (GABA binding site) and chloride ion 
channel (picrotoxinin, cage convulsant site) exists 
two states : Activated favouring GABA binding, and 
resting favouring picrotoxinin and cage compounds.
ACTIVATED qi
in
RESTIKG
ÜD-GÍ)
GABA Cl^-^A^Cl
I t
I «
t
RECEPTOR MODULATOR OP lOM CHABHEL
(GABA BB TODTO (PICROTOXHOT, CAGE 
SIIE) CONVULSABT BIBDIBG SITE)
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A-
A model for the allosteric effect of sodium ions on
opiate receptor is shxMm in ?i«.5.1. (SzsTdsr 1975^» Simon 17T*5).
When sodiTsn ions are botnad to the allosteric site there is a 
change in the shape of the receptor molecule. ’Biis causes an 
alteiation . of the opiate hinding site shidi can now hind antagonists 
with greater affinity, ««ri agonists with reduced affinity.
results show that the opiate receptor has a 
certain plasticity permitting it to exist in mrious conformational 
states. OhvioxBaly in vivo the cells %could he hathea in 
xsaysiologiaal fluids containing sodium ions and wuld normally 
exist in the state which would he recepti'»« to opiate antagonists.
Bfft if the receptor is mobile and was able to shuttle
and outside of cell membranes there would be a 
Leant difference in sodium ion concentration which wouic. 
oanformation of the receptor which may expla in the 
poLLersnoe to opiates (Simon 1979) •
I M 2, agonist opiate was applied it wouio. provoice 
toof the antagonist confomaation of receptor to an 
^adsoe the sodium binding to the receptor 
bixm of permaability.
for the opiate reoeptor has been 
gljcine reoeptor. Studies with the
(•^) —  strychnine ahowea that 
^  glycine involTFBd an increase in the 
(Ibnng sni Snyder 1973). Chloride ions
and also decreased the
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A model for the allosteric effect of sodium ions on
opiate receptor is shown in Pig.5,1.* (Snyder 197?b» Simon 1975).
When sodium ions are bound to the allosteric site there is a 
change in the shape of the receptor molecule. This causes an 
alteration., of the opiate binding site which can now bind antagonists 
4fith ^ a t e r  affinity, . and agonists with reduced affinity.
These results show that the opiate receptor has a 
certain plasticity permitting it to exist in various conformational 
states* Obviously in vivo the colls would be bathed in 
physiological flxdds containing sodium ions and would normally 
exist in the state which would bo receptive to opiate antagonists.
But if the receptor is mobile and was able to shuttle 
between the inside and outside of cell membranes there would bo a 
significant difference in sodium ion concentration which would 
affect the conformation of the receptor %diich may explain the
phenomenon of tolerance to opiates (Simon 1979).
Also if an agonist opiate was applied it would provoke
a transformation of the antagonist conformation of receptor to an 
agonist conformation and reduce the sodium binding to the receptor 
complex causing an alteration of membrane permeability.
5.3. The Qlvcine receptor.
The model developed for the opiate receptor has been
extended to include the glycine receptor. Studies with the 
radiolabelled glycine antagonist (^) - strychnine showed that 
hyperpolarisation elicited by glycine involved an increase in the 
chloride ion conductance (Toung and Snjrder 1973). Chloride ions 
reduced the binding of (h) - strychnine and also decreased the
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affinity of glycine for the hinding sites (Young and Snyder 1974). 
However it heus not heen established whether these interactions 
distinguish between glycine agonists and antagonists.
Whether or not strychnine binds directly to the 
chloride ion channel is uncleau:* but work done on ( ^ )  - strychnine 
binding with chloride ion displacement suggested that chloride 
interacts with strychnine b inding in a cooperative fashion and 
that glycine strychnine bind to two different sites (Snyder
and Young 1975).
Strychnine binding associated with the ionic conductance 
mechanism for chloride with glycine interacting with the recognition 
site also has implications for elucidating synaptic features of other
neurotransmitters including GABA..
Picrotoxin blocks GABA effects non-competitively in 
analogy to the strychnine glycine interactions. Studios in 
neuromuscular junctions of invertebrates (Takeuchi and Takeuchi 
1969, Brookes and Herman 1973) showed that chloride ions reduce 
the ability of picrotorin to block GABA effects and that 
conceivably the GABA interactions take place between the GABA 
recognition site and the chloride ionophoro whore picrotoxin may
act.
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5.4. The Q A M  receptor
The first stiadies of the G A M  receptor utilising 
the "binding assay technique were carried out hy Snyder and 
his co-^orkers. A similar synaptosomal tissue technique was 
used that was developed in the study of the opiate receptor 
described previously.
(^)-GABA was used as the radioligand (Zukin et al.
1974, Hinna. and Snyder, 1977)« A sodium-independent specific 
binding of GABA to synaptic membrane fractions of rat brAin would 
appear to be associated with the GABA receptor. This binding was 
found to differ from sodium-dependent binding to subcellular 
particles of brain tissue which was involved with the high-affinity 
transport of GABA into the nerve-terminals and glia (DePeudis 1973» 
Kuriyama et al. 1963). The sodium-dependent binding was probably due to 
the attachment of GABA to these uptake sites (Roberts and Kuriyama 1963).
The sodium-independent binding of GABA to these synaptic 
membranes was facilitated by a freezing-thawing process which appeared 
to destroy the uptake sites and a washing process to got rid of 
excess endogenous GABA already present (Zukin et al. 1974).
This study also employed a sipilar synaptosomal preparation
to stiKiy the sodium-independent binding of a potent GABA agonist 
which was labelled with tritiiam ((^)- muscimol) and also a 
further study with the tritium labelled GABA antagonist (^) “ a “ 
dihydropicrotoxinin. The findings related to the binding of these 
ligands will bs dasoribod: imter in the chapter.
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Ttofinition of the Bpecific binding of QAM,
In their studies Snyder and his co-workers defined 
the specific binding of GABA as the binding which was 
displaced by a h i ^  concentration of GABA (10 or (+) - 
bicuculline (10^ )  t the remainder being the non-specific
binding.
However, this definition did not differentiate between 
specific and non-specific saturable binding as described in the 
binding studies with the opiates. In order to demonstrate the 
stereospecific binding sites which was analogous to the opiate 
receptor, incubations were performed using (+) - bicuculline 
methohalide and the pharmacologically inert (-) - bicuculline 
methohalide. The difference being the stereospecific binding 
(Enna Snyder 1977 ) •
The above definition assumed that all the drugs were 
acting at the same receptor but this has been shown not to be 
the case with the GABA antagonists picrotoxinin (Bnna and Snyder
1977, Olsen et al-1977) and bicyclic phosphates (Ticku and Olàen
1978, Fnr«. et al. 1977). The actions of those antagonists will
be discussed later.
5.4.2 Distribution of specific ~ QABA binding^
In a whole brain homogenate the specific binding of 
{h) - GABA (bicuculline displacable) was about 10^ of the total 
binding, but during subsequent fractionation of the tissue the 
specific ratio increased progressively. In the crude mitochondrial 
pellet (?2 fraction) this increase was about 50^  and in a crude
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synaptic fraction increased to 70^ specific "binding 
(Zukin et al. 1974)»
The regional distribution of sodium-independent 
GABA binding did not always correlate olosely with exKlogenous 
GABA (Zukin et al. 1974» Enna and Snyder 1975) in nat brain, 
but this may have been due to the surface area of the 
postsynaptic membranes varying independently of,the transmitter 
content of the nerve terminal. In monkey brain regions however 
there was a close correlation between endogenous GABA and sodium - 
independent GABA binding (Enna et al. 1975)- More recently 
immunocytochemical studies in brains have shown a much greater 
correlation between sodium - independent GABA binding and 
postsynaptic GABA receptors (Roberts 1979)*
5.4.3 Saturabilitv of ■ GABA, binding
Specific (^) - QABA binding to synaptosomal membranes
was found to be saturable with increasing concentration, half 
maximal binding occuring at about lOnM. The non-epecifxc binding 
was not satxirable and increased linearly with increasing 
concentration, of (^) - QABA (Enna and Snyder 1975).
5 .4.4 Sodium - dependent and sodium - independent bind!
Two completely different types of (^) - GABA binding
have been identified*
i) Sodium - dependent binding.
In the presence of sodium ions (%) - GABA binding to 
synaptosomal membranes appears to involve the uptake site 
and is hardly affected by (+) - bicuculline (Peck et al. 1973,
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Martin 1976). A hig^i-affinity tremsport of GABA into 
the nerve terminals was involved which was inhibited hy 
cis-3-amino-cyclohexane carboxylic acid (ACHC) (Collins 
et al. 1975, Bowery et al 1976b) and also into glial cells 
which could bo inhibited by p-alanino (Moldrum 1979).
There is also a low-affinity uptake of ( % )  - GABA involved 
in rat brain synaptosomos which is adso sodium dependent 
(Levi and Raitory 1973). 
ii) Sodium — independent binding.
In the absence of sodium ions it was shown that the specific 
(^) - binding was with the post synaptic GABA receptor.
This binding was inhibited by (+) - bicuculline but not by 
(-) bicuculline (Zukin et al. 1974, ; Bnna and Snyder 1975).
If the brain synaptosomal tissue was frozen at -20 C and 
stored this facilitated the specific binding of (%) - GABA 
causing some destruction of the sodium-dependent uptake sites 
in nerve endings and glia. Antagonists of the sodium - 
dependent uptake sites such as nipecotic acid and ACHC had 
very little effect on the sodium dependent binding 
(Krogsgaard-Larsen and Johnston 1978, Johnston et al. 1979).
5.4.5 Treatment of tissues with ions,
i) Cations.
Lithium, potassium and magnesium ions were found to have 
little effect on the specific sodium dependent binding of 
(^) - GABA to freshly prepared membranes. Cupric and mercuric 
ions however were found to be potent inhibitors of specific 
( % )  - GABA binding but none of the cations had any effect on
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the non-specific binding (Enna and Snyder 1977)» 
ii) Aniona.
Specific sodium - independent binding to ( ^ )  - GABA 
was reduced by thiocyanate, nitrate euid iodide while they 
enhanced the potency of (+) - bicuculline (Enna and 
Snyder 1977)«
In all experiments with the sodium — independent 
binding of ( ^ )  ~ muscimol to rat brain synaptosomal membranes 
no ions were added to the Tris-citrate buffer used as the
incubating medium*
5,4,6 TVARtma^ with detergents.
The detergent, Triton X—100 in concentrations of 0*05^ 
increased the sodium - independent binding of (%) - GABA about 
five times and also produced frcm Scatchard analysis two binding 
sites for (^) - GABA, a high affinity site and a low affinity 
site (Enna and Snyder 1977)«
A similar increase in ( ^ )  - muscimol sodium - independent 
binding was produced with Triton X-100 in concentrations of 0.05^ 
to yield only one binding site on Scatohard analysis (Beaumont et 
al* 1978) in moTise brain synaptosomal tissues the addition of 
Triton X-100 and several other detergents to the preparation had 
little effect on the sodium - independent ( % )  - muscimol binding 
(Wang et al. 1979). This difference may be attributed to freeze- 
thaw cycle and washing tdiich removed an endogenous inhibitor of 
riA-RA (Greenlee et al. 1978, Guidotti et al. 1978, 1979)*
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In all experiments the tissue wais freese—thawed 
auid waished before usin« and no treatment with any detergent 
was employed. It was assumed that any endogenous G A M  or 
inhibitor of G A M  had boon removed by this process (Greenlee
ot al. 1978).
^e^tjjOTrb^jiith^^enzymo^.
Sodium - independent (^) - G A M  receptor binding 
was resistant to treatment by several enzymes (o.g. neuraminidase, 
trypsin or phospholipidase). However, with sodium - dependent 
specific (^) - G A M  binding in fresh synartosomal preparation 
was reduced by with trypsin and 80^  with phospholipase.
In all experiments with (%) - muscimol sodium - 
independent binding to rat synaptosomal preparations no enzymes 
were employed.
5,4,8 En^geE£us,^odul^or__of_^AM
There is a substantial difference in the kino^i^ 
properties of (^) - CSAM . . ^ sodium - independent ^to brain
synaptosomal preparations when used fresh or udiether the 
preparation has been throu^ a freeze-thaw and washing sequence 
(Enna and Snyder 1977, Olsen 1978a) suggesting that there may be 
an endogenous agent which modulated the affinity of GABA for its 
receptor which was washed out during the freeze-thaw and washing 
process. This modulator was purified and when added to a freeze- 
thawed and washed preparation the binding of G A M  was decreased 
and the h i ^  affinity site masked as in G A M  binding to fresh 
tissue (Toffano et al. 1978).
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It has "been proposed that this modulator is a 
protein kinase which is involved with the interaction of 
benzodiazepines as their facilitâtory function of GÂBA
(Guidotti et al. 1979)«
5^5  ^ The use- of ( -  muscimol in GABA, binding.
5,5.1 Introduction;
Muscimol (5-aminomethyl-3-isoxazolol) is one of the 
alkaloid compounds occurin« naturally in the fly agaric mushroom,
muflcaria (Wasser 196? 1 Theobald et al, 1968, B u g s t e r  I969).
It is a potent agonist of the (+) - bicuculline - sensitive G A M  
postsynaptic receptor, beinfir six or seven times more potent than 
G A M  itself (Krogsgaard-Larsen et al. 1975» Johnston 1976,
Beaumont et al. 1978, Johnston et al. 1979), and has been used 
extensively for studies on the central G A M  system.
It is a relatively toxic compound, having an LD^q after
intrap.riton.al ind.ction in mio. of 2.5<v/ke (Llojrd .t al. 1969) 
but thi. may b. du. to its toxic notabolit.s aft.r rapid ¿onvarsion 
In vivo. (Ott .t al. 1975t Haik .t al. 1976, Biggio .t al. 1977).
The 3-isoxazolol moiety of muscimol can bo regarded as a 
maskod carboxyl group of fixed conformation with relatively free 
rotation of the aliphatic side chain (Krogsgaard-Larsen et al. 1979). 
X-ray crystallographic structure and noleoular orbital calculations 
with studies of protolytic properties (pE^ values) show that low 
value of acidic functicn is an indicaticn cf h i ^  degree cf 
delccalisaticn cf the negative charge cf the correspending anion, 
the lower the pK. value the higher the affinity for the 0AB4
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receptor, pK. values for GABA, zwitterion are 4.0; 10.7t and
pK values for muscimol axe 4*8? 8*4 (Krogsgaard—lArson et 
 ^A
al. 1975f 1979).
Muscimol is not a substrate or inhibitor of GABA- 
trauisaminase (Johnston et al, 1979) and has a low affinity for 
the hig^ affinity GABA uptake system in rat brain slices
(Johnston 1971).
When injected into the substantia nigra an increase 
in dopamine metabolites was observed (Cheramy et al. 1978, 
Scheel-Kruger et al. 1979) and if pretreated with kainic acid 
there was an increase in cerebellar GMP levels (Biggio et al.
1979).
It has some convulsant and some anticonvulsant 
properties, ca\asing audiogenic seizures in rodents (Anlezark 
et al. 1978) and acting as an anticonvulsant (Lloyd at al. 19791
Meldrum 1979, Delini-Stula 1979).
Clearly muscimol is a useful tool in the identification
of the postsynaptic GABA receptor and this study utilises a 
radiolab.ll«i ligMd in th. study of (^) - muscimol binding to the 
rti-RA receptor in rat brain synaptosomal preparations.
5.5.2 Specific of muscimol.
The specific binding of sodium-independent (^) - 
muscimol can bo defined as the difference of tissue incubated with 
(%) - muscimol and that of a similar experiment but with an
added h i ^  concentration of GABA (10‘^). This was found to be 
about 8056 specific with 20^ non-epecific binding in several 
synaptosomal preparations of different species (Beaumont et al.
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19781 Snodgrass 19781 Leach and Wilson 19781 Williams and 
Risely 1979). This correlated with the 85^  specific binding for 
(^) - GABA, under similair conditions (Enna 8uid Snyder 1977)»
5 . 5.3  Distribution of specific« sodium - independent ~ muscimoj^
binding.
Specific (^) - muscimol binding was foiuad to bo most 
enriched in the cnado synaptosomal fraction (Pg) consisting of 
about 75jt of the total observed in all the subcollular fractions
of rat brain (Boaiimont ot al. 1978).
The regional distribution of (^) - muscimol binding 
was shown to have its highest density in the cerebellum with 
varying concentrations in other regions of the brain and less 
than lOji of that in the cerebellum was found in the spinal cord 
by filtration assay or centrifugation (Beaumont et al. 1978,
Williams & Risley 1979)* results were consistent with those
for (%) - sodium - independent binding in rat brain regions
(Enna and Snyder 1973)*
Further stxidies on rat brain slices using an 
autoradiographic study for (^) - muscimol binding also observed 
highest (^) - muscimol binding in the. cerebellum and 'similar 
binding in other regions of the brain consistent with (%) - 
nniscimol binding in synaptosomal preparations and also show a 
pharmacological specificity comparable with that of the GABA 
receptors (Palacios et al. I98O).
5.5.4 nn,. .«• BOdi,..- >>■  th . of (% ) -  m u.ci..gl.
‘in both froBh and previously froeen rat brain synaptosomal 
membranas the addition of sodium ions to th. inoubatin« medium 
caused a deorease in speoifio (%) - musoimol binding (Beaumont
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et al. 1978).
At a concentration of lOOmM sodium chloride there 
was a decrease of specifically bound (^) *" muscimol of about 
15^ in fresh tissue and a decrease of about a third in previously
frozen tissue.
In similaup preparations using specifically bound 
(^) - GABA the same concentration of sodium chloride a 
10-fold increase in specifically bound (^) - GABA was observed 
(Bnna and Snyder 1977)*
These results indicate that muscimol has little effect 
on the sodium dependent hi^-affinity uptake of GABA in neuronal 
and glial cells and the specific binding is sodium - independent 
exerting its effects cn the postsynaptic GABA receptcr hence 
m^ ir-iwg it a useful tool in the evaluation of GABA agonists ahd
stntagonists on the post-synaptic GABA receptor.
5,5,5 Effects of freey-jytff and wanhing on specific muscimol
•hiwding.
The specific binding of (%) - muscimol to fresh tissue 
is very low (Leach and Wilson 1978, Beaumont et al. 1978, Maurer
1979). The specific binding can be almost doubled if the tissue 
is frozen and thawed (Beaumont et al. 1978)or dialised (Maurer 1979).
These processes have the effect of removing endogenous 
compound like GABA or sodium ions which would interfere with the
assay.
This compared favourably to results obtained with 
specific sodivB - iMependeirt (^H) - GAB4 binding (Bnna and Snjrder
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1975 f 1976 f Won« and Horn« 1977). It has also been suggested 
that there is an endogenous modulator of Q A M  of hij^er 
molecular wei^t »diich is also washed out during the freeze-thaw 
awH washing processes which decreased the G A M  binding because 
it masked the hi^-affinity binding site (Toffano et al. 1978) and 
this modulator was involved with benzodiazepines fianction as 
facilitators of the effects of Q A M  (Quidotti et al. 1979)« 
experiments were therefore carried out after the freeze-thaw and 
washing process so these agents could not interfere with the assay.
5.5.6 Th« «f'faota of aetergenliB on eaeolfie ( -  amsoinol binding.
Treatment with a concentration of 0.25^ of the detergent 
Triton X-100 has boon reported to increase specific sodium- 
independent (^) - muscimol binding by 2-fold in rat brain 
synaptosomal tissues by both filtration assays and centrifugation 
assays (Beaumont ot al. 1978, Williams and Risley 1979).
However no increase in specific binding of ( ^ )  - 
muscimol was reported using Tritonised mouse brain synaptosomal
tissues (Wang et al. 1979)»
Treatment with another detergent, Tween 20, at a
concentration of 0.1^^ enhanced specific ( % )  - muscimol binding
40jt, (Wang ot al. 1979)«
Treatment with 0.1^ Lubrol PX did not decrease the
specific binding of (%) muscimol but as with Triton X-100 the 
ability of G A M  and 0-alanine to compete with (%) - muscimol was 
increased. The potency of the antagonist. (+) -. biououlline to 
displace (%) - muscimol binding however was decreased (Wang
et al. 1979).
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In specific sodium — independent binding of (%) - 
Q A M  to rat brain synaptosomal preparations treatment with 
0.03^ Triton X-100 increased 5“f‘old and the potency of 3- 
aminopropane sulphonic acid to displace (%) - Q A M  was increased 
idiereaa the potency of (+) - bicuculline in the Displacement of 
- G A M  was decreased.
In view of the conflicting evidence above all experiments 
were carried out in the absence of detergents in order to perhaps 
resemble physiological conditions in the CBS more closely.
5,6. The use of ■ g " dihvdropicrotoxinin(( - IHP) binding in
j^^^j^agtosoma^jregajWition^.
5.6.1 Introduction:
Picrotoxin, a natural product of plants from the 
Minispermaceae faxailyi consists of a molar ratio of 1:1 of 
picrotoxinin and the less active picrotin (Jarboe et al. 1968).
Piorotoxinin is a potent inhibitor of the inhibitory 
synaptic transmission mediated by G A M  (Johnston 1978) and its 
action is not in direct competition with the G A M  recognition site 
but by inhibition of the G A M  regulated chloride permeability on 
the post synaptic membrane (Takeuchi and Takeuchi 19691 Ticku and
Olsen 1977)*
This effect on chloride ion permeability being possibly 
due to its action at a G A M  receptor-ionophore complex (Ticku and 
Olsen 1978, Olsen et al. 1978a, d, Olsen et al. 1979)*
a-Dihydropicrotoxinin (DHP) has similar actions to 
picrotoxinin but has one seventh the activity as a convulsant
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(Jarboe et al. I968).
a-Dihydropicrotoxinin can be obtained by reduction 
of the double-bond in picrotoxinin. This is done by catalytic 
hydrogenation at room temperature under 1 atmosphere of 
hy(lPOgen platinum on charcoal as the catalyst (Mercer and
Robertson 1936). (Pig.2.3)*
This method could be used to radioactively label 
picrotoxinin by using tritiated hydrogen as the gas under the 
above conditions to give (h) - a - dihydropicrotoxinin ((%) - IHP) 
(Ticku et al. 1978b) as a useful tool to study binding of (%) - 
DHP to the proposed ionophore site on the postsynaptic tissues.
5.6.2 Snecifio binding ot ( h ) ^ a - dihydropicrotoxinin.
The specific binding of (%) - DHP has boon defined by 
the Riverside Group as the difference of tissue incubated with 
_ 7TBP «.wH that of a similar experiment with an added hi£^ 
concentration of non-radio labelled a - dihydropicrotoxinin (O.lmM). 
This was found to be about Ijf, specific and 3 5^ non-specific in rat 
synaptosomal fractions (Pg) Ticku ot al. 1978b, Ticku and Olson, 
1979, Ticku ot al. 1979). A similar report for specific binding 
of (^) - DHP was found in a microsomal (P^) fraction of crayfish 
muscle which was.not enhanced with a more sophisticated 
fractionation of the tissue (Olsen et al. 1978d).
5.6.3 n^«4:T»ibntion cf f%) - DHP binding in brain tissue.
Binding of (^) - DHP varied with brain region being 
higgler in the cerebellum and cerebral cortex than the brain stem 
(Ticku et al. 1978b). This distribution was of a similar ratio to
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that of (%) - Q A M  binding althou^ about 2.3 times lower 
(Enna and Snyder 1973)*
The location of (%) - DHP binding sites in rat brain 
paa*allels closely, but not exactly, that of G A M  receptor sites 
with greatest amounts in the synaptosomal (P2) li^t 
microsomal fractions (Ticku et al. 1978a, b).
The quantity of binding sites (Ticku et al. 1978b) has 
been found to be about twice that of (^) - G A M  binding sites 
(Olsen Greenlee 1978, Olsen et al. 1978aJ.
These reports suggest that the majority of G A M  and 
TBP binding sites may be coupled.
5,5,4 i0P8 on specific binding of (^)*-» mP^.
(^) - DHP binding was not significantly affected by 
variation of the chloride ion concentration from O^OOmM in either 
crayfish muscle preparations or rat brain synaptosomal preparations 
(Olson ot al. 1978d, Ticku et al. 1978b). It is unlikely that 
(^) - DHP would complete with chloride ions as it is not a
charged molecule.
There was no effect on (%) - DHP binding on rat brain 
synaptosomal membranes when a complete replacement of sodium ions 
with potassium ions was undertaken (Ticku ot al. 1978b).
5,6.5 The effects of detergents protein reagent treatment on_
sgecific,^ in^ g^„of__(,^ H},^ ,J®£»
In contrast with its effect on (%) - G A M  binding and
(h) - muscimol binding (Enna and Snyder 1977, Beaumont et al. 1978), 
trMtinMil! irtth th. detergent Triton X-100 inhibited (%) - M P  
binding to brain ^ynaptosomos in the rat. At a concentration of
170
0.1^ Triton X-100 there was a 90^ inhibition of the specific
binding (Ticku. et al. 1978®-)»
Diethylpropylcarbonate in concentrations of ImM had
little effect on specific (%) - M P  binding in contrast to a 
reduction by half with specific (%) - G A M  binding (Ticku et
al. 1978a).
U-ethylmaleimide in concentration a of IniM reduced 
sx>ecific (%) - IHP binding by about 90^ specific (%) -
f»A~RA binding waa only reduced by about 15^ (Ticku et al. 1978a).
These differential effects of the detergent and the 
two protein reagents suggest that sites for binding of G A M  and 
IHP OLre distinct.
5.6.6 Eguilibrium dissociation constants.
The equilibrium dissociation constant (Kjj) reported 
for (^) - DHP binding was found to be l-2pM using 63nM con­
centration of (%) - DHP (Ticku et al. 1978b, Olsen et al. 1978d), 
and this value is much hi^er than that usually found for 
transmitter antagonists and would therefore raise the question 
whether this binding site is relevant to meaningful drug effects
(Snodgrass 1979)«
of the actions G A M  agonists and antagonists on t ^
sgecifi^^inding.^ ^^^^J|_j^^^^* 
i) Picroto-»-»" «yiAlQgues
Tutin(Pig.2.2)'«s found to be the most potent in the displacement 
of (%) - DHP binding in rat membranes and crayfish muscle
having IC50 values of 0.35mM a»i 0-5mK  respectively 
(Ticku et al. 1978a, Olsen et al. 1978d), being sli^tly more 
potent than picpotoxinin (ICjq 0.4mM and 0.6mM), ^ , i i ^ -  
piorotoxinin (IC^q 1.1m* <«>8 2-lM*) »hereas picrotin (Pig.2.2.)
5e6e7
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was a weak displacer of (^) - DHP ‘binding 
(IC5Q 70mM) . - ' '
ii) f-h) Bicuculline
An IC^Q value for displacement of (%) - DHP in rat 
brain manbranes of 100|jM (Olsen et al. 1979)t a much 
higgler value for that reported in specific (^) - GABA 
binding in the same tissue (Enna and Snyder 19751 
Johnston et al. 1979)*
iii) Biovclio phosphates.
As previously reported the bicyclic phosi^iates have 
little effect on displacement of specific (^H) - GABA 
binding (Bowery et al. 1977) but on the several analogues 
tested, having R-eubstituents; t-butyl, isopropyl, 
n-propyl, ethyl and methyl bicyclic phosphate the IC^q 
values for displacement of (%) — brain
membranes appeared to follow their respective biological 
activities. The t-butyl bicyclic phosphate being the 
most potent and had about half the potency in(^) ~ DHP 
displacement as a-dihydropicrotoxinin (Olsen et al. 1979f 
Ticku and Olsen 1979). However a-dihydropicrotoxinin 
was shown to be less active than t-butyl bicyclio 
phosphate as a convulsant (Eto et al. 1976, Jarboe et al.
1968).
iv) flABA and muscimol.
As expected GABA did not displace specific (^) - 
dihydropicrotoxinin binding in concentrations of up to
ImM (Olsen et al. 1979)*
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Muscimol was also ineffective in displacement of 
(%) - IHP binding in rat brain membranes in 
concentrations up to 100|jM (Ticku at al* 1978a,)»
v) Barbiturates.
The convulsfiurt barbiturate (—) “ 5 ~ (l»3*^i®®‘thyl butyl) —
3 - ethyl bairbiturio acid (HCBB) was the most 
potent displacer of specific (^) ~ IHP binding in rat 
brain membranes with an value of 0.03mN vdiich was
nearly ten times that of picrotoxinin. Other 
convulsant barbiturates were also found to be potent 
displacers of (^) - IHP binding (Ticku and Olsen 1978a, 
Olsen et al. 1979). However, the depressant barbiturates 
were much less active in displacement of (%) - IHP 
binding. Pentobarbital yiaa 10,000 times less
potent than IMBB and phénobarbital was ei^ty
times less potent than the pentobarbital (Ticku and Olsen
1978a, Olsen et al. 1979)»
vi) Others.
A range of t^utyl^icyclocarboxylates with suitable 
R-eubstituents on the bridge head of the molecule were 
found to have similar potencies as the bicyclic phosphates 
in displacement of (%) - IHP binding in rat brain 
membranes (Olsen et al» 1979)»
The potent GABA antagonist totramethylenodisulphotetramine
(TETS) (Pig.2.1 ) (Collins et al. 1975, Bowery et al. 1975) 
displaced specific (^) - IHP binding in rat brain
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membranes with a similar potency to t-butyl bicyclic 
phosphate (Olsen et al. 1979. Tioku and Olsen 1979). 
p-Chlorophenylsilatrane, a caged compound with potent 
convulsant activity (Pig. 2.l) (Eto et al. 1976) was 
about half as potent as TETS in displacing specific 
(%) - IHP binding (Olsen et al. 1979. Ticku and Olsen
1979).
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5»7. The Binding Assay.
a) Prepaurution of the tissue.
The preparation of the synaptosomal (P2) fraction of 
the rat brain tissue was basically that used by Zukin et al.
(1974)» This will be described in full later.
b) Incubation of the tissue.
The rates of association and dissociation of QABA. to its 
receptor are very rapid (Toun^ et al. 19761 Zukin et al. 1974).
This may not be the case with all dru^ ps tested and because of 
saturablef non-specific actions this may not necessarily be 
reversible (Enna and Snyder 1973).
In the case of a readily reversible non-labelled ligeindt 
at the end of the incubation period» the labelled ligand and 
non-labelled ligand should be in equilibrium with the receptor, 
but because the non-labelled ligand is \isually in excess it is 
more likely to occupy the receptor sites.
c) Termination of incubation.
The inctibation can be stopped in two ways, either by 
filtration under reduced pressure and washing or by centrifugation.
Although the filtration method is a quick and simple process 
as described for (^) - muscimol binding (Williams emd Risely 1978, 
Leach and Wilson 1978, Snodgrass 1978) there may be binding to 
the filter by the radiolabelled ligand which would cause an 
increase in non-epeCific binding. The washing process may also 
cause some specifically bound (^) — muscimol to be washed off 
the filter to cause more inaccuracies. Due to the rapid 
dissociation of agonist from the QABA receptors the filtration
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assays are dj.fficult (Snodgrass 1979) this method is 
not an equilihriton process.
The other method is by centrifugation of the tissue 
as described by Zukin et al. 1974* The great advantage of 
this method is thatf at all timest there is an equilibrium 
between the bouxid and unbound drugs. The termination of 
inciibation can be rapidly achieved by pelleting the tissue» 
rapidly x^moving the supernatant by suction and carefully 
removing any excess supernatant by drying the disposable 
centrifxige tube. This method also greatly reduces any non­
specific binding. Due to all the obvious aidvantages of the 
centrifugation method all binding experiments were carried 
out this way.
5.7.1 Method;
Preparation of the synaptosomal (P2 )fractions.
Ton rats (Spraguo-Dawloy, 250-350 St nialo or female) 
were killed by decapitation, their brains rapidly removed and 
homogenised in 1 5  volumes of ice cold 0.32N sucrose solution using 
a Pottor-^lvehjem glass homogeniser fitted with a Teflon pestle.
The homogenate was then centrifuged at lOOOxg for 10 minutes on a 
bench centrifuge. The Pellet (P^ )^ was discarded and the supernatant 
centrifuged at 20,000xg (13K on an MSB Hi^-Spood 18 Centrifuge).
The supernatant osmotically shocked by suspending it in cold, 
distilled water auai dispersed using a high-speed stirrer (Einematica 
PCV-2, setting Mo. 6 for 20 seconds). The suspension was then 
centrifuged at 8,000xg (8K on an MSB High-Speed 18 centrifuge). The
ilM
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supernatant was co lle c te d  and the p e lle t, a h ila y e r w ith  a so ft 
b\2f f y  upper la ye r which was rinsed  c a re fu lly  w ith  the supernatant 
to  c o lle c t i t .  The m itochondria l p e lle t W6is discarded. The 
combined supernatant was then cen trifuged  a t 40,000zg (idK  on an 
NSE H i-Sp in  21 cen trifu g e ) fo r  20 m inutes. The supernatant was 
discarded and the p e lle t resuspended in  ice-K^old d is t i l le d  water 
w ith  a hi£^-«i>eed s t ir r e r  (Kinematica PCV-2, s e ttin g  Ho. 3 fo r  
10 seconds) auid cen trifuged  again a t 40,000xg (13K on an USE H i-6 p in  
21 ce n trifu g e ) fo r  20 m inutes. This f in a l crude sjfnaptosomal 
membrane ( fra c tio n  P2 ) had the supernatant discarded auid the p e lle t 
was frozen a t »30°C fo r  a t le a s t 24 hours before use.
5«7.2 The Assay.
The frozen p e lle t vias allowed to  thaw and was then 
suspended in  30cm  ^ o f d is t i l le d  water and le f t  fo r  30 minutes a t 
room temperature. A sample was removed fo r  p ro te in  determ ination  
using a m odified method o f Lowry e t a l.  ( I9 3 l)*  p ro te in  sample
was d isso lved in  sodium hydroxide (0.2N) fo r  30 m inutes. This 
rev ised method being necessary fo r  a more accurate determ ination  
o f the p ro te in  content o f the tissue  because under normal cond itions  
the p ro te in  from the synaptosomal fra c tio n  d id  not always d isso lve  
ft-wH inaccuracies ocoured when the concentra tion was worked out from 
the standard curve which was p lo tte d  using re a d ily  soluble bovine 
albumen as the p ro te in  standard.
The suspension was then adjusted in  volume w ith  d is t i l le d  
water to  g ive a f in a l ooncentra tinn o f Img o f prote in/cm ^. Then 
Icm^ a liq u o ts  o f the suspension wore trans fe rred  in to  the appropria te  
number o f 1.5cm^ Eppendorf tubes and cen trifuged a t SOOOzg fo r
; I
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2 minutes u s in ^ a M icrofuge B, bench ce n trifu g e .
The supernatant was removed by suction and discarded. 
Each p e lle t was resuspended in  0.03M T r is -c itra te  b u ffe r (adjusted  
to  pH 7*1) and incubated w ith  the appropria te un labe lled  drug 
(d isso lved  in  the b u ffe r whenever poss ib le ) fo r  10 minutes fo llowed  
by a fu r th e r 10 minxxte incuba tion  time a fte r  the a d d itio n  o f the 
ra d io la b e lle d  drug (e ith e r ( ^ )  -  muscimoli 3nN o r ( ^ )  -  a -  
d ih yd ro p ic ro to x in in , 5nK).
Incuba tion was term inated by ce n trifu g a tio n  a t 9t000xg 
fo r  3 minutes on the M icrofuge B. The supernatant was ra p id ly  
removed by suction  and the ins ides o f a l l  the tubes c a re fu lly  
wiped w ith  co tton  buds to  remove any excess supernatant.
The p e lle ts  were d isso lved overn ight in  Soluene tissue  
s o lu b ilis e r (O .lcm ^). A fte r n e u tra lis a tio n  o f the Soluene w ith  
1.5M hyd roch lo ric  a c id  (O .lcm^) the s o lu b ilis e d  p e lle ts  were 
tra n s fe rre d  in  the opened Eppendorf tubes to  glass s c in t illa t io n  
vxa ls to  each sample was added llcm ^ o f s c in t il la t io n  c o c k ta il. 
The v ia ls  were thorough ly to  ensure a l l  the so lu b ilis e d
tissue  had d isso lved in  the c o c k ta il.
Samples were allowed to  s ta b ilis e  fo r  1 ho\ir before  
countings on an ICT 2700 liq td d  s c in t il la t io n  co im ter using a 
medium quench counting^ e ffic ie n c y  o f 23^« The e ffic ie n c y  being 
p rev ious ly  determined from a standard so lu tio n  o f ( ^ ) -  ”■ muscimol 
o f known a c t iv ity .
Between 6 12 determ inations in  t r ip lic a te  fo r  each
h  i M
ill M  !
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concentra tion o f un labe lled  dru^ were used against (% ) -  
mxiscimol, 5»** and (% ) -  a -  d ih yd ro p ic ro to x in in  ( ( ^ )  -  DHP),
^nN. Any de te rm ina tion  d if fe r in g  by more than 10^ o f the mean 
was discarded.
5 , 7 .3  M a te ria ls ;
The s c in t i l la t io n  ooc lc ta il consisted o f:
to luene : T r ito n  X—100 ( 2 : l) ;  2,5 ~ diphenyloxazole (PPO),
0 . 556; 1,4 -  b is  (5 -pheny loxazo l-2 -y l) -  benzene (POPOP), 0 .05^.
Radio la b e lle d  drugs:
Methylamine -  (% ) -  muscimol (s p e c ific  a c t iv ity ,  12.5 Ci/mmole) 
was obtained from the Radiochemicas Centre, Amersham. I t ' s  
radiochem ical p iir ity  was checked by th in —la ye r chromatography on 
s il ic a  ge l in  an isopropanol : methyl e th y l ketone : ammonia 
(65 : 15 : 2 5 ) system and found to  bo 97^ 6 rad iochem ica lly pure.
The R f. value corrosponded to  th a t o f un labe lled  muscimol. The 
1 a b i l i t y  o f the la b e l was te s ted  by b o ilin g  (% ) -  muscimol 
(im C i) in  water fo r  48 hours. Less than 5^ ra d io a c tiv ity
associated w ith  ( ^ )  -  muscimol was lo s t (D. C. W a rro ll, the 
Radiochemical Centro : p riva te  communication).
(^) - a —  dihydropicrotoxinin (specific activity 30Ci/mmolo) was 
obtained from Row England Ruclear, U.S.A.
A ll b ic y c lic  phosphates wore synthesised as described in  Chapter 3 in  
th is  th e s is  (+ ) and (- ) -b ic u c u llin e  mothobromide, a -d ih yd rop ic ro to x in in  
and isoguvacino hydrcch lo ride  were prepared by Dr. J . P. C o llin s . A ll 
the o the r compounds wore obtained from commercial sources.
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Resu lts;
5. 8. B inding stud ies using -  muscimol on ra t "brain 
synaptosomal p repa ra tions,
5 , 8 .1 C a lcu la tio n  o f the number o f recep to r s ite s  from the
s te re o spe c ific  b ind ing .
The s p e c ific  ( ^ )  -  muscimol b ind ing  was obtained 
by sub tra c tin g  from the to ta l bo\md ra d io a c tiv ity  the 
amoTint not d isp laced by a h igh concentra tion o f GABA.
( 10” ^ )  fo r  Img o f p ro te in  used. A mean value o f 6 
experiments was worked out fo r  one set w ith  o f ( ^ )  -  
muscimol «-nd the value fo r  the re s u lts  o f the o ther set w ith  
5nM o f (% ) -  muscimol p lus 10 GABA present. These were 
converted to  d is in te g ra tio n s  per minute/m^ o f p ro te in  and 
subtracted to  g ive the s te reospec ific  (% ) — muscimol 
b ind ing .
The ca lcu la ted  s te re o spe c ific  ( ^ )  -  miiscimol
b ind ing
S p e c ific  a c t iv ity  o f muscimol
1 C \irie
'n ie re fo re  3466 dpm 
s te re o spec ific  b ind ing
3644 d is in te g ra tio n s  per 
minute/mg o f p ro te in .
19 Curies/mmole.
122.22 X 10 d is in te g ra tio n s  
per m inute.
1 .9  X  1 0 ^  moles o f ( ^ )  -  
muBoiaoI.
3466
(2.22 X  10^^) X  ( 1 .9  X 10^) 
8 .217 X 10“ ^^ moles o f ( ^ )  •
muscimol/mg o f p ro te in .
0.08 pmoles o f ( ^ )  -  
muscimol/mg o f p ro te in
Therefore the re  are O.O8 pmoles o f s te reospec ific  bin din g o f ( ^ )  “  
muscimol fo r  each mg o f synaptosomal tis s u e .
t- :
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Pig. 5«1» Total (a ) and non-specific (a ) binding of H 
muscimol with increasing concentrations of((^H) 
muscimol synaptic membrane suspensions. (P^ fractions) 
which had previously been frozen were incu^ted (l.Omg 
protein/tube) in Tris-citrate buffer (pH 7.1). 
Hon-specific binding was determined from assays 
conducted in the presence of ImH GABA. Values are 
the meeuis of triplicate determinations, each experiment 
being replicated twice.
I8l
Pig. 5*2. Saturation of specific (^) muscimol 
binding with increasing concentrations of (^) 
muscimol. Values for specific binding being 
obtained after subtracting the non-specific 
binding from total binding in Pig. 5,1 ,
CO
.11
(^) mxiscimol concentration (nM)
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»
Fig» 5»3* Sc^tchard plot of saturation of
'binding u 
muscimol.
ax
specific (■^) muscimol bindi sing increasing 
concentrâtioner of (%) 
from Pig.5.1. showing Kjj ^ T.dnM and "Bmax 
pmole/mg.
Data obtained 
2.37
I I
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5»3.2 Specific and non-epecifio binding of - mtgoimol.
Two sets of experiments were done in triplicate with 
increasing concentrations of (%) - musoimol (^nN - lOOnM) 
on Im^ of synaptosomal ftuctions. The second set of 
experiments had a hig^ concentration of G A M  (lO“^ )  to 
displace all specifically bound (^) - muscimol.
The results of these experiments were represented 
graphically ( Fig.3«l* ) with binding of (^) - muscimol 
in dpm/m^ protein plotted against the concentration of 
muscimol.
The values for each concentration of (%) • muscimol 
were then subtracted to give the specific binding of muscimol 
in dpm/mg protein this plotted against the concentration 
of (%) ~ muscimol. This was represented graphically in 
(Pig. 5.2.)
From the graph it showed'that an increase in 
concentration of (^) ” muscimol after SO^OnM did not 
increase the specific binding capacity of the tissuey 
showing that the specific binding was satiirable and 
indicating there were a finite number of z^ceptors present 
in the tissue.
5.8.3 Scatchard analysis of specific - mxisoimol binding in
rat brain synaptosomal tissue.
Scat chard analysis of Q A M  displacement of (^) — 
musoimol using rat brain synaptic membranes plotting bouzid 
musoimol/free (pmol/mg protein) against specifically bound
i:
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(^) - miisoimol (Pig.5*3. ) showed that there was only 
one possible slope for the line of best fit indicating 
the presence of one binding site of high affinity.
This result was in agreement with some results 
previously docnmented with specific (^) - muscimol 
binding (Maurer 1978, Snodgrass 1978, Wang at al. 1978, 
DePeTsiia et al. I98O, Kingsbury et al. I98O, Palachios 
et al. 1980), but reports of another h i ^  affinity binding 
site have also been produced with Scatchard analyses 
indicating two sepeu»te slopes on the graph (Williams and 
Risely 1978) and a possibility of two sites in the report 
by Wang at al. (1978)and Bemasconi et al. (198O).
The slope of the graph was fitted by least squares 
linear regression. -  The equilibrium
dissociation constant (K^) was estimated as the negative 
reciprocal of the slope of the line of best fit and was
7.4nM.
This homogenoiis binding site having a Bnax, the 
maximum number of binding sites, calculated by the abscissa 
intercept of the line was 2.-^ 7 pmoles/mg of protein.
5.8.4 of (%) - muscimol to rat brain synaptoeomaj^
in tbo presence asopiata end antagonists.
ABBm±n« that the unlabelled ligand behaves at the 
receptor site in a similar way to the labelled ligand (which 
is not the case when antagonists are used) and that binding
r i i il-l. : i
m.
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phATinmA^^ follows classic loass actioiif "thsii "ths 
concentration of unlabslled ligand of »rtiich maxiiiiuni 
binding of labelled ligand is displaced by 50^ (^^50  ^
this will be a reasonable approximation of the apparent 
equilibrium dissociation binding constant.
The ICcA values for all unlabelled GABA, agonists50
and antagonists were calculated by measurement from the 
graphs of log concentration of unlabelled compo\aid 
against (h) - muscimol binding. This was done by 
measuring from the graph the concentration of compound 
which caused a reduction in specific binding of 
(^) - muscimol.
(^) - muscimol binding in the absence of unlabelled 
ligand was approximately 6,000 dpm and the non-specific 
binding was approximately 1,500-2,000 dpm.
The graphs plotted (Pigs. 5«4-5-9) showed 
displacement of (^) - muscimol binding at a concentration 
of 5nM to img of synaptosomal (Pg) fraction of rat brain by 
unlabelled agonists and antagonists against the log of the
concentration of the unlabelled drugs.
All the results were the means with standard errors 
for 3-5 determinations done in triplicate. The I C ^  values
are shown in Table 5»
Th. potenoi.. of the 0AB4 a«oni.t, on (h) -
binding «.r. nm.oiinol>3-M>inoproi«. snlphonic a o i d >  
irognv»oine>0AB4>P - hjrdroiy OABl.
s
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Pig. 5.4. Displacement of specific (^)-muscimol 
binding to rat brain synaptic membrane suspensions 
(P« fractions) (img protein/tube) assayed with 5nM 
(l9Ci/mmole) radioactive ligand. Specific binding 
was measured in the presence of various concentrations 
of GABA (a ), B-hydroxy GABA (v) and 3-Aminopropane 
sulphonic acid (□). Each point and vertical line on 
the graph being the mean and standard error for 3-5 
separate determinations done in triplicate.
”■ I
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Pig,5»5» Displacement of specific (^)-muscimol 
binding to rat brain synaptic membrane suspensions 
(Po fractions) Img protein/tube) assayed with 
(l9Ci/mmole) radioactive ligand. Specific binding 
was measured in the presence of various concentrations 
of isoguvacine (■) and muscimol (o). Each point and 
vertical lino on the graph being the mean and standard 
error for 3-5 separate determinations done in 
triplicate.
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Pig* 5.6.. Displacement of specific (^)-muscimol
binding to rat brain synaptic membrane suspensions 
(P« fractions) Img protein/tube) assayed with 5 ^  
fl^Ci/mmole) radioactive ligand. Specific binding 
was measured in the presence of various f  
Qf (+)^icuculline methobromide (■) and (-)-bicuculline 
methobromide (□). Each point and vertical line on 
the graph being the mean and standard error for 3-5 
separate determinations done in triplicate.
I I
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F ig , 5.7. Displacement of specific ( H)-muscimol
■binding to rat brain synaptic membrane suspensions 
(P2 fractions) Img protein/tube) assayed with 
(19Ci/mmole) radioactive ligand. Specific binding 
waa measured in the presence of various concentrations 
of picrotoxinin (^) and a-dihydropicrotoxinin (^)»
Each point and vertical line on the graph being the 
m e w  and standard error for 3~5 separate 
determinations done in triplicate.
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Fig, 5.3. Displacement of specific (^)-muscimol
'binding to rat brain synaptic membrane suspensions 
(P9 fractions) (img protein/tube) assayed with 5«» 
(l9Ci/mmole) radioactive ligand. Specific binding 
was measured in the presence of various concentrations 
of dimethyl propyl bicyclophosphate (▼) and neopentyl 
bicyclophosphate (o). Each point and vertical line 
on the graph being the mean and standard error for
3-5 separate determinations done in triplicate.
1 i
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Fig. 5.9. Displacement of specific (^)-muscimol
binding to rat brain synaptic membrane suspensions 
(P2 fractions) Img protein/tube) assayed with 5nM 
(l9Ci/mmole) radioactive ligand. Specific binding 
was meas\ared in the presence of various concentrations 
oT'cyclopentyl bicyclophosphate (v) and phenyl 
bicyclophosphate (▼). Each point and vertical line 
on the graph being the mean and standa^ error for 
3-5 separate determinations done in triplicate.
6 0 0 0
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10r9 1 0 '  10'
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TABIg 5
Inhibitors of (^)-musoimol binding to rat brain synaptosomes
! 1
Compound 1O50 (m*)i
Musoimol
3-Aminopropeme sidphonio acid 
Isoguvacine hydrochloride 
aiBA.
3^iydro:^ GABA.
(■f )—Bicuculline methobromide 
^^^•Bicuculline methobromide 
Picrotoiinin 
a’-Bihydropicrotoxinin 
Beopentyl bicyclic phosphate 
Dimethyl propyl bicyclic phosphate 
Cyclopentyl bicyclic phosphate 
Phenyl bicyclic phosphate
>10CX)
)
The following substances had no effect up to IOOOmM t^utyl bicyclic 
phosphatef isopropyl bicyclic phosphate, tetramethylenedisulphotet- 
ramine (TETS), Cis-3-amino-cyclohexane carboxylic acid (ACHC), glycine, 
(t)-nipecotic acid. Bone of these substances have been represented
graphically.
All results for the binding were determined in sodium-free buffer 
using frozen, thawed and thoroughly washed membranes as described 
previOTisly. All results were made from 3-5 separate determinations 
done in triplicate.
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Muaoimol
An value of 12nN was obtained from the 
graph analysis* This result was of the same order as 
reported on (^) - muscimol binding being about half 
that rex)orted in mouse brain and calf cerebellum 
tissue (Leach Wilson 1978? Wemg et al. 1978)? 
about a quarter of that in neTaron-enriched ctdture 
of rat (DePeudis et al. I98O) and double that reported 
for rat brain binding (Beaumont at al. 1978). These 
results also compau:^ favourably to the results 
obtained for muscimol in (^) — QABA binding 
(&ogsgaard-Larsen and Johnston 1978f Johnston ot al. 
1979, Olson et al. 1979) in ill® ®®“® ii®»ne preparation. 
^-Aminonropane sulphonio acid
An value of 87nM, approximately one50
seventh the potency of muscimol in its ability to 
displace (^) — muscimol was obtained. A result of 
lOOnK in motise brain fractions for this was obtained 
and would be in good agreement with the above result, 
(Wang et al. 1978), and l60nlC in cultured rat 
cerebellum (DePeudis et al. I98O). However, 3 - amino- 
propane sulphonio acid was found to be equipotent with 
muscimol in rat brain fractions in other studies 
(Beaumont et al. 1978).
In (%) - OABA binding studies 3 - aminopropane
. t
194
sulphonic acid weus found to be one sixth as 
active as muscimol idiich %iould a^ pree with the 
results obtained abovey (Enna and Snyder 1977)* 
iii) Isoguvacine hydrochloride»
An I C ^  value of 0,4mM waa obtained which 
%ras of the same order as the resxdt in mouse brain 
tissue (Wan« et al. 1978). However, the result 
for Isoguvacine was found to be a more effective 
displacer of (^) - muscimol than 0AB4. itself, in 
agreement with Lodge et al. (1978). In studies 
with (^) - binding there was some conflicting 
evidence,with Olsen et al. (1978b) in agreement with 
this Krogsgaard-Larsen and Johnston (1978) in 
disagreement on the relative potencies of GABA, and 
isoguvacine.
iv) g a-ba
An I C ^  value for GABA at IpM would appear 
to bo b-igh in comparison to results obtained in the 
mouse and rat brain (^) - mtiscimol binding experiments 
(Leach and Wilson 1978, DePeudis et al. I98O,
Wang et al. 1978), and also with (^) - GABA binding 
in similar preparations (Enna and Snyder 19771 
Johnston et al. 1978), but it was found to be of the 
same order and this result may account for the 
discrepancy and disagreement over the results obtained
in comparison to isoguwacine.
Í
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v) B-tmLroxv Q A M
An IC_rt value of 1.8mM was obtained ehowing
50 ,
it to be about half aui potent as QABA in ('^) - 
muscimol displacement. Althou^ no direct comparison 
can be made with other work on (^) - nmsoimol 
binding the result agrees with all other work on 
(^) - binding (Young et al. 1976f Olsen et
al. 1979).
All the agonists tested were shown to bo effective 
in dlsplaein« (%) - nusolnol from the membr«». m d  it «»b 
assumed that their actions were at the QABd recognition site. 
Howeimr %*en the antagonists wore tested only (+) - bicttonllino 
methobromide wa. able to displace the {h) - muscimol binding 
to a significant ertönt. All the other compounds wore 
tested up to a concentration of Im« bat even at these very 
h i ^  oonoentiations a marimum of 10-15^  of the specific
binding was displaced.
i )  ^  B i e u c u l l i n e  methobromide.
A high lOjo 1®°*^ * "  obtained for
{+) - biouculline mothobromide >*ioh was nearly twice 
that obtained for the methoohloride salt in the calf 
oorebollum (Leaoh and Wilson 1978). This was 
approiimatoly 200 times loss potent than OABA in 
displacing (®H) - muscimol binding. Howsver, the 
relative ratio of the potencies of OABA and (+) - 
bioacullino in both (®H) - muscimol binding and (®H) -
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QABA binding to those membranes is simileur 
(Enna et al, 19771 Enna and Snyder 19771 
BeatBoont et al. 1978? Wang et al. 1978).
ii) j^—^^^^Bicnoullinejaothobromide^.
Althou^ at very higji concentrations (imW)
(-) - bicuculline methobromide failed to displace 
(%) - muscimol binding to the rat brain membranes 
there was a 15-203t reduotion in the binding at the 
highest concentration, but this was probably a non­
specific effect. This agrees with evidence in (%) - 
muscimol bindizig (Beaumont et al. 1978, Straughd^l978), 
although an I C ^  value was obtained in (^) - GABA, 
binding studies in brain membranes a very hig^ value 
was obtained for this and the (-) - isomer was found 
to be about 100 x less potent than the (+) - isomer.
iii) Picrotoxinin and - dihydropicrotonnin.
»
Agein, even at very high concentrations (imM), 
these oompoxands only produced 15-20^ displacement of 
(%) - musoimol. This agrees with picrotoxin used to 
displace (^) - muscimol whore concentrations from 
lOpM - IfflK failed to produce an IC^q value (Beaumont 
et al. 1978, Leach and Wilson 1978, S t r a u b  1978,
Wang et al. 1978, DePeudis ot al. I98O).
Picrotoxin used to displaico (^) - GABA binding 
from brain membranes in consent rat ions of up to ImM 
also failed to produce an IC^q value (Enna et al. 1977.
Olsen et al. 1979)»
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v)
Bic2clic_^^hw8^hjate_e8t^^
Six different analogues of the hioTclic 
phosphates were tested up to concentrations of InM. 
None of them produced any displacement more than 
10-1556 of (^) - muscimol hinding. However 
isopropyl hioyclophosphate was shown to produce an 
IC^Q of 135mM ^  (^) “ muscimol hinding (Strau^in 
1978) isopropyl bicyclic phosphate also has been 
shown to give an IC^q value of 200mM in (^) - G A M  
binding (Bnna et al. 1977). The results for 
dimethyl propyl, neopentyl, phenyl and cyclopentyl 
derivatives have been represented graphically
(Figs. 5*8 5.9).
Others
(t) - Hipecotic acid, a potent inhibitor 
of G A M  uptake into neuronal and glial colls (Brehm 
et al. 1978) had little effect of (%) - musoiinol 
binding in concentrations of IOOOmM in agreement with 
Beaumont ot al. (1978) and Hang et al. (1979).
The inhibitory amino acid, glycine (Curtis
and Johnston 1974^1 McGeer et al. 1978) was also 
ineffective in displacing - muscimol in
concentrations of lOOOyM which again agreed with 
results obtained in binding to mouse brain fractions
(Wang et al. 1978).
Tetramethylenedisulphotetramine (TSaJS), an
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inhibitor of OASA (Bowery et al. 1975f Collins 
et al. 1975) also had no effeot on displaoement of 
(^) - nrusoimol in this prepairation, in 
oonoentrations of IOOOmM.
Cis-3-amino-oyolohezane oarboa^rlic acid 
(AGHC), a potent blocker of neuronal GABA uptake 
(Collins et al. 19751 Bowery et al. 1976b, Johnston 
et al. 1978), also had little effeot on (%) - 
muscimol bizkLing in concentrations of lOCWnM.
5.8.5 ~Genclusions
Results from the Scat chard analysis showed there 
was only one h i ^  affinity binding site for (^) - muscimol 
which had an equilibrium dissociation constant (K^) of 7.4nM.
In other preparations using rat brain reports of 
a single h i ^  affinity binding site were of the same order 
as results for Kjj ranging from 1.88nM to 13nK (Snodgrass 1978, 
Bemasooni et al. I98O, Kingsbury et al. I98O). In mouse 
brain fractions a high affinity binding site with a K^ of lOnM
was obtained (Hang et al. 1979)*
However, reports of two sites, one of low affinity
and one of high affinity show a different dissociation constant 
value for the high affinity site with values ranging from 
9nM - 60nH (Bea\amont et al. 1978, Hang et al. 1979i Hilliams
9
and Risley 1979)*
The number of binding sites for (^) —
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muBoimol (Bnaz) found in the preparation was found to he 
2.37 pmoles/m^ of protein. Other results showed very 
similar observations in rat brain tiss\aes s 3*3 pmoles/m^ 
protein (Snodgrass 1978), 2.8 pmoles/mg protein (Beaumont 
et al. 1979), 2.34 pmoles/ng protein (Kingsbury et al. I98O), 
tLY^ using a radioreceptor assay Bnax of 2.08 pmoles/mg 
protein (Bemasooni et al. I98O). The high affinity binding 
'RnMi.-y in mouse brain also correlated well with the results 
found here being 2.1 pmoles/mg protein (Wang et al. 1979).
However two reports showed a much lower a «  
than those reported above. On rat synaptosomal binding a 
Vi-igh affinity site Emax of O.5I pmoles/mg of protein was 
found (Williams and Risley 1979) and also using a radioreceptor 
assay a of 0.28 pmoles/mg of protein was found (Palacios
et al. 1980).
Overall the results from Scatchard analysis 
obtained here would agree with most of the work undertaken
for the specific binding of (%) - muscimol.
The (%) - muscimol appeared to bind in a
specific fashion to the synaptic 0AB4 receptor in rat brain 
membranes. The substrate specificity of the (%) - muscimol 
binding sites provides strong evidence that muscimol is 
highly specific for the OABA receptor because of the (%) - 
musoimol receptor showing appreciable affinity and 
stereospecifioity only for those drugs which are known to act
■;* i
y.
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neuroidiysiologically with the QABA. receptor. In 
addition the results with the QABA agonist drugs on 
(^) - muscimol compare very favourably with similar
experiments using (hi) - QABA.
As expeoted only (+) - biouculline 
methobromide had auay sigpificant effect on the 
displaoement of (^) - muscimol from its receptor with 
(-) - bicuoulline methobromide having little effect.
These results again confirmed reports using (%) - OABl 
on the same tissues.
Similar results and reports using auto­
radiographic techniques also support the evidenoe that 
(hi) - musoimol is aoting at the QABA receptor (DePeudis
et al. 1980).
The lack of effeot of picrotoxinin and 
o -dihydropicrotoxinin on (%) - muscimol binding is in 
acoord with other results on brain synaptosomes (Beaumont 
et al. 1978, Williams and Risley 1979) ^  with (h) - muscimol 
binding using autoradiographic techniques on cultured brain 
cello (DePeudis et al.‘ I98O, Palacios et al. I98O), and 
supported with their lack of effeot of (h) - QABA binding 
(Enna et al. 1977r Olsen et al. 1979) would support the 
contention that they aot on a QABA regulated chloride
ionophore (e.g. Olsen et al. 1978a»b).
The lack of effeot of the bicyclio phosphates in
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(%) - muscimol binding (Straugfan 1978) and in (^) - 
G A M  binding (Bnna et al. 1977) except in very high 
concentrations would also support the contention that they also 
act at a similar site to piorotoxinin (Olsen et al. 1978b»
Ticlcu axid Olsen 1979)»
(t) - nipecotic acid, a potent inhibitor of
G A M  uptake into neuronal and glial cells (Brehm et al.
1978) ois - 3 — — cyclohexane carboxylic aoid
(ACHC), a potent inhibitor of G A M  uptake into neuronal 
cells (Collins et al. 19751 Bowery et al. 1976b, Johnston 
et al. 1978) both had little effect of (^) - muscimol 
binding again correlating with sodi\im independent (^) - 
m u A  binding (Krogsgaard-Larsen and Johnston 1978, Johnston 
et al. 1979) that muscimol has little or no affinxty for 
the sites related to G A M  uptake (Krogsgaard-Larsen and 
Johnston 1978).
The inhibitory amino aoid, glycine (Johnston 
19741), Snyder 1975), »leo had. little effect on (h) - nraaoimol 
tiinllng corroborating evidence by Wang et ol. (1979) »nd 
Beaumont et al. (1978). Again this compares favourably with 
results in (%) - QABA binding (Olsen et al. 1978b).
Tetiamethylenedisulphotetramine (U?PS) a potent
inhibitor of OABA in the rat superior cervical ganglion 
(Bowery et al. 1975) «“ d ouneate nucleus (Collins et »1. 
1975) had little effect on (^) - muscimol displacement as it
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did in (^) - GABA displacement (Bnna et al, 1977 )f 
suggesting an action at some site away from 'bhe GABA 
receptort possibly at a similar site of action as
picrotoxinin (Ticku and Olsen 1979)*
Some of the values for the f®r some of
the agonists which were tested seemed higher than reported 
elsewhere hut this may have been due to the treatment of 
tissue with detergents which increased both (^) - GABA 
bindio« (Em» and Snyder 1977) and (^) - musoiaol
(Beaumont et al. 1978, Williams and Risley 1979). 
Whereas no such treatment was used in any of the tissue 
preparations in those orperimonts.
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Fig. 5.10. Total (•) and non-specific (O) Tsinding
of (^H)-a-^ihydropiorotoxinin (IHP) with increasing 
concentrations of P h )-IHP. Synaptic memhrane 
suspensions which had pre^^ously been frozen were 
incubated (1.0 mg protein/tube) in Tris citrate 
buffer (pH 7.l). Kon-specific binding was determined 
from assays conducted in the presence of ImM 
picrotoxinin. Values are the means of triplicate 
determinations, each experiment being replicated 
2-3 times.
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Pig. 5.11. Displacement of (^)-DHP binding to 
rat brain synaptic membrane susnensions 
(Pj fractions) Img protein/tube) assayed with 
5nM (19.0 Ci/mmole) radioactive ligand.
Binding was measured in various concentrations 
of picrotoxinin (■) and a-dihydropicrotoxinin (□). 
Bach point and vertical line on the graph being 
the mean and standard error for 4-11 separate 
determinations done in triplicate.
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Pig. 5.12. Displacement of (^)-DHP Tainding to rat brain synaptic membrane susnensions 
(P2 fractions) Img protein/tube) assayed with 
5nM (1 9 . 0  Ci/mmole) radioactive ligand.
Binding was measured in various concentrations 
of neopentyl bicyclophosphate (a ) and (+)— 
bicuculline methobromide (a ). Each point and 
vertical line on the graph being the m e ^  and 
standard error for 4-11 separate determinations 
done in triplicate.
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5.9. wnHiTY|> s-fciidiftg iminir (^) - tt - dltordropicrotoxinin on 
rat brain gynapt0B0inal__niemb^ ^6s»
5,9,1 Soeoifio and non-epecific binding of (%) - a -
dihydJODiorotoxinin»
Two sets of experiments done in triplicate 
with inoz'easinf concentrations of (^) — a ~ 
dihydropiorotoxinin (5hlC - lOOnM) on Im« of synaptosomal 
fractions. The second set of experiments had a high 
ooncentration of piorotoxinin (10 to displace any 
specifically bound (%) - a - dihydropicrotoxinin.
The results of those experiments were 
represented graphically (Pig.5»10) with binding of 
(^) - a - dihydropiorotoxinin in dpm/m« of protein 
plotted against concentration of (^) - a - dihydro­
picrotoxinin.
The results from the graph showed that there was 
no displacement at any concentration of (%) - a - 
dihydropiorotoxinin by a h i ^  concentration of picrotoxinin. 
It therefore must be concluded that for these experiments
there w m  no specific binding.
5.9,2 ni^ iftiilAtion of the number of receptor sites from
stereospecifio binding^.
Since no stereospeoific binding was found in any 
of 11 experimentsf each done in triplicate using 5dM (^) “ 
a - dihydropicrotoiinin and ones with a h i ^  concentration
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of picrotoxinin (lO“^ )  the number of receptor sites 
could not be calculated.
3 Binding of f ~  a - dihardropicrotoxinin to rat brain 
synaptosomal prepauration in the presence of QABA. 
antagonists and aigonists.
Assuming that the unlabelled ligand behaves at 
the receptor site in a similar %iay to the labelled 
ligazKl (idiich is not the case idien agonists are used)
ATtA that binding phenomena follows classic mass actiony 
then the concentration of unlabelled ligand of vdiich 
maximum binding of labelled ligand is displaced by 50^ 
(IC^) this will be a reasonable approximation of the 
apparent equilibrium dissociation binding constant.
(%) - a - dihydropiorotoxinin binding in the 
absence of unlabelled ligand was approximately 7 »000 dpm 
and the non-specific binding was approximately 7 »000 dpm.
Graphs plotted ( Pigs. 5* 11-5»12) 
displacement of (%) - a - dihydropicrotoxinin binding a 
a concentration of 5nM to Img of synaptosomal (Pg) fraction 
of rat brain by unlabelled antagonists a^inst the log of 
the concentration of unlabelled antagonists.
All results were the means with standard errors for
4—11 determinations done in triplicate. The results are 
shown in Table 6 •
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TABI£ 6
Inhibitors of (^)-a-dihydropicrotoiinin hindin^f to 
rat brain synaptosomes
Compotmd IC50 (liM)
Picrotoxinin 
a—Dihydropi cro t oxinin
Bicuculline msthobromids 
Keopentyl bicyclic phosphate
yiooo
The following compounds had no effect up to lOOOpM t*^utyl 
bicyclic phosphate, dimethyl propyl bicyclic phosphate, cyclopentyl 
bicyclic phosphate, GAM, 3-aminopropane sulphonic acid, (-)- 
bicuculline methobromide. None of these compounds have been 
represented graphically.
All results for the binding were determined in sodium-free buffer 
using frozen, thawed and thorou^ly washed membranes as described 
previously. All results were made from 4- H  separate determinations
done in triplicate.
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TABIE 7.
Results showing the action of various agonists and 
antaigonists on the synaptosomal fraction of the rat "brain 
which was incubated with (^)-dihydropicrotoiinin at a 
concentration of 5nM).
Cold drug 
incubated
Radioactivity residixal in P2 synaptosomal ^  
fraction after incubation with cold drug auid ("^)- 
IHP (5riH) in disintegrations per minute as means 
with standard errors. (Rumber of experiments for 
each concentration is shown in brackets.
Cold drug 
incubated
Concentration of drug etdded
10"^ 10^ 10“ M^
Picrotoxinin 7084 - 257 
(33) .
6972 - 184 
(24)
7137 - 168
(Z't)________
a-Dihydro- 6963 - 652 (27)
7006 i 244 
(15)
6862 i 250 
(15)
(+)-Bicuctilline 
Nethobromide
7573 - 642 (12)
6898 - 354 
(15)
7031 - 469
(12)________
Reopentyl
PBTO
7537 i 490 
(9)
7311 i 574 
(^ ^
7593 - 202 (12)
Cyclopentyl
PHPO
1.
t-Butyl 7 3 5 1 -
PBTO__________ (12
GABA 7 1 1 0  i  :
(24
R.B. All experiments were carried out with internal
for each batch of binding studies undertaken and these showed 
that ^  all the cases there appeared to be no displacement of
the
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Piorotoxinin aind a - dihydropicrotoxinin,
neither compound showed any significant 
displacement of (%) - a - dihydropiorotoxinin and. 
in all experiments performed there appeared to he no 
signifioant difference between the results with high 
concentrations of the unlabelled compound azKi the 
results obtained for the controls* with no displacement of 
unlabelled compound. The results are shown in 'T
Ho IC-rt coiild therefore be obtained.50
(-!•)- Bicuoulline methobromide and - bicuoulline 
methobromide.
Again there was no significant difference between 
the control experiments with 5nM (^) — a “ dihydro— 
picrotoxinin and the results obtained with concentrations 
of (+) - biouculline methobromide in concentrations of
10"5 - 10"^. Ho ICcn value could therefore be established50
from this. (-) Bicuculline methobromide also had
no effect in concentrations of 10 hi.
The bicyclic i^ps^ateg^.
Pour different bicyclic phosphates were tested up 
to concentrations of lO"^. The neopantyl bicyclic 
phosphate represented in Pig. 5.12 appeared to have no effect 
at all on (^) — a - dihydropicrotoxinin binding. Similar 
results were obtained for dimethyl propyl, t-butyl and 
cyolopentyl axialogues in concentrations of 10
211
others
The GASA agonist 3"^inopropeuie sulphonic 
aoid GABA itself had no effect on (^) ~* a ~ 
dihydropicrotoxinin binding in concentrations of 
10“^ .
5.9.4 Conclusions
Bone of the GABA antagonists or agonists 
caused any displacement of (^) — a dihydropicrotoxinin in 
concentrations of up to lO”^  in any experiment compared to 
the control. Bven the use of a separate, different batch of 
— a — dihydropicrotoxinin obtained from a different 
source produced no displacement at all. The results here are 
in complete contrast to those obtained by the Riverside group 
using a similar rat brain synaptosomal method of binding but 
only obtaining a specific binding of less than 12^ (Ticku 
et al. 1978b). Other work on this prepauration has produced 
displacement of specific binding to rat brain tissues' with 
\mlabelled picrotoxinin, bicyolic phosphates, (+) - bicuoulline, 
barbitTirates, bicyclocarboxylates, benzyl penicillin, TESTS and 
silatrane,(Ticku and Olson 1978a, b, Ticku ot al. 1978a,b and 
Olsen et al. 1979^)»
The Riverside group have also obtained a specific 
binding of (^) - dihydropicrotoxinin of about 16^ in crayfish 
muscle preparation. Displacement by picrotoxinin, tut in and 
a - dihydropiorotoxinin were obtained (Olsen et al. 1978d).
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Althou^ all the results have been obtained 
by the Riverside gro\ip, no other group of workers has 
published any results oonfinning a specific binding of (^) - 
a - dihydropicrotoxinin and all the resoxlts obtained in the 
experiments here are in complete disagreement, and that no 
specific binding of (^) - a - dihydropicrotoxinin can be 
obtained in sodium free buffer, using frozen, thawed and 
thorou^ly washed membranes of Pg fractions of rat brain in 
tris-oitrato buffer at pH 7.4, but the results obtained by 
the Riverside group for rat brain synaptosomal membrane 
preparations and crayfish muscle microsomal fractions were 
performed using fresh tissue without the frozen, thawing, and 
washing process, and all binding assays were performed in 0.2M 
sodium chloride - 5mll sodium phosphate buffer at pH 7.0 which 
probably accounts for the discrepancies in results obtained
here, comp8UC*ed to their results*
Two different batches of (^) “ were used
for the experiments, one from the Radiochemical Centre, 
Amershan, specific activity 30.0 Ci/mmole and the other from 
Sew iCngiMvi Huolear, specific activity X9.0 Ci/mmole. Neither 
were displaced hy any of the agonists or antagonists used in
these experiments.
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6.1 Introduction
The actions of a dru^t to be classed as suchi 
must qualify in three major criteria:
■ i. It must have a high effective potency (often
acting^ in concentrations of the nanomolar range),
ii. It must have chemical specificity, showing a
great difference in potency between optical isomers 
(e.g. effects of (+)-and (-)-bicuculline binding 
to Q A M  receptors, the (+)- isomer being 2 to 3 
orders of magnitude more potent than the (“)“isomer, 
(Enna et al. 1977) or a sli^t change in a chemical 
side r»hA.in of compounds (e.g. in the bicyclic 
phosphates a change in the side chain from isopropyl 
to n-C^H., reduced the potency by more than three 
orders of magnitude), (Casida et al. 1976).
iii. Biological specificity must be demonstrated (e.g.
adrenaline has marked effect on cardiac muscle but 
very little effect on striated muscle).
These criteria have led to the generally accepted 
theory that some cells possess specific regions which 
interact in some way with the drug to cause an effect ? 
these regions on the colls are the drug receptors.
Several different types of receptors have been 
characterised and various theories have been proposed as 
d r u e ^ e p t o r  mod.ls (tong, 1971. Holl«nb.rg 1979). Some
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of these theories have been applied to this study ^^ here 
they are applicable to the QABA. receptor.
6.2 The receptor model
A fundamental assumption that if a dru^ is to
have any action it must be bound. The site of this 
initial binding is termed the receptor and on first 
approximation in simple chemical terms as a bamolecular 
drug-receptor interaction (Equation D 3  )•
D + R ^ ^ ^  ^  Response C“*!
K-1
Where D « drug or neurotrcuMmitter, R « receptor,
I® ■ the drug—receptor complex, and the equilibrium 
dissociation constant Kp is given by the quotient of the 
rate constants, K.i / %  • equilibrium forms
the basis of the theories of drug action (Clark 1937»
Patón 1961, Patón and Waud 1964).
If the magnitude of the biological response is
proportional to the amount of drug-receptor complex formed 
and a bimolecular action is assumed in equation then
at equilibrium the law of mass action can be applied to give 
the equilibrium dissooiation constant (Kp) in equation [2]
Kj, - M fel C2]
Cm)
«h.r.»Cli) . Ck ] r.p«s.nt th.
concntrstlons of fr.® drug r«c.ptor and drur-r.c.ptor 
complex respectively.
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However there m\ist he a finite amo\mt of 
receptors a maximal response would he obtained if 
all these receptors were occupied hy the dru^ to give 
the equation fsj •
Response ■ Ifaximad^esponse^i^^ f
Kd  + & ]
Prom this the concentration which produces half-maximal 
response[®]o.5 (usually termed BD^q ) can he equated with 
the equilibrium dissociation constant for the drug receptor 
interaction.
6.3 The two-etate receptor model
The observation of sigmoid concentration - effect
curves for QABA. (and ocurhachol) could not ho attributed to 
s^ jr^ ifacte of measuring the ionic conductance as the response.
Therefore an allosteric model based on the sigmoid 
velocity-eubstate relationship observed with ensymes 
(Monod et al.1 9 6 5 ) was adapted to models of drug action
(torlin 1967, Changeaux et al. 1967).
The observations, based on electrophysiological 
data, suggested that the membrane components-involved ion 
transport (ion "channels**) existed in two states, either 
open or shut, irrespective of the drug responsible for the
modulation of conductivity.
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In these receptor models it is assumed that 
the receptor and ionophore form a closely acting membrane- 
localised complex which only exists in two conformations 
for which the affinity for the drug for these sites 
may he different. In the absence of any drug an 
equilibrium will be adopted between the T-state (closed) 
and R-etate (open).
In thevcase of potent agonists the affinity 
for the R-state (open) is much more than that of the T-etate 
(closed). Therefore agonists will shift the equilibrium 
to the R-etate and open the ion channel. In the case of 
potent antagonists the affinity for the T-etate (closed) 
is far greater than that of the R—state (open) shifting 
the equilibrium to close the ion channels. The affinity 
for an agonist or antagonist drugs for either conformations 
site would determine its efficacy in opening or closing 
the ion channels.
The observation of h i ^  and low affinity 
binding sites for the binding of muscarinic agonists 
(Birdsall and Hulme 1976) and G A M  agonists (Enna and 
Snyder 1976, Beaumont et al. 1978) may be rationalized
in terms of this two state model.
It has been suggested that receptors for
aevirotran«iiitt.rs ar. abl. to axiat in mora than ona 
oonfornation (Han* 1971, Snydar 1978) and that thay ara
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multi-eubimit proteins (C\aatreoases 1974? Chauigeui 
et al 1967). These subunits may be a group of oligomers 
(Khrlin 1967) or a lattice-s-like network (Changeux et al 1967) 
with the constraint that units in the same oligomer are 
forced to adopt the same conformation or neighbours in 
the same lattice interact in such a way that they all 
adopt • the s€une confoimiation*
Clearly these models predict that a single 
membrane-localised receptor recognition macromolec\ile 
can display more than one affinity for a given ligand 
so the Hill coefficient can assume any value and this 
would explain fractional values obtained for various
t
drugs (Rang 1971? Colquhoim 1973).
Hii^ly co-operative binding of transmitter 
molecules to successive receptor subunits could account 
for the complex sigmoid dose-response curves (Rang 1971? 
Colquhoun 1973). Alternatively, binding of more than 
one transmitter molecule to receptors could be needed to 
produce an ionophore response (Olsen et al. 1975? Brookes 
and Merman 1973)? the latter model being supported by 
binding studies in synaptic membranes does not appear to 
be oo-operative (Olsen 1976).
 ^i
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Probably a combination of co-operativity and 
h i ^  reaction order seems to be plausible for the 
ne\irotransmitter to the receptor or receptor/ionophore 
coupling events. Ionox>hores may be co-operatively activated 
by allosteric interactions throu^ either direct receptor- 
ionophore interactions or membrane lattice effects 
(Levy et al. 1975). Another model proposed involves 
chants in membrane mobility of the receptor and ionophore 
macromolecules. When transmitter is botmd to the 
recepjbor these ionophore aggregates are stabilised and 
an opening of the chloride ion channel formed (Olsen 1976).
6.4 Tha_^Gti^e_conformation of QABA
The molecule has considerable flexibility
as a result of free rotation stround the single bonds 
(Fig. 6.1). This conformational mobility can be reduced 
in analogues of QABA by incorporation of unsaturation 
and/oT ring structures into the basic molecular structure. 
The first studies using QABA analogues of restricted 
conformation to probe the molecular aspects of QABA 
interaction were performed on the crayfish stretch 
receptor (McOeer et al. 1961). The application of some 
of these analogues was done in mammalian CBS in the 
cat cerebral cortex (Curtis et al 1971a). New QABA 
analogues of restricted conformation were tested for in
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other QAMHnediated prooesses such as hi^-€iffinit7 
isptake (Beart et al 1972a) azid Q A M  transamination 
(Beart et al. 1972b). Ligand binding with synaptcsomal 
membrane preparations has also been used to elucidate 
GABA processes with these analogues (Bnna and Snyder 1975)» 
The studies were accompanied with stinicture-activity 
specTilations with respect to charge separation on the 
molecule or whether it was in the extended form (Beart 
et al 1971, Johnson ot al 1975) and/or the folded form 
(Steward et al 1971» Van Gelder 1974).
One of these restricted isomers is m\isoimol 
(Fig. 1.4) in idiich the restriction of conformaton of the 
molecule by linking C3 and C1 atoms where the 3-isoxazol 
moiety acts as a masked carboaqrl groiJP ”^0 restrict its 
conformation (Johnston et al. 1968). Muscimol is a potent 
selective bicuculline-eensitive GABA agonist and binds 
to rat brain membranes with a hi^er affinity than GABA 
o,)5o. muscimol and GABA bind to common sites (Beaumont 
et al 1978, Palacios et al I98O). The effects of muscimol 
would appear to be exerted at the GABA recognition receptor 
site because muscimol has very little effect on the 
transport-related uptake rsoognition site, being more 
than 1,0CX) times less potent than GABA itself for this 
site (Krogsgaard-Larsen and Johnston 1975) and *
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substrate for nor an inhibitor of GABA, transaminase 
(Johnston et al 1979)*
Restriction of rotation around the 1T-C4 
bond provided the GABA antagonist (+)-^icuoulline 
Pig. 2.4). Structural similarities between GABA and 
(4.)^biouculline have been noted (Curtis et al. 1970a» 
Johnston 1976). Also rotation aroiaad the single bond 
joining the two ring structures (C1-^9) is restricted 
(Andrews and Johnston 1973). Ligand binding studies 
with GABAf (+)-bicuculline and muscimol, indicate that 
these compounds share some common binding sites (Gnna 
et al 1977, Möhler and Okada 19771 Beaumont et al 1978). 
Bicuoxilline also has a stereoselective action, the (-)- 
isomer being much less active than the (+)-isomer 
(Bnna and Snyder 1977). (+)-Bicttculline has other 
actions but appears to have no effect on GABA hig^ 
affinity uptake or GABA transamination (Johnston 1976,
1978).
Trans-4-«minoorotonio acid (Pig. 1.5) has 
restriction of rotation around C3-^2 bond and has 
higgler activity than GABA with respect to the GABA 
binding site (Beart et al 1972a) also it acts as a 
substrate for GABA transaminase and has activity similar 
to GABA for the h i ^  affinity GABA uptake. However, 
the cis-isomer (Pig. 1.5) has little activity in GABA
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binding axKi is inactive against QASA h i ^  affinity 
i:qptake or transamination (Johnston et al 19731 1979)»
There are many other ways to restrict the 
conformation of Q A M  analogues and clearly some of 
these have selective actions on partictilar GABA, 
processes, often acting with a hi^er potency than 
GABA itself. These actions provide evidence for a 
miiltiplicity of GABA receptors such as the postsynaptic 
GABA receptor, GABA neuronal uptake, GABA transaminase 
a-nd GABA glial uptake.
It has been suggested that the extended 
conformation of GABA binds to the receptor-recognition 
site awH that the folded conformation of GABA binds to 
the transport—recognition site (De Feudis 1977)» It is 
also possible that the GABA molecule attaches itself 
to the receptor-recognition site with one side of the 
extended conformation and to the transport-recognition 
site with the opposite side of the extended molecule 
(Roberts 1979). This suggests that if the two sites 
are in close proximity, attachment of a GABA molecule 
to the transport site may automatically remove a 
molecTile from the receptor-recognition site and cause 
an opening of the anion channel.
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The similarities of the conformations of 
GABA, (top view) and mtisoimol space filling CPK models 
(Pig. 6.3) show that this side is the most probable,
»diioh »rill facilitate binding to the receptor 
recognition site (Roberts 1979)« Also similarities 
were noticed between the bottom view of the extended 
GABA model a-rid some of the compounds kno»m to have 
their actions at the GABA transport site. This 
suggestion eliminates the process of a passive 
equilibrium dissociation of the transmitter and anion 
channel opening.
6.5 The anion channel
The GABA molectile itself does not have any
direct effect on the channel opening site and it is 
likely that picrotoxinin and several cage compounds, 
including the bicyclic phosphates, have their inhibitory 
actions on or around this site (Pig. 6.2).
In the case of picrotoxinin binding this 
prevents the opening of the chloride ion channel with 
these actions being reversible »rith depressant and 
anticonvulsant barbiturates and potentiated by convulsant 
barbiturates (Ticku and Olsen 1978a).
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Sdv6r&l compouxids similar in siructura to 
picrotoxinin have been examined for their convulsant 
activity! of which piorotoxin, a-dihydro picrotoxinin, 
tutin «-«d coryamytrin (Fig. 2.2) have been shown 
to be potent 0 A M  antagonists (Kelly and Beart 1975a-) •
For the most potent activity as G A M  antagonist 
several conclusions were drawn from the shape of the 
molecules (Fig. 2.2). The compound must have a 
lactone function containing C-5 and C-3 of the skeleton.
The carbonyl function must be cis to the fused ring 
g^27xcture ju combination with the bridgehead
hydroxyl group at C-6. The alkyl side chain features 
already described appear to comprise an absolute
structural requirement for activity.
Acetylation of the C-6 hydroxyl or cleaving 
the lactone ring leads to a groat reduction in potency. The 
oxitano ring and the lactone ring joining the C-2 and 
C-9 (absent in tutin and coryamytrin) do not appear to
bo necessary for activity (Fig. 6.4)*
T h o T  (pi) Cloud of the isopropyl side chain 
and the hydrogen of the C-6 hydroxyl interact to form a 
hydrogen bond which holds the side chain approximately 
planar to the lactone ring (joining C-3 and C-5).
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The postulated site of action of these 
compounds has a lipophillic cleft which would easily 
incorporate the isoprenyl side chain indicating the 
reason for the decrease in activity of a-dihydro- 
picrotoxinin, which has a satiirated side-chain and
is therefore less lipophillic.
The action of picrotoxinin could he to 
shorten the lifetime of the GABA-activated opening/ 
formation of this channel or possibly to prevent the 
formation/opening of the channel. It is unlikely that 
picrotoxinin blocks the opening physically because of its 
size since pentobarbitone reverses both picrotoxin and 
bicyclic phosphate GABA antagonism (Bowery and Dray 1976) 
that it also competes with picrotoxinin for the 
same receptor or one in a closely related position.
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6,6 Prospects
Malfunction of the GABA system in the brain 
cause various neurological and psychiatric disorders, such as 
Huntington's chorea, involving reduction in levels of GABA in 
certain brain areas. Administration of a GABA-mimetic has 
been shown to bo effective in the treatment of some patients 
(Bartholini et al. 1978) but unsuccessful in others (Chase and 
Taminga 1978). Parkinson's Disease also involves a reduction 
in function in the substantia nigra (Lloyd et al. 1979)* 
Also malfunction of GABAergic neurones is thou^t to bo an 
important factor in epilepsy (Meldrum 1975) and schizophrenia
(Iverson ot al. 1978, Moldrum 1979).
Since the GABA antagonists do not exert their
actions at the same site as agonists they can bo of no use in 
evaluation or the clinical treatment of these dysfunctions.
They may however help in elucidation of the overall effects of 
the inhibitory GABA system especially as the distribution of 
GABA in the CBS varies and there may be different developments
of the system with ago.
The \aso of evaluation clinically is limited because 
of their potency in produoin« seizures and death in a wide 
range of species (Casida et al. 1976, Eto et al. 1976) does 
not detract from their usefulness as a pharmacological tool in 
the elucidation of the QABA receptor complex helping to 
characterize the specificity and efficacy between the different
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antagonistic sites of action; the bicyclic phosphates 
acting at the picrotoxin sensitive anion channel rather than 
the bicuculline sensitive site of action.
Conclusions
Althou^ the syntheses involving production of a 
hi^ly-branohsd, lipophillio substituent on the bridgehead 
of the bioyolio phosphate esters produced the predicted 
potencies in QABA. antagonism, other compounds possessing such 
groups need to be synthesised in order to give some more 
insist into the nature of the receptor of channel involved in 
the process. The theiyl compound which was ultimately not 
possible to synthesise at this time should have produced a 
very potent antagonist due to its shape and the lipophxllioity 
of this group. This work in collaboration with more research 
into the synthesis and evaluation of analogues of piorotoiinin 
and the silatranes would be very useful in order to compare the 
effects, site of action and potencies of these compounds.
Development of binding studies utilising the OABA 
system on different tissues would also prove invaluable in the 
study of antagonists. This done in conjunction with studies 
involving the radiolabelling of other antagonists such as the 
silatrsnes, bioyolooarbomyUtes end the bioyolio phosphate esters 
themselves would bring about major advances in the understanding 
of the interactions between the different types of antagonists
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and their sites of action involving the Q A M  receptor 
complex and its indirect actions, I see development of 
the study of QABA antagonists in these directions the 
most usefxil in the stniy for further understanding of 
the inhibitory actions of GABA,
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